
<html lang="en"     class="pb-page"  data-request-id="ba1a0095-9509-4c62-9914-e0d65a6065c6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-14;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01976"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases" /></meta><meta name="dc.Creator" content="Scott J.  Hecker" /></meta><meta name="dc.Creator" content="K. Raja  Reddy" /></meta><meta name="dc.Creator" content="Olga  Lomovskaya" /></meta><meta name="dc.Creator" content="David C.  Griffith" /></meta><meta name="dc.Creator" content="Debora  Rubio-Aparicio" /></meta><meta name="dc.Creator" content="Kirk  Nelson" /></meta><meta name="dc.Creator" content="Ruslan  Tsivkovski" /></meta><meta name="dc.Creator" content="Dongxu  Sun" /></meta><meta name="dc.Creator" content="Mojgan  Sabet" /></meta><meta name="dc.Creator" content="Ziad  Tarazi" /></meta><meta name="dc.Creator" content="Jonathan  Parkinson" /></meta><meta name="dc.Creator" content="Maxim  Totrov" /></meta><meta name="dc.Creator" content="Serge H.  Boyer" /></meta><meta name="dc.Creator" content="Tomasz W.  Glinka" /></meta><meta name="dc.Creator" content="Orville A.  Pemberton" /></meta><meta name="dc.Creator" content="Yu  Chen" /></meta><meta name="dc.Creator" content="Michael N.  Dudley" /></meta><meta name="dc.Description" content="Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme..." /></meta><meta name="Description" content="Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 9, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01976" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01976" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01976" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01976" /></link>
        
    
    

<title>Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01976" /></meta><meta property="og:title" content="Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0023.jpeg" /></meta><meta property="og:description" content="Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme NDM-1 of Enterobacteriaceae and the class D (OXA) enzymes of Acinetobacter baumannii. Continuing the boronic acid program that led to vaborbactam, efforts were directed toward expanding the spectrum to allow treatment of a wider range of organisms. Through key structural modifications of a bicyclic lead, stepwise gains in spectrum of inhibition were achieved, ultimately resulting in QPX7728 (35). This compound displays a remarkably broad spectrum of inhibition, including class B and class D enzymes, and is little affected by porin modifications and efflux. Compound 35 is a promising agent for use in combination with a β-lactam antibiotic for the treatment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous and oral administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01976"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01976">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01976&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01976&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01976&amp;href=/doi/10.1021/acs.jmedchem.9b01976" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 7491-7507</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00191" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c01000" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Scott J. Hecker</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott J. Hecker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (858) 500-8299. Email: <a href="/cdn-cgi/l/email-protection#73001b1610181601330203160b111a1c5d101c1e"><span class="__cf_email__" data-cfemail="5e2d363b3d353b2c1e2f2e3b263c3731703d3133">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott+J.++Hecker">Scott J. Hecker</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9082-1982" title="Orcid link">http://orcid.org/0000-0002-9082-1982</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">K. Raja Reddy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">K. Raja Reddy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=K.+Raja++Reddy">K. Raja Reddy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Olga Lomovskaya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Olga Lomovskaya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Lomovskaya">Olga Lomovskaya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David C. Griffith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David C. Griffith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Griffith">David C. Griffith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Debora Rubio-Aparicio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debora Rubio-Aparicio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debora++Rubio-Aparicio">Debora Rubio-Aparicio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kirk Nelson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirk Nelson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirk++Nelson">Kirk Nelson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruslan Tsivkovski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruslan Tsivkovski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruslan++Tsivkovski">Ruslan Tsivkovski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dongxu Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dongxu Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dongxu++Sun">Dongxu Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mojgan Sabet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mojgan Sabet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mojgan++Sabet">Mojgan Sabet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ziad Tarazi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ziad Tarazi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ziad++Tarazi">Ziad Tarazi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan Parkinson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Parkinson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Parkinson">Jonathan Parkinson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maxim Totrov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maxim Totrov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molsoft LLC, 11199 Sorrento Valley Road, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maxim++Totrov">Maxim Totrov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Serge H. Boyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Serge H. Boyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Serge+H.++Boyer">Serge H. Boyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomasz W. Glinka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomasz W. Glinka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomasz+W.++Glinka">Tomasz W. Glinka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Orville A. Pemberton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Orville A. Pemberton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Orville+A.++Pemberton">Orville A. Pemberton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Medicine, University of South Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu++Chen">Yu Chen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5115-3600" title="Orcid link">http://orcid.org/0000-0002-5115-3600</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Michael N. Dudley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael N. Dudley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Qpex Biopharma, Inc., 6275 Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+N.++Dudley">Michael N. Dudley</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01976&amp;href=/doi/10.1021%2Facs.jmedchem.9b01976" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 7491–7507</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 9, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2019</li><li><span class="item_label"><b>Published</b> online</span>9 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01976" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01976</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ec-1612971054143.svg" alt="ACS Editors’ Choice" /></img><span>ACS Editors’ Choice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01976"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">9737</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01976" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;J. Hecker&quot;},{&quot;first_name&quot;:&quot;K.&quot;,&quot;last_name&quot;:&quot;Raja Reddy&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Lomovskaya&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Griffith&quot;},{&quot;first_name&quot;:&quot;Debora&quot;,&quot;last_name&quot;:&quot;Rubio-Aparicio&quot;},{&quot;first_name&quot;:&quot;Kirk&quot;,&quot;last_name&quot;:&quot;Nelson&quot;},{&quot;first_name&quot;:&quot;Ruslan&quot;,&quot;last_name&quot;:&quot;Tsivkovski&quot;},{&quot;first_name&quot;:&quot;Dongxu&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Mojgan&quot;,&quot;last_name&quot;:&quot;Sabet&quot;},{&quot;first_name&quot;:&quot;Ziad&quot;,&quot;last_name&quot;:&quot;Tarazi&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Parkinson&quot;},{&quot;first_name&quot;:&quot;Maxim&quot;,&quot;last_name&quot;:&quot;Totrov&quot;},{&quot;first_name&quot;:&quot;Serge&quot;,&quot;last_name&quot;:&quot;H. Boyer&quot;},{&quot;first_name&quot;:&quot;Tomasz&quot;,&quot;last_name&quot;:&quot;W. Glinka&quot;},{&quot;first_name&quot;:&quot;Orville&quot;,&quot;last_name&quot;:&quot;A. Pemberton&quot;},{&quot;first_name&quot;:&quot;Yu&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;N. Dudley&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;7491-7507&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01976&quot;},&quot;abstract&quot;:&quot;Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme NDM-1 of Enterobacteriaceae and the class D (OXA) enzymes of Acinetobacter baumannii. Continuing the boronic acid program that led to vaborbactam, efforts were directed toward expanding the spectrum to allow treatment of a wider range of organisms. Through key structural modifications of a bicyclic lead, stepwise gains in spectrum of inhibition were achieved, ultimately resulting in QPX7728 (35). This compound displays a remarkably broad spectrum of inhibition, including class B and class D enzymes, and is little affected by porin modifications and efflux. Compound 35 is a promising agent for use in combination with a β-lactam antibiotic for the treatment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous and oral administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01976&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01976" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01976&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01976" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01976&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01976" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01976&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01976&amp;href=/doi/10.1021/acs.jmedchem.9b01976" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01976" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01976" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01976%26sid%3Dliteratum%253Aachs%26pmid%3D32150407%26genre%3Darticle%26aulast%3DHecker%26date%3D2020%26atitle%3DDiscovery%2Bof%2BCyclic%2BBoronic%2BAcid%2BQPX7728%252C%2Ban%2BUltrabroad-Spectrum%2BInhibitor%2Bof%2BSerine%2Band%2BMetallo-%25CE%25B2-lactamases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D14%26spage%3D7491%26epage%3D7507%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/jmcmar.2020.63.issue-14/20200723/jmcmar.2020.63.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Despite major advances in the β-lactamase inhibitor field, certain enzymes remain refractory to inhibition by agents recently introduced. Most important among these are the class B (metallo) enzyme NDM-1 of Enterobacteriaceae and the class D (OXA) enzymes of <i>Acinetobacter baumannii</i>. Continuing the boronic acid program that led to vaborbactam, efforts were directed toward expanding the spectrum to allow treatment of a wider range of organisms. Through key structural modifications of a bicyclic lead, stepwise gains in spectrum of inhibition were achieved, ultimately resulting in QPX7728 (<b>35</b>). This compound displays a remarkably broad spectrum of inhibition, including class B and class D enzymes, and is little affected by porin modifications and efflux. Compound <b>35</b> is a promising agent for use in combination with a β-lactam antibiotic for the treatment of a wide range of multidrug resistant Gram-negative bacterial infections, by both intravenous and oral administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It has now been several years since the scourge of carbapenem-resistant Enterobacteriaceae was recognized and the call was sounded for new agents by WHO and other public health authorities.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> β-Lactamase inhibitor (BLI) combination products have played a major role in the response, with FDA approvals awarded for avibactam (with ceftazidime, 2015),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> vaborbactam (with meropenem, 2017),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and relebactam (with imipenem–cilastatin, 2019)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). While these agents address the problem of class A serine carbapenemases such as KPC, they have no activity against metallo-β-lactamases such as NDM-1 and also have no activity against the problematic class D enzymes of <i>Acinetobacter baumannii</i>, such as OXA-23. Hence, there is an ongoing need for inhibitors showing a broader spectrum that captures these other types of β-lactamases. Current work in this area has been reviewed recently.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Recently introduced β-lactamase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">When our team first began synthesizing boronic acid inhibitors in 2009, many had doubts about whether it would be possible to achieve potent inhibition of both serine and metalloenzymes with a single compound. However, recent publications have described boronates with activity against some enzymes from both classes.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Herein we describe our own efforts to achieve broader spectrum, higher potency, and reduced susceptibility to uptake resistance mechanisms (porin modifications and efflux), resulting in discovery of QPX7728 (<b>35</b>), a remarkably potent and broad-spectrum inhibitor with potential for both intravenous and oral application.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60560" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60560" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Early Evolution of Bicyclic Boronate BLIs</h3><div class="NLM_p">The benzoxaborinine <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), first reported by researchers at the University of Toronto,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> has proven to be an extremely important lead structure in the β-lactamase inhibitor arena because of its broad spectrum of inhibition of serine β-lactamases. Early efforts to develop compounds included those by Protez Pharmaceuticals<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> and Rempex Pharmaceuticals,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> with RPX7009 (vaborbactam)<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> being the first inhibitor to enter the clinic and achieve regulatory approvals in the U.S. and EU. Other groups have recently entered other boronate BLIs into clinical development.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The benzoxaborinine β-lactamase inhibitors lead that started it all.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Effect of Substitution Ortho to the Carboxylate</h3><div class="NLM_p">Soon after vaborbactam was advanced into development, members of the team that discovered this agent began investigations into compounds related to benzoxaborinine <b>1</b>. Work by this team<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14,20)</a> and others<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a> explored a wide variety of acyl groups on the amine α to boron. As was observed in the vaborbactam discovery effort,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> this region is largely insensitive to modification, as potent, broad-spectrum activity is obtained with a wide variety of substituents. Conversely, little had been described with respect to substitution on the aromatic ring. Thus, our initial efforts were directed toward determining the effect of such substituents.</div><div class="NLM_p">One of the acylamido substituents conferring the best activity in this series was the methylthioacetamide; therefore, this substituent is selected for purposes of illustration of synthesis and SAR. Analogs were prepared by analogy to the methods shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. α-Chloroboronate <b>2</b> was obtained by Matteson reaction of its benzylboronate precursor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Displacement of the chlorine atom of <b>2</b> with inversion is effected with lithium hexamethyldisilazide and is followed by acylation with methylthioacetic acid, giving <b>3</b>. The protecting groups are removed by treatment with acid, affording analog <b>4a</b>.<named-content content-type="anchor" rid="fig3" type="simple"></named-content></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzoxaborinine <b>4a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Evaluation of a range of ortho-substituents against organisms expressing common enzymes of classes A and C is shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Potency is expressed as the amount of BLI needed to reduce the MIC of aztreonam to 4 μg/mL, a concentration that corresponds to a PK–PD breakpoint based on human dosing. (Aztreonam was selected as the β-lactam partner because, unlike carbapenems, it is hydrolyzed by all of these enzymes.) As with the <i>N</i>-acyl substituent, the effect of substitution ortho to the carboxylate on spectrum and potency of β-lactamase inhibition was relatively modest. There is a clear trend toward smaller substituents being preferred, but all compounds in this set show good potency (≤5 μg/mL) against most strains, including those with positively (<b>4f</b>) and negatively (<b>4i</b>) charged substituents. A detrimental effect of substitution is seen with the AmpC enzymes from <i>E. cloacae</i> and <i>P. aeruginosa.</i></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity of α-Methylthioacetamides <b>4a</b>–<b>l</b> Substituted Ortho to the Carboxylate<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0012.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: ATM, aztreonam.</p></div></div><div></div></div><div class="NLM_p">One of the issues that we had encountered with earlier unsubstituted analogs in this series was a propensity to form oligomers in solution. This phenomenon was observed by HPLC as longer retention time peaks whose mass corresponded to dimers, trimers, etc. The extent of formation was pH- and concentration-dependent. Such species were not observed with monocyclic BLIs such as vaborbactam. Although the structures were never formally characterized, we believed these to be of the type shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, as boronic acids are known to complex with salicylates.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Representative chromatograms, LC–MS data, and tentative structural assignments are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf" class="ext-link">Supporting Information</a>. While we believed these issues were manageable, we envisioned that the formation of such species in an intravenous dosage form would complicate the toxicological qualification of impurities to enable human administration.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative structures of dimer <b>5a</b> and trimer <b>5b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon synthesis of ortho-substituted analogs, we quickly learned that the presence of an ortho-substituent markedly reduces the extent of oligomer formation. The extent of oligomerization was evaluated by HPLC–UV at various concentrations at pH 7.8 and is expressed as area % of monomer (the desired form). As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compounds lacking an ortho substituent exhibited a concentration-dependent decrease in monomer content, whereas compounds with an ortho substituent had a much-reduced tendency to undergo oligomerization, even at higher concentrations.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Monomer Content at pH 7.8 ± 0.2 at 1, 10, and 100 mg/mL Concentrations</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0013.gif" alt="" id="GRAPHIC-d7e547-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">% monomer (HPLC, 220 nm)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">1 mg/mL</th><th class="colsep0 rowsep0" align="center" char=".">10 mg/mL</th><th class="colsep0 rowsep0" align="center" char=".">100 mg/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">72.1</td><td class="colsep0 rowsep0" align="char" char=".">43.0</td><td class="colsep0 rowsep0" align="char" char=".">14.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">98.0</td><td class="colsep0 rowsep0" align="char" char=".">97.5</td><td class="colsep0 rowsep0" align="char" char=".">96.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">98.2</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td><td class="colsep0 rowsep0" align="char" char=".">96.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">80.0</td><td class="colsep0 rowsep0" align="char" char=".">37.0</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4n</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">94.6</td><td class="colsep0 rowsep0" align="char" char=".">93.5</td><td class="colsep0 rowsep0" align="char" char=".">87.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td><td class="colsep0 rowsep0" align="char" char=".">98.6</td><td class="colsep0 rowsep0" align="char" char=".">67.0</td></tr></tbody></table></div></div><div class="NLM_p">Another benefit of substitution ortho to the carboxylate concerned the extent to which the MIC in <i>P. aeruginosa</i> was affected by the MexAB-OprM efflux pump. To evaluate the impact of substitution in this region on efflux, the plasmid expressing the gene encoding the KPC-2 carbapenemase was introduced into two isogenic strains of <i>P. aeruginosa</i>, PAM1032 and PAM1154, that overexpressed or lacked MexAB-OprM, respectively. Biapenem is not affected by efflux in <i>P. aeruginosa</i>, and both strains had the same biapenem MIC of 32 μg/mL due to the expression of KPC-2. The potency of BLIs in potentiation of biapenem in these strains was determined. Potency was defined as the minimum concentration of BLI needed to decrease the MIC of biapenem 64-fold, from 32 μg/mL to 0.5 μg/mL, or minimum potentiating concentration (MPC<sub>64</sub>). The efflux index (EI) for each BLI was defined as the ratio of MPC<sub>64</sub> values in PAM1032/KPC-2 (efflux proficient) and PAM1154/KPC-2 (efflux deficient).</div><div class="NLM_p"><a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> shows MPC<sub>64</sub> and EI values for selected analogs. A modest but consistent trend is observed wherein the impact of efflux is reduced by the presence of a methoxy or fluoro substituent. Interestingly, a hydroxy substituent (<b>4d</b>) does not offer this benefit. It is also noteworthy that incorporation of a basic group on the acylamido substituent (<b>4p</b>–<b>r</b>) completely removes the impact of efflux, even when no ortho substituent is present.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. MexAB-OprM Dependent Efflux of BLIs from <i>P. aeruginosa</i></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0014.gif" alt="" id="GRAPHIC-d7e692-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">PAM1032/KPC-2</th><th class="colsep0 rowsep0" align="center">PAM1154/KPC-2</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">biapenem MPC<sub>64</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center">biapenem MPC<sub>64</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center">EI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4n</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4o</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4p</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4q</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4r</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> α-Thio Analogs with Much Improved Metallo Activity</h3><div class="NLM_p">While in this compound series the potent inhibition of a broad spectrum of serine β-lactamases was well-established, activity against metalloenzymes (class B) had not been reported at that time. Our modeling studies suggested that members of this series would be capable of binding in the active site of metallo-β-lactamases such as NDM-1. Compounds were therefore evaluated in biochemical and microbiological assays to determine the extent of inhibition of this enzyme. Indeed, compound <b>4s</b>, in addition to being a potent inhibitor of the serine carbapenemases KPC-2 (class A) and OXA-48 (class D), demonstrated modest inhibition of NDM-1 (class B) with a <i>K</i><sub>i</sub> of 7.4 μM (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Whole-cell activity against NDM-1 producing strains, however, was lacking.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biochemical and Whole-Cell Activity of Compounds <b>4s</b> and <b>6a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0015.gif" alt="" id="GRAPHIC-d7e881-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="."><i>K</i><sub>i</sub> (μM) of inhibition of purified enzyme with indicated substrates</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">concentration of BLI (μg/mL) to decrease MIC to biapenem to 1 μg/mL</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">KPC-2</th><th class="colsep0 rowsep0" align="center" char=".">OXA-48</th><th class="colsep0 rowsep0" align="center" char=".">NDM-1</th><th class="colsep0 rowsep0" align="center" char=".">KPC-2</th><th class="colsep0 rowsep0" align="center" char=".">OXA-48</th><th class="colsep0 rowsep0" align="center" char=".">NDM-1</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">BLI</th><th class="colsep0 rowsep0" align="center" char=".">nitrocefin</th><th class="colsep0 rowsep0" align="center" char=".">nitrocefin</th><th class="colsep0 rowsep0" align="center" char=".">imipenem</th><th class="colsep0 rowsep0" align="center" char=".">KP1004</th><th class="colsep0 rowsep0" align="center" char=".">KP1086</th><th class="colsep0 rowsep0" align="center" char=".">KP1081</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">avibactam</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">>80</td><td class="colsep0 rowsep0" align="char" char=".">≤0.04</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4s</b></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.0005</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">0.0014</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td></tr></tbody></table></div></div><div class="NLM_p">In parallel with pursuit of the above series, one of our chemists prepared sulfur-linked compound <b>6a</b>, in part because it was easily accessible from the α-chloroboronate intermediate being used to make amide-linked analogs. These efforts resulted in a 300-fold improvement in potency against NDM-1 (<i>K</i><sub>i</sub> = 0.024 μM). Importantly, in whole cells this compound at a concentration of 0.6 μg/mL restored susceptibility to biapenem of an NDM-1 producing strain of <i>K. pneumoniae</i> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The potency of compound <b>6a</b> was not affected by increasing concentrations of zinc (up to 0.6 mM), suggesting a mechanism other than zinc chelation or competition with zinc for binding to the protein. Importantly, this compound did not inhibit any members of a panel of human metalloproteases. Recently, other reports have appeared on observations of metallo activity with certain acylamido analogs.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a></div><div class="NLM_p">On the basis of the observations above, an optimization program was initiated around sulfur- and oxygen-linked analogs. Initial efforts in this series were conducted in the series with no substituent ortho to the carboxylate, with the intention of optimizing that substituent later. Compounds <b>6a</b>–<b>r</b> were obtained by reaction of chloroboronate <b>2</b> with the appropriate nucleophile, followed by deprotection (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Displacement by sulfur nucleophiles was straightforward, whereas displacement by oxygen nucleophiles failed in most cases; thus, only two examples are shown.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>6a</b>–<b>r</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, activity is expressed as the minimum concentration of BLI needed to reduce the MIC of a specified β-lactam (β-L) to the concentration that corresponds to the PK–PD breakpoint for that β-lactam based on human dosing (potentiation target value, PTV). Since aztreonam is stable to metallo-β-lactamases, biapenem was selected as the partner β-lactam for evaluation of inhibition of NDM-1 and VIM-1. Analog selection was influenced by a desire to maintain small size and incorporate noncharged polarity, as these features were generally associated with better uptake (as measured by the ratio of MIC to IC<sub>50</sub>; data not shown). Simple substituents like methylthio (<b>6b</b>) and methoxy (<b>6c</b>) were among the first to be made and have some of the best potency. These compounds had good activity against carbapenemases (KPC, NDM, and VIM) but had poor activity against important cephalosporinases (CTX-M, SHV, TEM). Simple uncharged substituents (<b>6d</b>–<b>e</b>) had a similar profile to <b>6b</b> and <b>6c</b>, whereas basic groups were variable (<b>6f</b> vs <b>6g</b>). Among nitrogen-containing heterocyclic analogs, activity varied widely depending on the location of the nitrogen atoms. Most analogs retained activity against the metalloenzymes (NDM, VIM) with the exception of imidazole-2-ylthio <b>6l</b> and pyrid-2-ylthio <b>6m</b>; perhaps this is due to the interaction of a nucleophilic nitrogen with the boron atom. In this heteroarylthio series, activity against KPC was only observed with <i>N</i>-aminotriazolylthio analog <b>6k</b> and aminothiadiazolylthio <b>6q</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Activity of <b>6a</b>–<b>r</b> with Oxygen- and Sulfur-Linked Substituents α to Boron<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0016.gif" alt="" id="GRAPHIC-d7e1105-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: β-L, β-lactam; PTV, potentiation target value; ATM, aztreonam; BP, biapenem.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Ortho-Substitution and Oral Bioavailability</h3><div class="NLM_p">In addition to potent, broad-spectrum activity, one of our objectives was to achieve suitable properties for oral administration. Of the analogs in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, we selected thiadiazole <b>6a</b> as the basis for further optimization of the substituent ortho to the carboxylate, since it displayed a balanced spectrum and did not contain an additional H-bond donor (which would likely hamper oral absorption). <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> shows the results of a series of small ortho-substituents <b>7a</b>–<b>k</b>. These compounds were prepared in a manner analogous to that used for compounds <b>6</b>, starting with the appropriate substituted benzoic acid.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Activity of Thiadiazolylthio Analogs <b>7</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0017.gif" alt="" id="GRAPHIC-d7e1147-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: β-L, β-lactam; PTV, potentiation target value; ATM, aztreonam; MP, meropenem; BP, biapenem.</p></div></div><div></div></div><div class="NLM_p">As was seen in the amide series (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), the best activity was observed with the small substituents methoxy (<b>7a</b>) and fluoro (<b>7b</b>). The benefit of this substituent (relative to unsubstituted analog <b>6a</b>) was apparent in all strains tested. With larger substituents, the benefit was greatly reduced or absent, particularly with respect to class A serine enzymes. Interestingly, activity against the metalloenzymes (class B) was less affected by the size of this substituent, and in fact activity against IMP-26 was significantly improved with the larger substituents in <b>7g</b>–<b>k</b>.</div><div class="NLM_p">Of the various substituted analogs <b>7</b>, ortho-methoxy analog <b>7a</b> displayed the best overall activity against Enterobacteriaceae; however, its oral bioavailability was poor (<5%). Given the presence of a carboxylic acid handle, prodrugs were investigated. In practice, it proved to be straightforward to obtain compounds displaying high oral bioavailability in the rat. These prodrugs were prepared in a single step by alkylation of the carboxylic acid under basic conditions. <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> shows the results of five prodrugs; double esters <b>8b</b> and <b>8c</b>, as well as carbonate <b>8d</b>, gave essentially quantitative oral bioavailability.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Oral Bioavailability of Prodrugs of <b>7a</b> in the Rat</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0018.gif" alt="" id="GRAPHIC-d7e1207-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0019.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Based on AUC relative to iv dosing of <b>7a</b>; 50–75 mg/kg dose.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Removal of the Substituent Next to Boron</h3><div class="NLM_p">To further broaden the scope of our findings, we sought to replace the methoxy-bearing carbon atom of <b>7a</b> with a nitrogen atom. As the synthesis of this target (<b>9</b>) was expected to be challenging, we began with a model system lacking the substituent next to boron. The synthesis of this compound (<b>16</b>) is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Saponification of methyl 3-benzyloxy-4-bromo-2-pyridinecarboxylate (<b>10</b>) followed by re-esterification affords <i>tert</i>-butyl ester <b>12</b>. Palladium-catalyzed installation of the vinyl group using potassium vinyltrifluoroborate affords <b>13</b>, which is subjected to iridium-catalyzed hydroboration to give boronate <b>14</b>. Hydrogenolysis of the benzyl group gives ester <b>15</b>; the <i>tert</i>-butyl ester was then hydrolyzed using TFA in triethylsilane. The crude product <b>16</b> was purified first as the free acid and then was converted to the sodium salt for repurification.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon successful synthesis of <b>16</b>, we observed far better activity than was expected, given the lack of a substituent thought to be required for potent inhibition. We immediately sought to capitalize on our previous observations that the fluoro and methoxy substituents generally afforded the best activity in the benzo series. The syntheses of these compounds are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf" class="ext-link">Supporting Information</a>.<named-content content-type="anchor" rid="fig4" type="simple"></named-content></div><div class="NLM_p">Results of microbiological testing of these compounds (<b>17b</b>,<b>c</b>), as well as the ortho-unsubstituted analog (<b>17a</b>), are shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>, in which the best performing compounds from earlier series (<b>4b</b> and <b>7a</b>) are included for comparison. The benefit of the ortho substituent (<b>17b</b>,<b>c</b> vs <b>17a</b>) is readily apparent in many (but not all) isolates. Compounds <b>17b</b> and <b>17c</b> display excellent potency against the class A and class C enzymes, and in addition these analogs show remarkable activity against the difficult class D (OXA-23, OXA-72) enzymes of <i>Acinetobacter baumannii</i>. Further, <b>17b</b> retains excellent activity against the class B (metallo) enzymes NDM-1 and VIM-2, with the only remaining deficiency being the metalloenzyme IMP-26.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Activity of Compounds Unsubstituted Next to Boron<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0020.gif" alt="" id="GRAPHIC-d7e1331-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">minimum concentration (μg/mL) of BLI needed to reduce the MIC of β-L to PTV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">BL</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">β-L</th><th class="colsep0 rowsep0" align="center">β-L alone</th><th class="colsep0 rowsep0" align="center">PTV</th><th class="colsep0 rowsep0" align="center"><b>4b</b></th><th class="colsep0 rowsep0" align="center"><b>7a</b></th><th class="colsep0 rowsep0" align="center"><b>16</b></th><th class="colsep0 rowsep0" align="center"><b>17a</b></th><th class="colsep0 rowsep0" align="center"><b>17b</b></th><th class="colsep0 rowsep0" align="center"><b>17c</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1009</td><td class="colsep0 rowsep0" align="left">CTX-M-15</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">ECM6625</td><td class="colsep0 rowsep0" align="left">SHV-5</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">ECM6619</td><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1004</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i></td><td class="colsep0 rowsep0" align="left">ECL1002</td><td class="colsep0 rowsep0" align="left">chAmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">PAM 2035</td><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1053</td><td class="colsep0 rowsep0" align="left">OXA-72</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1054</td><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1160</td><td class="colsep0 rowsep0" align="left">IMP-26</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1081</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1054</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: β-L, β-lactam; PTV, potentiation target value; ATM, aztreonam; MP, meropenem; BP, biapenem.</p></div></div></div><div class="NLM_p">Compound <b>17b</b> was advanced to further evaluation and displayed an excellent PK profile in the rat, including 50% oral bioavailability. Further evaluation in the dog and monkey, however, revealed significant oxidative deboronation to afford the long-lived metabolite <b>18</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The extremely slow clearance of <b>18</b> was attributed to high serum protein binding (approaching 100%). The generation of a substantial level of a long-lived metabolite was viewed as a development risk, and further efforts to advance <b>17b</b> into development were suspended.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oxidative deboronation of <b>17b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> SAR of Analogs Designed to Address the Metabolic Liability of <b>17b</b></h3><div class="NLM_p">In order to block the oxidative deboronation of <b>17b</b>, we sought to introduce steric congestion or alter the electronic environment close to the boronic acid moiety. The results of testing several analogs are shown in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. Unfortunately, in most cases modification resulted in a significant loss of potency and/or spectrum of inhibition. However, fused-cyclopropyl analog <b>25</b> (racemic) represented a notable exception, retaining essentially all of the activity of <b>17b</b>. This analog was immediately tested for metabolite formation, and it was shown to be far more stable to metabolic oxidation.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Analogs of <b>17b</b> Designed to Block Oxidative Deboronation<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0021.gif" alt="" id="GRAPHIC-d7e1799-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">minimum concentration (μg/mL) of BLI needed to reduce the MIC of β-L to PTV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">BL</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">β-L</th><th class="colsep0 rowsep0" align="center">β-L alone</th><th class="colsep0 rowsep0" align="center">PTV</th><th class="colsep0 rowsep0" align="center"><b>19</b></th><th class="colsep0 rowsep0" align="center"><b>20</b></th><th class="colsep0 rowsep0" align="center"><b>21</b></th><th class="colsep0 rowsep0" align="center"><b>22</b></th><th class="colsep0 rowsep0" align="center"><b>23</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1009</td><td class="colsep0 rowsep0" align="left">CTX-M-15</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">KP308</td><td class="colsep0 rowsep0" align="left">SHV-5</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">EC302</td><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1004</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i></td><td class="colsep0 rowsep0" align="left">ECL1002</td><td class="colsep0 rowsep0" align="left">chAmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">PAM 2035</td><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1053</td><td class="colsep0 rowsep0" align="left">OXA-72</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1054</td><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1160</td><td class="colsep0 rowsep0" align="left">IMP-26</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1081</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1054</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>20</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">minimum concentration (μg/mL) of BLI needed to reduce the MIC of β-L to PTV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">BL</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">β-L</th><th class="colsep0 rowsep0" align="center">β-L alone</th><th class="colsep0 rowsep0" align="center">PTV</th><th class="colsep0 rowsep0" align="center"><b>24</b></th><th class="colsep0 rowsep0" align="center"><b>25</b></th><th class="colsep0 rowsep0" align="center"><b>26</b></th><th class="colsep0 rowsep0" align="center"><b>27</b></th><th class="colsep0 rowsep0" align="center"><b>28</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1009</td><td class="colsep0 rowsep0" align="left">CTX-M-15</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">KP308</td><td class="colsep0 rowsep0" align="left">SHV-5</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">EC302</td><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1004</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i></td><td class="colsep0 rowsep0" align="left">ECL1002</td><td class="colsep0 rowsep0" align="left">chAmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">PAM 2035</td><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1053</td><td class="colsep0 rowsep0" align="left">OXA-72</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1054</td><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1160</td><td class="colsep0 rowsep0" align="left">IMP-26</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1081</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1054</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: β-L, β-lactam; PTV, potentiation target value; ATM, aztreonam; MP, meropenem; BP, biapenem.</p></div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Optimization of Cyclopropyl Analogs</h3><div class="NLM_p">Buoyed by these findings, we sought to prepare several close-in cyclopropyl analogs; the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>. Of the two enantiomers <b>29</b> and <b>30</b> of compound <b>25</b>, the one with the cyclopropyl group “down” as drawn (<b>30</b>) was consistently more potent. The same preference was observed with other substituents <i>ortho</i> to the carboxylate, including H (<b>32</b> vs <b>31</b>), F (<b>35</b> vs <b>34</b>), and replacement of the benzene ring by pyridine (<b>37</b> vs <b>36</b>). Overall, the best overall activity was observed with compounds <b>30</b> and <b>35</b>. Of the two, <b>35</b> (QPX7728) was preferred due to having lower human protein binding (89% vs 96%).<named-content content-type="anchor" rid="sch4" type="simple"></named-content></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Optimization of Cyclopropyl Analogs<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0022.gif" alt="" id="GRAPHIC-d7e2618-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">minimum concentration (μg/mL) of BLI needed to reduce the MIC of β-L to PTV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">BL</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">β-L</th><th class="colsep0 rowsep0" align="center">β-L alone</th><th class="colsep0 rowsep0" align="center">PTV</th><th class="colsep0 rowsep0" align="center"><b>29</b></th><th class="colsep0 rowsep0" align="center"><b>30</b></th><th class="colsep0 rowsep0" align="center"><b>31</b></th><th class="colsep0 rowsep0" align="center"><b>32</b></th><th class="colsep0 rowsep0" align="center"><b>33</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1009</td><td class="colsep0 rowsep0" align="left">CTX-M-15</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">KP308</td><td class="colsep0 rowsep0" align="left">SHV-5</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">EC302</td><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1004</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i></td><td class="colsep0 rowsep0" align="left">ECL1002</td><td class="colsep0 rowsep0" align="left">chAmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">PAM 2035</td><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1053</td><td class="colsep0 rowsep0" align="left">OXA-72</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1054</td><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1160</td><td class="colsep0 rowsep0" align="left">IMP-26</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1081</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1054</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">10</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">minimum concentration (μg/mL) of BLI needed to reduce the MIC of β-L to PTV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">BL</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">β-L</th><th class="colsep0 rowsep0" align="center">β-L alone</th><th class="colsep0 rowsep0" align="center">PTV</th><th class="colsep0 rowsep0" align="center"><b>34</b></th><th class="colsep0 rowsep0" align="center"><b>35</b></th><th class="colsep0 rowsep0" align="center"><b>36</b></th><th class="colsep0 rowsep0" align="center"><b>37</b></th><th class="colsep0 rowsep0" align="center"><b>38</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1009</td><td class="colsep0 rowsep0" align="left">CTX-M-15</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">KP308</td><td class="colsep0 rowsep0" align="left">SHV-5</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. coli</i></td><td class="colsep0 rowsep0" align="left">EC302</td><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1004</td><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">>128</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>E. cloacae</i></td><td class="colsep0 rowsep0" align="left">ECL1002</td><td class="colsep0 rowsep0" align="left">chAmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="left">PAM 2035</td><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">ATM</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1053</td><td class="colsep0 rowsep0" align="left">OXA-72</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>A. baumannii</i></td><td class="colsep0 rowsep0" align="left">AB1054</td><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1160</td><td class="colsep0 rowsep0" align="left">IMP-26</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">MP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1081</td><td class="colsep0 rowsep0" align="left">NDM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K. pneumoniae</i></td><td class="colsep0 rowsep0" align="left">KP1054</td><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">BP</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">>20</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">0.3</td><td class="colsep0 rowsep0" align="left">0.16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: β-L, β-lactam; PTV, potentiation target value; ATM, aztreonam; MP, meropenem; BP, biapenem.</p></div></div></div><div class="NLM_p">The synthesis of compound <b>35</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. 2-Bromo-5-fluorophenol (<b>39</b>) is converted to <i>tert</i>-butylcarbonate <b>40</b>; treatment with LDA effects deprotonation and acyl transfer, after which the resulting phenol is reprotected, giving <b>41</b>. The two protecting groups are replaced with a single acetonide in <b>42</b>, which is then subjected to a Heck reaction to introduce the acrylate side chain, giving <b>43</b>. Bromination is followed by decarboxylative elimination to afford <i>cis</i>-vinyl bromide <b>44</b>. Palladium-mediated borylation with the (+)-pinanediol ester of tetrahydroxydiboron affords <i>cis</i>-vinylboronate <b>45</b>, which is subjected to palladium-catalyzed cyclopropanation with diazomethane to afford <b>46</b>. Separation of the two diastereomers by HPLC is followed by sequential hydrolysis of the acetonide and pinanediol protecting groups. Single-crystal X-ray structure determination of the diastereomer of <b>46</b> leading to the more active final product allowed assignment of the cyclopropane stereochemistry as that shown in <b>35</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Structural Biology of Compound <b>35</b></h3><div class="NLM_p">The complex crystal structures of <b>35</b> with KPC-2, NDM-1, OXA-48, and VIM-2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) were obtained through soaking and cocrystallization experiments (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). In the serine enzymes KPC-2 and OXA-48, the catalytic serine residue is covalently bound to the boron atom of the inhibitor. In the metalloenzymes NDM-1 and VIM-2, the catalytic water molecule is covalently bound to the boron atom. The conformation of <b>35</b> is nearly identical in the various structures, with the exception of the carboxylate moiety which is nearly coplanar in the metalloenzymes and closer to orthogonal in the serine enzymes. While the polar interactions vary from one structure to another, in all cases the hydrophobic region of <b>35</b> is packed against lipophilic (predominantly aromatic) side chains.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High resolution structures of <b>35</b> with multiple enzymes. Hydrogen atoms were added using ICM-Pro (Molsoft, San Diego). Accession codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J">6V1J</a> (KPC-2:<b>35</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M">6V1M</a> (NDM-1:<b>35</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O">6V1O</a> (OXA-48:<b>35</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P">6V1P</a> (VIM-2:<b>35</b>)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Biochemical Evaluation</h3><div class="NLM_p">QPX7728 displays “slow-binding” kinetics with serine β-lactamases, whereas it exhibits “fast on–fast off” kinetics with metalloenzymes.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(26)</a> Inhibition constants (<i>K</i><sub>i</sub>) for various β-lactamases purified from overexpressing recombinant <i>E. coli</i> strains, using nitrocefin (NCF) or imipenem (IMI) as substrate, are shown in <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>. <i>K</i><sub>i</sub> values were <100 nM for all enzymes except IMP-1. Compound <b>35</b> was clearly superior to the comparators vaborbactam and avibactam against the class D enzymes OXA-48 and OXA-23 of <i>Acinetobacter baumannii</i> and against the class B metalloenzymes NDM-1, VIM-1, and IMP-1.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. <i>K</i><sub>i</sub> Values (in μM) of β-Lactamase Inhibition by <b>35</b>, Vaborbactam, and Avibactam<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center"><b>35</b></th><th class="colsep0 rowsep0" align="center">vaborbactam</th><th class="colsep0 rowsep0" align="center">avibactam</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTX-M-14</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">0.00029 ± 0.00006</td><td class="colsep0 rowsep0" align="left">0.033 ± 0.013</td><td class="colsep0 rowsep0" align="left">0.00041 ± 0.00013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TEM-10</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">0.00066 ± 0.00023</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.014</td><td class="colsep0 rowsep0" align="left">0.0014 ± 0.0004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SHV-12</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">0.00074 ± 0.00021</td><td class="colsep0 rowsep0" align="left">0.021 ± 0.004</td><td class="colsep0 rowsep0" align="left">0.00027 ± 0.00011</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KPC-2</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">0.0019 ± 0.0010</td><td class="colsep0 rowsep0" align="left">0.056 ± 0.015</td><td class="colsep0 rowsep0" align="left">0.011 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AmpC</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">0.0085 ± 0.0024</td><td class="colsep0 rowsep0" align="left">0.035 ± 0.015</td><td class="colsep0 rowsep0" align="left">0.010 ± 0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OXA-48</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">0.00028 ± 0.00015</td><td class="colsep0 rowsep0" align="left">14 ± 5</td><td class="colsep0 rowsep0" align="left">0.027 ± 0.015</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OXA-23</td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="left">0.00074 ± 0.00028</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VIM-1</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">0.0080 ± 0.0035</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NDM-1<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">0.032 ± 0.014</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IMP-1<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.05</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">>40</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub> values were measured with imipenem as substrate.</p></div></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Microbiology</h3><div class="NLM_p">Compound <b>35</b> (at a fixed concentration of 8 μg/mL) was evaluated in combination with cefepime, ceftolozane, and meropenem against panels of Enterobacterales, including <i>Klebsiella pneumoniae</i> (<i>n</i> = 511), <i>E. coli</i> (<i>n</i> = 297), <i>Enterobacter cloacae</i> complex (<i>n</i> = 88), and other organisms (<i>n</i> = 119); of these, 507 isolates expressed ESBL enzymes and 508 were carbapenem-resistant isolates. Compound <b>35</b> was also tested against carbapenem-resistant <i>Acinetobacter baumannii</i> (<i>n</i> = 503) and <i>Pseudomonas aeruginosa</i> (<i>n</i> = 500). The MIC<sub>50</sub>/MIC<sub>90</sub> values are shown in <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a></a>. Comparative data with the marketed agents ceftazidime–avibactam and meropenem–vaborbactam are also shown. All three combinations with <b>35</b> were highly effective against Enterobacterales producing ESBLs as well as strains expressing the KPC and OXA-48 carbapenemases. In strains expressing metalloenzymes (NDM and VIM), cefepime and meropenem potencies were enhanced to MIC<sub>90</sub> values of 1 and 2 μg/mL, respectively, whereas ceftolozane achieved little benefit. This is attributed to a high ceftolozane hydrolyzing activity of MBLs combined with a lower (compared to serine enzymes) inhibition of MBLs by <b>35</b>. Against carbapenem-resistant <i>A. baumannii</i>, only meropenem potency was adequately enhanced, whereas against <i>P. aeruginosa</i>, all three combinations achieved an MIC<sub>90</sub> ≤ 8 μg/mL. Studies in strains overexpressing and/or deficient in efflux pumps and porin modifications showed that <b>35</b> is largely unaffected by these common resistance mechanisms (data not shown). Interestingly, <b>35</b> displays weak antibacterial activity of its own, with a modal MIC of 16 μg/mL against Enterobacterales (range of <1 to ≥32 μg/mL); in general this activity is at much higher concentration than the potentiated MICs and therefore is unlikely to be a major contributor to the activity of the combinations. Overall, the results of these studies demonstrate the broad utility of <b>35</b> and that there may be benefit to more than one combination being available to the clinician.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Minimum Inhibitory Concentrations of β-Lactam Antibiotics Alone and in the Presence of Compound <b>35</b> (8 μg/mL)<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="8" align="center">MIC<sub>50/90</sub> (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">organism</th><th class="colsep0 rowsep0" align="center" char=".">no. of strains</th><th class="colsep0 rowsep0" align="center">CPM</th><th class="colsep0 rowsep0" align="center">CPM-<b>35</b></th><th class="colsep0 rowsep0" align="center">CTLZN</th><th class="colsep0 rowsep0" align="center">CTLZN-<b>35</b></th><th class="colsep0 rowsep0" align="center">MP</th><th class="colsep0 rowsep0" align="center">MP-<b>35</b></th><th class="colsep0 rowsep0" align="center">CTZDM-AVI</th><th class="colsep0 rowsep0" align="center">MP-VAB</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">all Enterobacterales</td><td class="colsep0 rowsep0" align="center" char=".">1015</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/0.25</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">0.125/8</td><td class="colsep0 rowsep0" align="center">1/>32</td><td class="colsep0 rowsep0" align="center">≤0.015/0.125</td><td class="colsep0 rowsep0" align="center">0.5/>32</td><td class="colsep0 rowsep0" align="center">0.06/>32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">ESBLs (no CRE)<a class="ref internalNav" href="#t12fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" char=".">507</td><td class="colsep0 rowsep0" align="center">16/32</td><td class="colsep0 rowsep0" align="center">≤0.015/0.0.03</td><td class="colsep0 rowsep0" align="center">8/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/0.25</td><td class="colsep0 rowsep0" align="center">0.03/0.125</td><td class="colsep0 rowsep0" align="center">0.015/0.03</td><td class="colsep0 rowsep0" align="center">0.125/0.5</td><td class="colsep0 rowsep0" align="center">0.03/0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">CRE KPC</td><td class="colsep0 rowsep0" align="center" char=".">157</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/0.25</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.125/0.5</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/0.125</td><td class="colsep0 rowsep0" align="center">1/4</td><td class="colsep0 rowsep0" align="center">0.06/2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">CRE OXA-48</td><td class="colsep0 rowsep0" align="center" char=".">150</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.125/0.5</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.25/0.5</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/0.125</td><td class="colsep0 rowsep0" align="center">0.5/1</td><td class="colsep0 rowsep0" align="center">16/>32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">non-CP CRE<a class="ref internalNav" href="#t12fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center" char=".">51</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.125/0.5</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.125/1</td><td class="colsep0 rowsep0" align="center">8/16</td><td class="colsep0 rowsep0" align="center">0.125/0.25</td><td class="colsep0 rowsep0" align="center">1/2</td><td class="colsep0 rowsep0" align="center">1/4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">CRE MBL (NDM, VIM)</td><td class="colsep0 rowsep0" align="center" char=".">150</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">≤0.06/1</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">16/>32</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">≤0.015/2</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">>32/>32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">CR <i>A. baumannii</i></td><td class="colsep0 rowsep0" align="center" char=".">503</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">16/32</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">8/32</td><td class="colsep0 rowsep0" align="center">>32/>32</td><td class="colsep0 rowsep0" align="center">0.5/4</td><td class="colsep0 rowsep0" align="center">32/>32</td><td class="colsep0 rowsep0" align="center">32/>32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><i>P. aeruginosa</i></td><td class="colsep0 rowsep0" align="center" char=".">500</td><td class="colsep0 rowsep0" align="center">4/32</td><td class="colsep0 rowsep0" align="center">2/8</td><td class="colsep0 rowsep0" align="center">0.5/4</td><td class="colsep0 rowsep0" align="center">0.5/1</td><td class="colsep0 rowsep0" align="center">0.5/16</td><td class="colsep0 rowsep0" align="center">0.25/8</td><td class="colsep0 rowsep0" align="center">2/4</td><td class="colsep0 rowsep0" align="center">0.5/16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: CPM, cefepime; CR, carbapenem-resistant; CTLZN, ceftolozane; MP, meropenem; CTZDM-AVI, ceftazidime–avibactam; MP-VAB, meropenem–vaborbactam.</p></div><div class="footnote" id="t12fn2"><sup><sup>b</sup></sup><p class="last">Strains that do not produce carbapenem hydrolyzing enzymes.</p></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Selectivity of Protease Inhibition</h3><div class="NLM_p">Compound <b>35</b> was evaluated against a panel of common mammalian serine and metalloproteases at concentrations up to 1000 μM. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a></a>, only one enzyme had an IC<sub>50</sub> below 100 μM, cathepsin A. The significance of the activity of <b>35</b> on this target has yet to be determined.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. IC<sub>50</sub> Values (μM) for Inhibition of Mammalian Proteases by <b>35</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protease</th><th class="colsep0 rowsep0" align="center">type</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub>, μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymotrypsin</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thrombin</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neutrophil elastase</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">132</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">trypsin</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasmin</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">elastase</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">urokinase</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymase</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPP7</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPP8</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DPP9</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsin G</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">666</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsin A</td><td class="colsep0 rowsep0" align="left">serine</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ECE-1</td><td class="colsep0 rowsep0" align="left">metallo</td><td class="colsep0 rowsep0" align="left">431</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACE-2</td><td class="colsep0 rowsep0" align="left">metallo</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-1</td><td class="colsep0 rowsep0" align="left">metallo</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-9</td><td class="colsep0 rowsep0" align="left">metallo</td><td class="colsep0 rowsep0" align="left">>1000</td></tr></tbody></table></div></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Pharmacokinetics</h3><div class="NLM_p">The pharmacokinetics of compound <b>35</b> by intravenous (iv) and oral (po) administration were evaluated in the rat at multiple doses (<a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a></a>). The systemic exposure by iv administration, as shown by the <i>C</i><sub>max</sub> and AUC values, increased in a dose proportional manner. Overall the parameters are similar to those of most β-lactam antibiotics, evidencing high <i>C</i><sub>max</sub> and AUC, short half-life, and low volume of distribution. Plasma protein binding in the rat is 85%.</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Pharmacokinetics of <b>35</b> in Rats Following Intravenous and Oral Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">AUC (mg·h/L)</th><th class="colsep0 rowsep0" align="center">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (mg/L)</th><th class="colsep0 rowsep0" align="center">half-life (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">35.2 ± 8.2</td><td class="colsep0 rowsep0" align="left">0.29 ± 0.06</td><td class="colsep0 rowsep0" align="left">26.1 ± 3.5</td><td class="colsep0 rowsep0" align="left">1.25 ± 0.36</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">221.0 ± 46.7</td><td class="colsep0 rowsep0" align="left">0.47 ± 0.16</td><td class="colsep0 rowsep0" align="left">208.3 ± 6.3</td><td class="colsep0 rowsep0" align="left">1.46 ± 0.72</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="left">608.1 ± 15.3</td><td class="colsep0 rowsep0" align="left">0.49 ± 0.01</td><td class="colsep0 rowsep0" align="left">543.8 ± 22.3</td><td class="colsep0 rowsep0" align="left">1.18 ± 0.41</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left">34.0 ± 7.3</td><td class="colsep0 rowsep0" align="left">0.91 ± 0.18</td><td class="colsep0 rowsep0" align="left">8.6 ± 1.5</td><td class="colsep0 rowsep0" align="left">4.40 ± 1.23</td><td class="colsep0 rowsep0" align="left">53.2 ± 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="left">89.7 ± 10.4</td><td class="colsep0 rowsep0" align="left">1.11 ± 0.13</td><td class="colsep0 rowsep0" align="left">28.8 ± 2.5</td><td class="colsep0 rowsep0" align="left">3.23 ± 0.61</td><td class="colsep0 rowsep0" align="left">42.6 ± 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="left">176.8 ± 28.0</td><td class="colsep0 rowsep0" align="left">1.71 ± 0.28</td><td class="colsep0 rowsep0" align="left">52.0 ± 5.0</td><td class="colsep0 rowsep0" align="left">3.65 ± 0.25</td><td class="colsep0 rowsep0" align="left">28.0 ± 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="left">504.2 ± 141.7</td><td class="colsep0 rowsep0" align="left">2.05 ± 0.54</td><td class="colsep0 rowsep0" align="left">90.4 ± 8.7</td><td class="colsep0 rowsep0" align="left">4.00 ± 1.33</td><td class="colsep0 rowsep0" align="left">24.3 ± 7.5</td></tr></tbody></table></div></div><div class="NLM_p last">Compound <b>35</b> also displays oral bioavailability (<i>F</i>) in fasted rats, with values ranging between 43% and 53% at doses of 30–100 mg/kg, whereas it declined to 24–28% at higher doses. Given its polarity (log <i>D</i><sub>7.4</sub> = −2.85), we speculate that active transport may be involved in oral uptake, which may be saturated at higher doses. The compound was well tolerated at all doses.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Efficacy in Infection Models</h3><div class="NLM_p">Compound <b>35</b> was evaluated in a 24 h neutropenic mouse thigh infection model against <i>Klebsiella pneumoniae</i> strain KP1244 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). This strain expresses KPC-3, SHV-11, and SHV-12 and is resistant to carbapenems, with an MIC to meropenem of >64 μg/mL; in the presence of 8 μg/mL of <b>35</b>, the MIC to meropenem is 0.25 μg/mL. The doses shown of both meropenem and QPX7728 were administered every 2 h for 24 h (12 doses of the designated amount per day). In this study, meropenem at a dose of 300 mg/kg given every 2 h fails to control the infection, whereas the coadministration of 0.5–1 mg/kg of <b>35</b> affords a static effect, and 10 mg/kg achieves a >1 log reduction in CFU/thigh (relative to the start of treatment).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activity of meropenem alone or in combination with compound <b>35</b> against <i>K. pneumoniae</i> KP1244 in a 24 h neutropenic mouse thigh infection model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Safety</h3><div class="NLM_p last">Compound <b>35</b> was studied in a 7-day pilot toxicology study at daily doses of 30, 100, and 300 mg/kg in rats (five males, five females per dose level) administered by iv infusion. No changes were observed (tissue histology and clinical chemistry).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">This Drug Annotation describes the path from the narrow-spectrum first-generation boronic acid BLI vaborbactam to a remarkably potent and broad-spectrum agent <b>35</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The amide series represented by <b>4b</b> displays potent inhibition of serine enzymes of classes A and C but has only weak activity against class B (metallo) enzymes. Replacement of the amide linkage by a thio linkage, as exemplified in <b>7a</b>, achieves much-improved potency against class B enzymes. As a model system for introduction of a heteroatom into the aryl ring, compounds unsubstituted next to the boron atom were prepared. Compound <b>17b</b> represented a breakthrough in terms of potency and spectrum. Susceptibility of <b>17b</b> to metabolism precipitated work to identify substituents that would block metabolism while retaining all other desirable properties, culminating in <b>35</b> (QPX7728).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Evolution of β-lactamase inhibitors leading to compound <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>35</b> displays potent activity against the vast majority of β-lactamase enzymes, including not only the serine enzymes of classes A and C but also metalloenzymes such as NDM-1 and the difficult class D (OXA) enzymes of <i>Acinetobacter baumannii</i>. <i>In vivo</i>, <b>35</b> displays pharmacokinetics in the rat similar to β-lactam antibiotics and has good oral bioavailability without the need for a prodrug. Efficacy in a mouse infection model in combination with meropenem against a strain of <i>Klebsiella pneumoniae</i> expressing multiple β-lactamase enzymes was established. Selectivity for the β-lactamase target was established by screening against a panel of mammalian proteases. Preliminary toxicology studies in rats showed no adverse findings. Compound <b>35</b> has been advanced to late-stage preclinical development to support IND filing.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Methods</h3><div class="NLM_p">Unless otherwise noted, solvents and reagents were obtained from commercial suppliers and were used without further purification. All reactions involving air- or moisture-sensitive reagents were performed under an argon atmosphere. Thin-layer chromatography was performed on Merck silica gel 60 plates coated with 0.25 mm layer with fluorescent indicator. Components were visualized by UV light (λ = 254 and 366 nm) and iodine vapors. Column chromatography was conducted either under medium pressure on silica gel (Merck silica gel 40–63 μm) or on prepacked silica gel cartridges (Isco) on an Isco system. Purity and low-resolution mass spectrometry (MS) data were determined on a ThermoFinnigan Surveyor HPLC and ThermoFinnigan LCQ Advantage instruments equipped with ESI, using an Agilent Eclipse Plus C18 (4.6 mm × 150 mm, 5 μm) column. Mobile phase A was 0.1% trifluoroacetic acid in water, and mobile phase B was 0.1% trifluoroacetic acid in acetonitrile. The following conditions were used: a gradient from 10% to 90% B in 6 min and held at 90% B for 1.5 min; UV detection at 220 and 254 nm; a flow rate of 2 mL/min; an injection volume of 10 μL; full scan, mass range from 100 to 1000 amu. Masses are given as an <i>m</i>/<i>z</i> ratio. <sup>1</sup>H NMR spectra were acquired in the indicated solvents on a Bruker NMR spectrometer (Avance 400 MHz for <sup>1</sup>H). Data are reported as the following: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, bs = broad singlet, dd = doublet of doublet, td = triplet of doublet, m = multiplet), coupling constants, and number of protons. The purity of all compounds by HPLC was ≥95% except where noted in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_p last">All experiments utilizing animals were conducted under protocols approved by the Qpex Institutional Animal Care and Use Committee (IACUC).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Disodium Salt of 4,4-Dihydroxy-5-oxa-8-aza-4-boranuidabicyclo[4.4.0]deca-1(6),7,9-triene-7-carboxylate (<b>16</b>)</h3><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-(Benzyloxy)-4-bromopicolinic Acid (<b>11</b>)</h4><div class="NLM_p last">To a solution of compound <b>10</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(27)</a> (7 g, 21.73 mmol, 1.0 equiv) in THF:MeOH:H<sub>2</sub>O (2:2:1, 100 mL) was added LiOH (1.37 g, 32.6 mmol, 1.5 equiv) at room temperature. The mixture was stirred at room temperature for 1.5 h. The solvent was removed under reduced pressure. The residue was redissolved in water, adjusted pH to 1 with 1 N HCl, and extracted with ethyl acetate. The organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to yield residue, which was purified by column chromatography (DCM:MeOH = 10:1) to give compound <b>11</b> (4.85 g, 72%). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz): δ 8.21 (d, <i>J</i> = 4.8 Hz, 1H), 7.88 (d, <i>J</i> = 4.8 Hz, 1H), 7.55–7.36 (m, 5H), 5.15 (s, 2H).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>tert</i>-Butyl 3-(Benzyloxy)-4-bromopicolinate (<b>12</b>)</h4><div class="NLM_p last">To a solution of compound <b>11</b> (4.8 g, 15.58 mmol, 1.0 equiv) in <sup><i>t</i></sup>BuOH (150 mL) were added DMAP (195 mg, 1.596 mmol, 0.1 equiv) and Boc<sub>2</sub>O (10.2 g, 46.74 mmol, 3 equiv). The mixture was stirred overnight at 60 °C. The solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography (ethyl acetate:hexanes = 1:3) to give compound <b>12</b> (4.9 g, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 8.23 (d, <i>J</i> = 4.8 Hz, 1H), 7.63 (d, <i>J</i> = 5.1 Hz, 1H), 7.55–7.38 (m, 5H), 5.13 (s, 2H), 1.58–1.57 (m, 9H).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>tert</i>-Butyl 3-(Benzyloxy)-4-vinylpicolinate (<b>13</b>)</h4><div class="NLM_p last">To a solution of compound <b>12</b> (4.9 g, 13.45 mmol, 1.0 equiv) in isopropyl alcohol (250 mL) were added PdCl<sub>2</sub>(dppf) (878 mg, 1.08 mmol, 0.08 equiv), potassium vinyltrifluoroborate (4.5 g, 33.59 mmol, 2.5 equiv), and triethylamine (2.04 g, 20.17 mmol, 1.5 equiv). The mixture was purged with N<sub>2</sub> and stirred at 86 °C for 3 h. The solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography (ethyl acetate:hexanes = 1:3) to give compound <b>13</b> (3.77 g, 90%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 8.38 (d, 1H), 7.52–7.28 (m, 6H), 6.95 (dd, 1H), 5. 95 (dd, 1H), 5.56 (dd, 1H), 5.01 (s, 2H), 1.6–1.58 (m, 9H).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>tert</i>-Butyl 3-(Benzyloxy)-4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)picolinate (<b>14</b>)</h4><div class="NLM_p last">To a solution of pinacolborane (1.86 g, 14.54 mmol, 1.2 equiv), [IrCl(COD)]<sub>2</sub> (163 mg, 0.263 mmol, 0.02 equiv), and dppe (191 mg, 0.479 mmol, 0.04 equiv) in DCM (100 mL) was added compound <b>13</b> (3.77 g, 12.11 mmol, 1.0 equiv) in DCM (50 mL). The mixture was purged with N<sub>2</sub> and stirred overnight at room temperature. After addition of MeOH (10 mL), the solvent was removed under reduced pressure, and the resulting residue was purified by column chromatography (ethyl acetate:hexanes = 1:3) to give compound <b>14</b> (2.58 g, 48%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 8.36 (d, 1H), 7.51–7.29 (m, 6H), 5.03 (s, 2H), 2.80 (t, 2H), 1.59 (s, 9H). 1.29–1.18 (m, 14H).</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 2-Hydroxy-3,4-dihydro-2<i>H</i>-[1,2]oxaborinino[6,5-<i>c</i>]pyridine-8-carboxylate (<b>15</b>)</h4><div class="NLM_p last">To a solution of compound <b>14</b> (2.58 g, 5.87 mmol, 1.0 equiv) in MeOH (100 mL) was added Pd/C. The mixture was stirred overnight at room temperature. The mixture was filtered through Celite and concentrated under reduced pressure. The resulting residue was purified by column chromatography (DCM:MeOH = 10:1) to give compound <b>15</b> (1.5 g). MS calcd for (C<sub>12</sub>H<sub>16</sub>BNO<sub>4</sub>): 249. MS (ESI, positive) found: (M + 1) 250.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Disodium Salt of 4,4-Dihydroxy-5-oxa-8-aza-4-boranuidabicyclo[4.4.0]deca-1(6),7,9-triene-7-carboxylate (<b>16</b>)</h4><div class="NLM_p last">A solution of compound <b>15</b> (1.5 g, 6 mmol, 1.0 equiv) in TFA (12 mL) and TES (3 mL) was stirred at room temperature for 1.5 h. The mixture was concentrated and purified by C<sub>18</sub> reverse-phase prep-HPLC (acetonitrile and water as mobile phases, 0.1% formic acid). After lyophilization, the obtained white solid was dissolved in MeCN/H<sub>2</sub>O and adjusted to pH of about 7.9 using 0.1 N aqueous NaOH. After stirring at room temperature overnight, the solution was concentrated and repurified by C<sub>18</sub> reverse-phase prep-HPLC (acetonitrile and water as mobile phases, neutral) to give the desired <b>16</b> sodium salt as a white solid (460 mg, 30%). MS calcd for (C<sub>8</sub>H<sub>8</sub>BNO<sub>4</sub>): 193. MS (ESI, positive) found: (M + 1) 194; (M + 1 + H<sub>2</sub>O) 212. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O): δ 7.59 (d, 1H), 7.08 (d, 1H), 2.55 (t, 2H), 0.48 (t, 2H).</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Disodium Salt of (2<i>S</i>,4<i>R</i>)-9-Fluoro-5-hydroxy-5-oxonio-6-oxa-5-boranuidatricyclo[5.4.0.02,4]undeca-1(7),8,10-triene-8-carboxylate (<b>35</b>)</h3><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Bromo-5-fluorophenyl <i>tert</i>-Butylcarbonate (<b>40</b>)</h4><div class="NLM_p last">To a solution of 2-bromo-5-fluorophenol (<b>39</b>) (13.5 g, 71 mmol) and Boc<sub>2</sub>O (18.5 g, 85 mmol) in DCM (300 mL) at room temperature was added DMAP (439 mg, 3.6 mmol). The mixture was stirred at room temperature for 0.5 h, concentrated to dryness, and purified by silica gel chromatography to afford compound <b>40</b> (20.1 g, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.54 (m, 1 H), 6.98 (m, 1 H), 6.89 (m, 1 H), 1.56 (s, 9H).</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl 3-Bromo-2-(<i>tert</i>-butoxycarbonyloxy)-6-fluorobenzoate (<b>41</b>)</h4><div class="NLM_p">To a solution of compound <b>40</b> (21.7 g, 74.6 mmol) in THF (150 mL) at −78 °C was added freshly prepared LDA solution (140 mL, 82.1 mmol). The mixture was stirred at −78 °C for 1 h, then warmed up slowly to room temperature, quenched with 1 N HCl (aq, 200 mL), extracted with EtOAc, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate was evaporated to dryness to afford <i>tert</i>-butyl ester of phenol (17.9 g, 83%) which was used directly in the next step without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.23 (s, 1 H), 7.59 (m, 1 H), 6.53 (m, 1 H), 1.61 (s, 9H).</div><div class="NLM_p last">To a solution of compound <i>tert</i>-butyl ester of phenol (17.99 g, 62 mmol) and Boc<sub>2</sub>O (20.2 g, 92.7 mmol) in DCM (200 mL) at room temperature was added DMAP (400 mg, 3.1 mmol). The mixture was stirred at room temperature overnight, evaporated to dryness, purified by silica gel chromatography to afford compound <b>41</b> (19.1 g, 79%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.59 (m, 1 H), 6.93 (m, 1 H), 1.56 (s, 9H), 1.52 (s, 9H).</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 8-Bromo-5-fluoro-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one (<b>42</b>)</h4><div class="NLM_p">Compound <b>42</b> was prepared from Boc-<i>tert</i>-butyl ester intermediate <b>41</b> by TFA deprotection and isopropylidene formation following the general procedure described below.</div><div class="NLM_p">To a solution of compound <b>41</b> (80 mmol) in DCM (110 mL) was added TFA (110 mL) at rt. After 16 h at this temperature, the mixture was concentrated under reduced pressure and the residue was purified by flash chromatography on silica to give deprotection product as a white solid.</div><div class="NLM_p last">A syringe filled with trifluoroacetic anhydride (80 mmol) and a 20 mL syringe filled with acetone (240 mmol) were added simultaneously via syringe pump over 24 h to a clear solution of hydrolysis product of <b>41</b> (40 mmol) in TFA (10 mL) at 70 °C. After 1 h, the starting material began to crystallize out. TFA (5 mL) was added, affording a clear solution. After stirring at 70 °C overnight, the reaction mixture was cooled to room temperature, diluted with ethyl acetate (15 mL), filtered over Celite, and the pad and flask were rinsed with ethyl acetate (2 × 10 mL). The clear black filtrate was concentrated to dryness. The solids were taken up in ethyl acetate (50 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL, to improve solubility of the product) and washed twice with a saturated solution of NaHCO<sub>3</sub> (50 and 30 mL). The brown/black solution was concentrated to dryness. The residue was taken up in ethyl acetate (10 mL), and the mixture was heated to reflux. Heptane (3 × 10 mL) was added, and the mixture was brought to reflux (after the last addition of heptane, the product started crystallizing). The solids were collected by filtration, rinsed with 3:1 heptane/ethyl acetate at 0 °C (2 × 10 mL), and air-dried.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>E</i>)-3-(5-Fluoro-2,2-dimethyl-4-oxo-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-8-yl)acrylic Acid (<b>43</b>)</h4><div class="NLM_p last">To the solution of compound <b>42</b> (16.0 g, 58 mmol, 1.0 equiv) in DMF (50 mL) was added acrylic acid (6.0 mL, 87 mmol, 1.5 equiv), TEA (24 mL, 175 mmol, 3 equiv), Pd(OAc)<sub>2</sub> (651 mg, 2.9 mmol, 0.05 equiv), and tri(<i>o</i>-tolyl)phosphine (1.77 g, 5.8 mmol, 0.1 equiv). The reaction mixture was flushed with nitrogen and stirred at 100 °C for 14 h. The reaction mixture was concentrated to dryness and the solid was washed with 0.2 N HCl and DCM to give a yellow solid. The solid was recrystallized in EtOAc and hexanes to give compound <b>43</b> (8.2 g, 53%) as an off-white solid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.01 (dd, 1H), 7.78 (d, <i>J</i> = 16.4 Hz, 1H), 7.00 (dd, 1H), 6.57 (d, <i>J</i> = 16.0 Hz, 1H), 1.80 (s, 6H).</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>Z</i>)-8-(2-Bromovinyl)-5-fluoro-2,2-dimethyl-4<i>H</i>-benzo[<i>d</i>][1,3]dioxin-4-one (<b>44</b>)</h4><div class="NLM_p">To the suspension of compound <b>43</b> (8.2 g, 30.8 mmol, 1.0 equiv) in chloroform (300 mL) was added bromine liquid (1.8 mL, 35.4 mmol, 1.15 equiv) dropwise in 5 min at 0 °C. The reaction solution was stirred at 0 °C for 2 h before it was concentrated under reduced pressure. The dibromo intermediate was obtained as a yellow solid (14.7 g), which was directly used for the next step without purification.</div><div class="NLM_p last">To the solution of compound crude dibromide (14.7 g, 30.8 mmol, 1.0 equiv) in DMF (35 mL) was added triethylamine (8.6 mL, 61.6 mmol, 2.0 equiv) dropwise in 2 min at 0 °C. The resulting reaction mixture was slowly warmed up to room temperature and stirred for 8 h. The reaction mixture was diluted with EtOAc and washed with 0.1 N HCl and water. After the mixture was dried over Na<sub>2</sub>SO<sub>4</sub>, the organic layer was concentrated and chromatographed (hexanes/EtOAc = 3/1 to 1/1) to give compound <b>44</b> (5.5 g) as an off-white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.20 (dd, 1H), 7.08 (d, <i>J</i> = 8.0 Hz, 1H), 6.88 (t, <i>J</i> = 8.2 Hz, 1H), 6.55 (d, <i>J</i> = 8.0 Hz, 1H), 1.75 (s, 6H).</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-Fluoro-2,2-dimethyl-8-[(<i>Z</i>)-2-[(2<i>S</i>)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]vinyl]-1,3-benzodioxin-4-one (<b>45</b>)</h4><div class="NLM_p last">The mixture of compound <b>44</b> (700 mg, 2.3 mmol, 1.0 equiv), bis((+)-pinanediolato)diboron (1.24 g, 3.5 mmol, 1.5 equiv), PdCl<sub>2</sub>(dppf) (188 mg, 0.23 mmol, 0.1 equiv), and KOAc (450 mg, 4.6 mmol, 2.0 equiv) in dioxane (15 mL) was stirred at 60 °C for 2 h under nitrogen atmosphere. The reaction mixture was diluted with EtOAc and washed with 0.1 N HCl and water. After drying over Na<sub>2</sub>SO<sub>4</sub>, the organic layer was concentrated and purified by column chromatography (hexanes/EtOAc = 3/1 to 1/1) to give compound <b>45</b> (240 mg, 26%) as a yellow solid. ESI-MS: [M + H]<sup>+</sup> 401.</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 5-Fluoro-2,2-dimethyl-8-[(1<i>R</i>,2<i>S</i>)-2-[(2<i>S</i>)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]cyclopropyl]-1,3-benzodioxin-4-one (<b>46A</b>) and 5-Fluoro-2,2-dimethyl-8-[(1<i>S</i>,2<i>R</i>)-2-[(2<i>S</i>)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.02,6]decan-4-yl]cyclopropyl]-1,3-benzodioxin-4-one (<b>46B</b>)</h4><div class="NLM_p">To a solution of compound <b>45</b> (2.0 g, 5.0 mmol, 1.0 equiv) and Pd(OAc)<sub>2</sub> (56 mg, 0.25 mmol, 0.05 equiv) in THF (30 mL) was slowly added diazomethane (200 mL, freshly made, about 0.2 M in ether, 10 equiv) at −20 °C in 2 h. The solution was slowly warmed up to room temperature and stirred for 12 h before it was concentrated to dryness. The obtained residue was purified by column chromatography (hexanes/EtOAc= 3/1 to 1/1) to give a mixture of compounds <b>46A</b> and <b>46B</b> (1.96 g, 99%) as a yellow oil. The two isomers were further purified by prep-HPLC (C18, acetonitrile and water as mobile phases, 0.1% HCOOH) to give pure <b>46A</b> (650 mg, 31%) and <b>46B</b> (750 mg, 36%) as a white solid.</div><div class="NLM_p"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) for <b>46A</b>: δ 7.37–7.33 (m, 1H), 6.73 (t, <i>J</i> = 9.2 Hz, 1H), 4.02 (dd, <i>J</i> = 1.6, 1.6 Hz, 1H), 2.27–2.24 (m, 1H), 2.15–2.08 (m, 1H), 2.05–2.00 (m, 1H), 1.87 (t, <i>J</i> = 5.2 Hz, 1H), 1.76 (s, 3H), 1.74 (s, 3H), 1.29–1.21 (m, 2H), 1.19 (s, 3H), 1.17–1.13 (m, 1H), 1.07 (s, 3H), 0.69 (s, 3H), 0.56–0.53 (m, 1H), 0.52–0.49 (m, 1H). ESI-MS: [M + H]<sup>+</sup> 415.</div><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) for <b>46B</b>: δ 7.32–7.25 (m, 1H), 6.72 (t, <i>J</i> = 9.2 Hz, 1H), 4.00 (dd, <i>J</i> = 1.6, 1.6 Hz, 1H), 2.28–2.24 (m, 1H), 2.17–2.14 (m, 1H), 1.86–1.81 (m, 2H), 1.75 (s, 8H), 1.62 (d, <i>J</i> = 1.2 Hz, 1H), 1.21–1.19 (m, 1H), 1.18 (s, 3H), 1.17 (s, 3H), 1.16–1.13 (m, 1H), 0.72 (s, 3H), 0.53–0.47 (m, 2H). ESI-MS: [M + H]<sup>+</sup> 415.</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Disodium Salt of (1a<i>R</i>,7b<i>S</i>)-5-Fluoro-2-hydroxy-1a,7b-dihydro-1<i>H</i>-cyclopropa[<i>c</i>][1,2]benzoxaborinine-4-carboxylic Acid (<b>35</b>)</h4><div class="NLM_p last">The mixture of compound <b>46B</b> (750 mg, 1.8 mmol, 1.0 equiv) in dioxane (4 mL) and 3 N NaOH (1.2 mL, 2 equiv) was stirred at room temperature for 0.5 h. LCMS indicated the disappearance of starting material. The reaction mixture was cooled to 0 °C, TES (1 mL), and TFA (5 mL) and <i>i</i>-BuB(OH)<sub>2</sub> (369 mg, 3.6 mmol, 2 equiv) were added in sequence. The resulting yellow clear solution was stirred at room temperature for 0.5 h before it was concentrated to dryness. The residue was dissolved in water/MeCN and purified by prep-HPLC (C18, acetonitrile and water as mobile phases, 0.1% TFA) to give compound <b>35</b> free acid (160 mg) as a white solid after lyophilization. It was dissolved in MeCN/water and adjusted to pH = 9.5 with 1 N NaOH (1.38 mL). After lyophilization, the crude sodium salt was dissolved in 2.0 mL of water and was slowly added acetone (50 mL). The resulting suspension was stirred at room temperature for 3 h. The mixture was filtered and the solid was washed with acetone twice to give the disodium salt compound <b>35</b> (145 mg) as an off-white solid. <sup>1</sup>H NMR (D<sub>2</sub>O, 300 MHz): δ 6.87 (t, <i>J</i> = 7.2 Hz, 1H), 6.25 (d, <i>J</i> = 8.4 Hz, 1H), 1.65–1.56 (m, 1H), 0.67–0.57 (m, 1H), 0.14 (m, 2H). <sup>19</sup>F NMR (D<sub>2</sub>O, 300 MHz): δ −124.9. ESI-MS: [M – H<sub>2</sub>O + H]<sup>+</sup>: 205. Anal. Calcd for C<sub>10</sub>H<sub>8</sub>BFNa<sub>2</sub>O<sub>5</sub> + 1.0H<sub>2</sub>O: C, 40.03; H, 3.32; Na, 14.99. Found: C, 39.77; H, 3.34; Na, 15.23.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Determination of Monomer Formation</h3><div class="NLM_p last">Test compounds were weighed out into a 1.5 mL Eppendorf tube. A solution of water was prepared in 1.00, 10.0, or 100 mg/mL concentrations of the compound based on active fraction. A volume of 20 μL was subtracted to allow room for addition of acid or base to adjust the pH. The solution pH was measured. The pH was then adjusted through addition of acid or base as necessary until the reading was in the 7.6–8 range. A final pH measurement was made after ensuring all the compound was in solution. The solution was injected onto LC–UV in 0.1–5 μL volume within less than half an hour after the time the sample was prepared. Elution was done using 0.1% TFA in water for mobile phase A and 0.085% TFA in methanol for mobile phase B on an Excel ACE 5 Super C18 2.1 mm × 100 mm column at 0.6 mL/min flow rate with 9 min gradient, 3.9 min hold at 90% B, and 18 min run time. The absorption was measured at 220, 254, and 300 nm with a 4 nm bandwidth.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Susceptibility Testing</h3><div class="NLM_p last">MICs were determined using Clinical and Laboratory Standards Institute (CLSI) broth microdilution methods as described in CLSI document M07-A11 (2018).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(28)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Determination of <i>K</i><sub>i</sub> Values of Inhibition of β-Lactamases</h3><div class="NLM_p last"><i>K</i><sub>i</sub> values of inhibition of β-lactamases purified from overexpressing recombinant <i>E. coli</i> strains were determined spectrophotometrically using nitrocefin (NCF) or imipenem as reporter substrates. Enzymes were mixed with inhibitors at varying concentrations in reaction buffer (50 mM Na-phosphate, pH 7.0, 0.1 mg/mL BSA, plus 20 μM ZnCl<sub>2</sub> for metalloenzymes) and incubated for 10 min at 37 °C. 50 μM NCF was added, and substrate cleavage profiles were recorded at 490 nm every 10 s for 10 min on a SpectraMax plate reader for NCF. Substrate cleavage profiles were recorded at 294 nm every 30 s for 30 min on a SpectraMax plate reader for imipenem. <i>K</i><sub>i</sub> values were calculated by the method of Waley.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(29)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Effect of <b>35</b> on Serine Proteases</h3><div class="NLM_p">All enzymes and substrates were from commercial sources, and testing was performed according to manufacturer’s protocols with some modifications. Briefly, 50 μL of the diluted enzyme was mixed with 50 μL of an inhibitor at various concentrations and 50 μL of a corresponding buffer (<a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a></a>). Reaction mixtures were incubated for 10 min at 37C. Subsequently, 50 μL of corresponding substrate was added and absorbance or fluorescence was monitored for 30 min on SpectraMax M2 plate reader (Molecular Devices). 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF) and leupeptin were used as positive controls. Rates of reaction were calculated and presented relative to “no treatment” control. IC<sub>50</sub> values were calculated based on inhibitor concentration producing 50% of enzyme inhibition.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. Enzyme Substrates and Buffers Used in the Study</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">enzyme</th><th class="colsep0 rowsep0" align="center">buffer</th><th class="colsep0 rowsep0" align="center">substrate</th><th class="colsep0 rowsep0" align="center" char=".">substrate concn (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">trypsin</td><td class="colsep0 rowsep0" align="left">50 mM Tris-HCl, pH = 8.0, 10 mM CaCl<sub>2</sub>, 100 mM NaCl</td><td class="colsep0 rowsep0" align="left">N-Bz-R-AMC</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymotrypsin</td><td class="colsep0 rowsep0" align="left">20 mM Tris-HCl, pH = 8, 150 mM NaCl, 2.5 mM CaCl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Suc-AAPF-AMC</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasmin</td><td class="colsep0 rowsep0" align="left">100 mM Tris-HCl, pH = 7.5, 100 mM NaCl</td><td class="colsep0 rowsep0" align="left">H-D-VLK-pNA</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thrombin</td><td class="colsep0 rowsep0" align="left">20 mM Tris-HCl, pH = 8, 150 mM NaCl, 2.5 mM CaCl<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Benz-FVR-AMC</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">elastase</td><td class="colsep0 rowsep0" align="left">25 mM Tris-HCl, pH 8.0</td><td class="colsep0 rowsep0" align="left">Suc-AAPA-pNA</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">urokinase</td><td class="colsep0 rowsep0" align="left">50 mM Tris HCl, pH 8.5, 38 mM NaCl</td><td class="colsep0 rowsep0" align="left">NGK-pNA</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tissue plasminogen activator (TPA)</td><td class="colsep0 rowsep0" align="left">30 mM Tris-HCl, pH 8.5, 30 mM imidazole, 130 mM NaCl</td><td class="colsep0 rowsep0" align="left">GK-pNA</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chymase</td><td class="colsep0 rowsep0" align="left">100 mM Tris, pH 8.0, 2 M NaCl, 0.01% Triton X-100</td><td class="colsep0 rowsep0" align="left">Suc-AAPF-AMC</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dipeptidyl peptidase 7 (DPP7)</td><td class="colsep0 rowsep0" align="left">50 mM Na-Ac pH 5.8</td><td class="colsep0 rowsep0" align="left">H-Lys-Pro-AMC</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neutrophil elastase</td><td class="colsep0 rowsep0" align="left">50 mM Tris-HCl, pH = 7.5; 1 M NaCl</td><td class="colsep0 rowsep0" align="left">MeOSuc-AAVP-AMC</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsinA</td><td class="colsep0 rowsep0" align="left">25 mM MES, 5 mM DTT, pH 5.5</td><td class="colsep0 rowsep0" align="left">MCA-RPPGFSAFK-Dnp</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cathepsin G</td><td class="colsep0 rowsep0" align="left">50 mM Na-Ac, pH 5.8, 2 mM EDTA, 1 mM DTT</td><td class="colsep0 rowsep0" align="left">Suc-AAPF-AMC</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dipeptidyl peptidase 8 (DPP8)</td><td class="colsep0 rowsep0" align="left">10 mM Tris pH7.4, 10 mM MgCl2, 0.05% Tween-20</td><td class="colsep0 rowsep0" align="left">Lys-Pro-AMC</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dipeptidyl peptidase 9 (DPP9)</td><td class="colsep0 rowsep0" align="left">25 mM Tris, pH 7.5, 0.1% BSA</td><td class="colsep0 rowsep0" align="left">Lys-Pro-AMC</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ECE-1</td><td class="colsep0 rowsep0" align="left">100 mM MES, 0.1 M NaCl, pH 6.0</td><td class="colsep0 rowsep0" align="left">MCA-RPPGFSAFK(DNP)-OH</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ACE-2</td><td class="colsep0 rowsep0" align="left">50 mM MES, 0.3 M NaCl, 10 μM ZnCl<sub>2</sub>, 0.01% Brij-35, pH 6.5</td><td class="colsep0 rowsep0" align="left">Mca-APK(Dnp)</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-1</td><td class="colsep0 rowsep0" align="left">50 mM HEPES, 10 mM CaCl2, 0.05% Brij-35%, pH 7.5</td><td class="colsep0 rowsep0" align="left">McaPLGLDpaAR-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-9</td><td class="colsep0 rowsep0" align="left">50 mM HEPES, 10 mM CaCl<sub>2</sub>, 0.05% Brij-35%, pH 7.5</td><td class="colsep0 rowsep0" align="left">McaPLGLDpaAR-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Pharmacokinetic Studies in Rats</h3><div class="NLM_p last">After acclimation, rats (<i>n</i> = 3/dose level) were administered either single intravenous infusions (in 0.9% saline) of <b>35</b> at 30, 100, or 300 mg/kg or at 30, 100, 300, or 1000 mg/kg via the oral route (in water). Intravenous doses were infused over 0.5 h via an indwelling femoral vein cannula, while oral doses were administered via a bead tipped oral gavage. Plasma (∼0.3 mL) samples were collected from each rat at designated time points up to 24 h. Blood samples were centrifuged within 5 min of collection at 12 000<i>g</i> for 5 min to obtain plasma. The plasma samples were analyzed using an HPLC–MS method. PK analysis was performed using WinNonlin.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Mouse Efficacy Studies</h3><div class="NLM_p last">Swiss-Webster mice were rendered neutropenic by the administration of cyclophosphamide and were infected under isoflurane anesthesia by intramuscular injection of <i>K. pneumoniae</i> KP1244 (inoculum 1 × 10<sup>6</sup>) in both thighs (meropenem MIC of >64 μg/mL; meropenem MIC in the presence of 8 μg/mL <b>35</b> was 0.25 μg/mL). Treatments (formulated in water) were administered every 2 h by the intraperitoneal route, starting 2 h postinfection. Animals were sacrificed 24 h after the start of treatment, and the thighs were removed, homogenized, and plated to determine bacterial counts.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Cloning of the KPC-2, NDM-1, OXA-48, and VIM-2 Genes</h3><div class="NLM_p last">KPC-2 (residues 25–293) and NDM-1 (residues 42–270) constructs were designed as previously described.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(30,31)</a> The genes encoding OXA-48 (residues 23–265) and VIM-2 (residues 27–266) were custom synthesized by ATUM/DNA2.0 and inserted into the vector pD441-SR with an N-terminal His-tag and a TEV cleavage site.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Protein Expression and Purification</h3><div class="NLM_p last">KPC-2, NDM-1, and VIM-2 were expressed and purified as previously described.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(30,31)</a> Recombinant OXA-48 was produced in <i>E. coli</i> BL21 (DE3) cells grown at 37 °C using LB broth supplemented with 50 μg/mL kanamycin until an OD<sub>600</sub> of 0.6. Protein expression was initiated by the addition of 0.5 mM IPTG followed by incubation at 37 °C for 2 h. Cells were pelleted by centrifugation (4000<i>g</i>/20 min, 4 °C) and stored at −20 °C until further use. OXA-48 was purified by nickel affinity chromatography and gel filtration. Briefly, the cell pellets were thawed and resuspended in 20 mL of buffer A (20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 20 mM imidazole) with one complete EDTA-free protease inhibitor cocktail tablet (Roche) and disrupted by sonication. The lysate was centrifuged (15 000 rpm/50 min, 4 °C), filtered, and loaded onto a 5 mL HisTrap HP affinity column (GE Healthcare) pre-equilibrated with buffer A. OXA-48 was eluted by a linear imidazole gradient (20 mM to 500 mM). Fractions containing OXA-48 were concentrated and loaded onto a HiLoad 16/600 Superdex 75 pg column (GE Healthcare) pre-equilibrated with 20 mM Tris-HCl, pH 8.0, 300 mM NaCl. Protein concentration was determined by absorbance at 280 nm using a predicted extinction coefficient (Δε<sub>280</sub> = 65 430 cm<sup>–1</sup> M<sup>–1</sup>).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> X-ray Crystallography</h3><div class="NLM_p">The complex crystal structures of QPX7728 with KPC-2, NDM-1, OXA-48, and VIM-2 were obtained through soaking and cocrystallization experiments at 19 °C. For KPC-2, crystals were grown in 2 M ammonium sulfate and 5% (v/v) ethanol. A soaking solution of 5 mM RPX7728 was made in 2 M ammonium sulfate and 5% (v/v) ethanol. Crystals were soaked for 30 min and then cryoprotected with 2 M ammonium sulfate, 5% (v/v) ethanol, and 20% (v/v) glycerol before flash cooling in liquid nitrogen. For NDM-1, cocrystals were grown in 50 mM potassium phosphate dibasic, 10 mM calcium chloride, 25% (w/v) PEG8000, and 5 mM QPX7728. Crystals were cryoprotected with 50 mM sodium acetate, pH 3.85, 25% (w/v) PEG8000, and 20% (v/v) glycerol before flash cooling in liquid nitrogen. For OXA-48, cocrystals were grown in 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 8.5, 30% (w/v) PEG4000, and 1 mM QPX7728. Crystals were cryoprotected with 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 8.5, 30% (w/v) PEG4000, and 15% (v/v) glycerol before flash cooling in liquid nitrogen. For VIM-2, cocrystals were grown in 0.17 M ammonium acetate, 0.085 M sodium acetate, pH 4.6, 25.5% (w/v) PEG4000, 15% (v/v) glycerol, 1 mM TCEP, and 5 mM QPX7728. Crystals were directly flashed cooled from crystallization drop without any additional cryoprotection.</div><div class="NLM_p last">X-ray diffraction data for the QPX7728 complex structures were collected at the Advanced Photon Source (APS) beamlines 19-BM and 22-ID. Diffraction data were indexed and integrated with iMosflm<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> and scaled with Aimless<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(33)</a> from the CCP4 suite.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(34)</a> Phasing was performed using molecular replacement with the program Phaser<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(35)</a> and the following starting models: PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8">5UL8</a>/KPC-2, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF">4TZF</a>/NDM-1, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HBR">3HBR</a>/OXA-48, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3">1KO3</a>/VIM-2. Structure refinement was performed using phenix.refine<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(36)</a> of the PHENIX suite<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(37)</a> and model building in WinCoot.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(38)</a> The program eLBOW in PHENIX was used to obtain geometry restraint information.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(39)</a> The final model qualities were assessed using MolProbity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(40)</a> Processing and refinement statistics for KPC-2, NDM-1, OXA-48, and VIM-2 with QPX7728 are given in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf" class="ext-link">Table S1</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01976" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01976?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01976</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Methods for synthesis and characterization data on all compounds except those in the main manuscript; HPLC, MS data, and structure assignments for oligomers of compound <b>4a</b>; crystallographic statistics for enzymes bound to compound <b>35</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and microbiological data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Legend for data in molecular formula string table (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf">jm9b01976_si_001.pdf (1.58 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_002.csv">jm9b01976_si_002.csv (5.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_003.pdf">jm9b01976_si_003.pdf (127.09 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J">6V1J</a> (KPC-2:QPX7728), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M">6V1M</a> (NDM-1:QPX7728), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O">6V1O</a> (OXA-48:QPX7728), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P">6V1P</a> (VIM-2:QPX7728).</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01976" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott J. Hecker</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9082-1982" title="Orcid link">http://orcid.org/0000-0002-9082-1982</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#becdd6dbddd5dbccfecfcedbc6dcd7d190ddd1d3"><span class="__cf_email__" data-cfemail="5b28333e38303e291b2a2b3e2339323475383436">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">K. Raja Reddy</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Lomovskaya</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Griffith</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debora Rubio-Aparicio</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirk Nelson</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruslan Tsivkovski</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongxu Sun</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mojgan Sabet</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziad Tarazi</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Parkinson</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxim Totrov</span> - <span class="hlFld-Affiliation affiliation">Molsoft
LLC, 11199 Sorrento Valley
Road, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Serge H. Boyer</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomasz W. Glinka</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Orville A. Pemberton</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, University of South
Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine, University of South
Florida Morsani College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5115-3600" title="Orcid link">http://orcid.org/0000-0002-5115-3600</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael N. Dudley</span> - <span class="hlFld-Affiliation affiliation">Qpex
Biopharma, Inc., 6275
Nancy Ridge Drive, Suite 100, San Diego, California 92121, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Chemistry efforts were supported by Acme Bioscience, Palo Alto, CA. This project was funded in part with dederal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under OTA No. HHSO100201600026C. We thank the staff of beamlines 19-BM (Structural Biology Center, SBC) and 22-ID (Southeast Regional Collaborative Access Team, SER-CAT) at the Advanced Photon Source (APS), Argonne National Laboratory (ANL), for assistance with crystallographic data collection.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">β-lactamase inhibitor</p></td></tr><tr><td class="NLM_term">KPC</td><td class="NLM_def"><p class="first last"><i>Klebsiella pneumoniae</i> carbapenemase</p></td></tr><tr><td class="NLM_term">ESBL</td><td class="NLM_def"><p class="first last">extended spectrum β-lactamase</p></td></tr><tr><td class="NLM_term">CRE</td><td class="NLM_def"><p class="first last">carbapenem-resistant Enterobacteriaceae</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">PTV</td><td class="NLM_def"><p class="first last">potentiation target value</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming unit</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug application</p></td></tr><tr><td class="NLM_term">ATM</td><td class="NLM_def"><p class="first last">aztreonam</p></td></tr><tr><td class="NLM_term">BP</td><td class="NLM_def"><p class="first last">biapenem</p></td></tr><tr><td class="NLM_term">MP</td><td class="NLM_def"><p class="first last">meropenem</p></td></tr><tr><td class="NLM_term">CPM</td><td class="NLM_def"><p class="first last">cefepime</p></td></tr><tr><td class="NLM_term">CTLZN</td><td class="NLM_def"><p class="first last">ceftolozane</p></td></tr><tr><td class="NLM_term">CTZDM</td><td class="NLM_def"><p class="first last">ceftazidime</p></td></tr><tr><td class="NLM_term">AVI</td><td class="NLM_def"><p class="first last">avibactam</p></td></tr><tr><td class="NLM_term">VAB</td><td class="NLM_def"><p class="first last">vaborbactam</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dortet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance in Enterobacteriaceae: here is the storm</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.molmed.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=22480775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=263-272&issue=5&author=P.+Nordmannauthor=L.+Dortetauthor=L.+Poirel&title=Carbapenem+resistance+in+Enterobacteriaceae%3A+here+is+the+storm&doi=10.1016%2Fj.molmed.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance in Enterobacteriaceae: here is the storm</span></div><div class="casAuthors">Nordmann, Patrice; Dortet, Laurent; Poirel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The current worldwide emergence of resistance to the powerful antibiotic carbapenem in Enterobacteriaceae constitutes an important growing public health threat.  Sporadic outbreaks or endemic situations with enterobacterial isolates not susceptible to carbapenems are now reported not only in hospital settings but also in the community.  Acquired class A (KPC), class B (IMP, VIM, NDM), or class D (OXA-48, OXA-181) carbapenemases, are the most important determinants sustaining resistance to carbapenems.  The corresponding genes are mostly plasmid-located and assocd. with various mobile genetic structures (insertion sequences, integrons, transposons), further enhancing their spread.  This review summarizes the current knowledge on carbapenem resistance in Enterobacteriaceae, including activity, distribution, clin. impact, and possible novel antibiotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw3NvxiXmzF7Vg90H21EOLACvtfcHk0lgYm_YgFUJ-mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D&md5=afb14fc82cdcf73cb9c1fdf17b3c1a2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DNordmann%26aufirst%3DP.%26aulast%3DDortet%26aufirst%3DL.%26aulast%3DPoirel%26aufirst%3DL.%26atitle%3DCarbapenem%2520resistance%2520in%2520Enterobacteriaceae%253A%2520here%2520is%2520the%2520storm%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D5%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.molmed.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zasowski, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, M. J.</span></span> <span> </span><span class="NLM_article-title">The β-lactams strike back: ceftazidime-avibactam</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/phar.1622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1002%2Fphar.1622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=26289307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2mur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=755-770&issue=8&author=E.+J.+Zasowskiauthor=J.+M.+Rybakauthor=M.+J.+Rybak&title=The+%CE%B2-lactams+strike+back%3A+ceftazidime-avibactam&doi=10.1002%2Fphar.1622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The β-Lactams Strike Back: Ceftazidime-Avibactam</span></div><div class="casAuthors">Zasowski, Evan J.; Rybak, Jeffrey M.; Rybak, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">755-770</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gram-neg. resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics.  Ceftazidime-avibactam is a newly approved agent combining ceftazidime and a novel β-lactamase inhibitor with activity against multidrug-resistant gram-neg. bacteria.  Avibactam has increased potency and expanded spectrum of inhibition of class A and C β-lactamases relative to available β-lactamase inhibitors, including extended-spectrum β-lactamases, AmpC, and Klebsiella pneumoniae carbapenemase (KPC) enzymes.  Avibactam expands ceftazidime's spectrum of activity to include many ceftazidime- and carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa.  Early clin. data indicate that ceftazidime-avibactam is effective and well tolerated in patients with complicated urinary tract infections (cUTIs) and complicated intraabdominal infections (cIAI).  In a phase II trial of patients with cUTIs, ceftazidime-avibactam produced similar rates of clin. and microbiol. success compared with imipenem-cilastatin (70.5% and 71.4% microbiol. success rates, resp.).  Likewise, patients receiving ceftazidime-avibactam plus metronidazole in a phase II study of patients with cIAI had similar response rates to those receiving meropenem (91.2% and 93.4% clin. success rates, resp.).  Based on available in vitro, in vivo, and phase II trial data, as well as preliminary phase III trial results in ceftazidime-resistant, gram-neg. cUTI and cIAI, ceftazidime-avibactam received U.S. Food and Drug Administration approval for treatment of cUTI, including pyelonephritis, and cIAI, in combination with metronidazole, in adult patients with limited or no alternative treatment options.  The approved dosage, ceftazidime 2 g-avibactam 0.5 g administered as a 2-h infusion every 8 h, was selected based on pharmacodynamic anal. and available clin. data.  This dosage is under further investigation in patients with cUTI, cIAI, and nosocomial or ventilator-assocd. pneumonia.  The current body of evidence suggests that ceftazidime-avibactam is a promising addn. to our therapeutic armamentarium with potential to answer an urgent unmet medical need.  Further data in highly resistant gram-neg. infections, particularly those caused by KPC-producing Enterobacteriaceae, are needed.  As it is introduced into clin. use, careful stewardship and rational use are essential to preserve ceftazidime-avibactam's potential utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOTOxxlFRVx7Vg90H21EOLACvtfcHk0lj552yyWSeMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2mur7O&md5=6b383e5adb9ef14545f750d36541e15a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fphar.1622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1622%26sid%3Dliteratum%253Aachs%26aulast%3DZasowski%26aufirst%3DE.%2BJ.%26aulast%3DRybak%26aufirst%3DJ.%2BM.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520%25CE%25B2-lactams%2520strike%2520back%253A%2520ceftazidime-avibactam%26jtitle%3DPharmacotherapy%26date%3D2015%26volume%3D35%26issue%3D8%26spage%3D755%26epage%3D770%26doi%3D10.1002%2Fphar.1622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmarlicka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaeer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">Meropenem/vaborbactam, the first carbapenem/β-lactamase inhibitor combination</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1177/1060028018763288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1177%2F1060028018763288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=29514462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlSktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=769-779&issue=8&author=J.+C.+Choauthor=M.+T.+Zmarlickaauthor=K.+M.+Shaeerauthor=J.+Pardo&title=Meropenem%2Fvaborbactam%2C+the+first+carbapenem%2F%CE%B2-lactamase+inhibitor+combination&doi=10.1177%2F1060028018763288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Meropenem/Vaborbactam, the First Carbapenem/β-Lactamase Inhibitor Combination</span></div><div class="casAuthors">Cho, Jonathan C.; Zmarlicka, Monika T.; Shaeer, Kristy M.; Pardo, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">769-779</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Objective: To review the pharmacol., spectrum of activity, pharmacokinetics, pharmacodynamics, safety, efficacy, administration, and considerations for clin. use of meropenem/vaborbactam (M/V).  Data Sources: A literature search using PubMed and clinicaltrials.gov (June 2013 to Dec. 2017) was conducted using the search terms meropenem, vaborbactam, RPX7009, biapenem, RPX2003, and carbavance.  Refs. from relevant articles and conference abstrs. were also reviewed.  Study Selection and Data Extn.: Preclin., phase I studies, and phase III studies written in the English language were evaluated.  Data Synthesis: M/V is a novel carbapenem/β-lactamase inhibitor antimicrobial with in vitro activity against nearly 99% of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.  M/V is approved for the treatment of adults with complicated urinary tract infections (cUTIs), including pyelonephritis.  In a phase III cUTI trial (TANGO I), 98.4% of patients treated with M/V experienced overall clin. success compared with 94% of patients treated with piperacillin/tazobactam (95% CI = 0.7 to 9.1).  When compared with best available therapy for carbapenem-resistant Enterobacteriaceae (CRE) infections in TANGO II, patients receiving M/V were more likely to achieve clin. cure at both the end of therapy (64.3% vs 33.3%, P = 0.04) as well as at the test of cure (57.1% vs 26.7%, P = 0.04).  The most common adverse effects assocd. with M/V were headache, infusion-site reactions, and diarrhea.  Conclusion: M/V has a valuable role in the treatment of CRE and should be used judiciously to preserve its use for resistant infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIPjYbVsLZ7rVg90H21EOLACvtfcHk0lj552yyWSeMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlSktLbM&md5=efe79ffa9105cea570d2f78f38c2858c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1177%2F1060028018763288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018763288%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DJ.%2BC.%26aulast%3DZmarlicka%26aufirst%3DM.%2BT.%26aulast%3DShaeer%26aufirst%3DK.%2BM.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DMeropenem%252Fvaborbactam%252C%2520the%2520first%2520carbapenem%252F%25CE%25B2-lactamase%2520inhibitor%2520combination%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26issue%3D8%26spage%3D769%26epage%3D779%26doi%3D10.1177%2F1060028018763288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagacé-Wiens, P. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisuik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. P.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">Imipenem-relebactam and meropenem-vaborbactam: two novel carbapenem-β-lactamase inhibitor combinations</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/s40265-017-0851-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1007%2Fs40265-017-0851-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=29230684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=65-98&issue=1&author=G.+G.+Zhanelauthor=C.+K.+Lawrenceauthor=H.+Adamauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=M.+Zhanelauthor=P.+R.+S.+Lagac%C3%A9-Wiensauthor=A.+Walktyauthor=A.+Denisuikauthor=A.+Goldenauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+P.+Lynchauthor=J.+A.+Karlowsky&title=Imipenem-relebactam+and+meropenem-vaborbactam%3A+two+novel+carbapenem-%CE%B2-lactamase+inhibitor+combinations&doi=10.1007%2Fs40265-017-0851-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations</span></div><div class="casAuthors">Zhanel, George G.; Lawrence, Courtney K.; Adam, Heather; Schweizer, Frank; Zelenitsky, Sheryl; Zhanel, Michael; Lagace-Wiens, Philippe R. S.; Walkty, Andrew; Denisuik, Andrew; Golden, Alyssa; Gin, Alfred S.; Hoban, Daryl J.; Lynch, Joseph P., III; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-98</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam, differing by the addn. of a piperidine ring to the 2-position carbonyl group.  Vaborbactam (formerly known as RPX7009) is a non-β-lactam, cyclic, boronic acid-based, β-lactamase inhibitor.  The structure of vaborbactam is unlike any other currently marketed β-lactamase inhibitor.  Both inhibitors display activity against Ambler class A [including extended-spectrum β-lactamases (ESBLs), Klebsiella pneumoniae carbapenemases (KPCs)] and class C β-lactamases (AmpC).  Little is known about the potential for relebactam or vaborbactam to select for resistance; however, inactivation of the porin protein OmpK36 in K. pneumoniae has been reported to confer resistance to both imipenem-relebactam and meropenem-vaborbactam.  The addn. of relebactam significantly improves the activity of imipenem against most species of Enterobacteriaceae [by lowering the min. inhibitory concn. (MIC) by 2- to 128-fold] depending on the presence or absence of β-lactamase enzymes.  Against Pseudomonas aeruginosa, the addn. of relebactam also improves the activity of imipenem (MIC reduced eightfold).  Based on the data available, the addn. of relebactam does not improve the activity of imipenem against Acinetobacter baumannii, Stenotrophomonas maltophilia and most anaerobes.  Similar to imipenem-relebactam, the addn. of vaborbactam significantly (2- to > 1024-fold MIC redn.) improves the activity of meropenem against most species of Enterobacteriaceae depending on the presence or absence of β-lactamase enzymes.  Limited data suggest that the addn. of vaborbactam does not improve the activity of meropenem against A. baumannii, P. aeruginosa, or S. maltophilia.  The pharmacokinetics of both relebactam and vaborbactam are described by a two-compartment, linear model and do not appear to be altered by the co-administration of imipenem and meropenem, resp.  Relebactam's approx. vol. of distribution (Vd) and elimination half-life (t1/2) of ∼ 18 L and 1.2-2.1 h, resp., are similar to imipenem.  Likewise, vaborbactam's Vd and t1/2 of ∼ 18 L and 1.3-2.0 h, resp., are comparable to meropenem.  Like imipenem and meropenem, relebactam and vaborbactam are both primarily renally excreted, and clearance correlates with creatinine clearance.  In vitro and in vivo pharmacodynamic studies have reported bactericidal activity for imipenem-relebactam and meropenem-vaborbactam against various Gram-neg. β-lactamase-producing bacilli that are not inhibited by their resp. carbapenems alone.  These data also suggest that pharmacokinetic-pharmacodynamic parameters correlating with efficacy include time above the MIC for the carbapenems and overall exposure for their companion β-lactamase inhibitors.  Phase II clin. trials to date have reported that imipenem-relebactam is as effective as imipenem alone for treatment of complicated intra-abdominal infections and complicated urinary tract infections, including acute pyelonephritis.  Imipenem-relebactam is currently in two phase III clin. trials for the treatment of imipenem-resistant bacterial infections, as well as hospital-assocd. bacterial pneumonia (HABP) and ventilator-assocd. bacterial pneumonia (VABP).  A phase III clin. trial has reported superiority of meropenem-vaborbactam over piperacillin-tazobactam for the treatment of complicated urinary tract infections, including acute pyelonephritis.  Meropenem-vaborbactam has recently demonstrated higher clin. cure rates vs. best available therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE), as well as for HABP and VABP.  The safety and tolerability of imipenem-relebactam and meropenem-vaborbactam has been reported in various phase I pharmacokinetic studies and phase II and III clin. trials.  Both combinations appear to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.  In conclusion, relebactam and vaborbactam serve to broaden the spectrum of imipenem and meropenem, resp., against β-lactamase-producing Gram-neg. bacilli.  The exact roles for imipenem-relebactam and meropenem-vaborbactam will be defined by efficacy and safety data from further clin. trials.  Potential roles in therapy for these agents include the treatment of suspected or documented infections caused by resistant Gram-neg. bacilli-producing ESBL, KPC, and/or AmpC β-lactamases.  The usage of these agents in patients with CRE infections will likely become the std. of care.  Finally, increased activity of imipenem-relebactam against P. aeruginosa may be of clin. benefit to patients with suspected or documented P. aeruginosa infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYBXUqPtdemrVg90H21EOLACvtfcHk0lgUpuqR0cbtxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7bK&md5=a8506d493387208f8ac429057ca15a49</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0851-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0851-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DLawrence%26aufirst%3DC.%2BK.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DZhanel%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9-Wiens%26aufirst%3DP.%2BR.%2BS.%26aulast%3DWalkty%26aufirst%3DA.%26aulast%3DDenisuik%26aufirst%3DA.%26aulast%3DGolden%26aufirst%3DA.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BP.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DImipenem-relebactam%2520and%2520meropenem-vaborbactam%253A%2520two%2520novel%2520carbapenem-%25CE%25B2-lactamase%2520inhibitor%2520combinations%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26issue%3D1%26spage%3D65%26epage%3D98%26doi%3D10.1007%2Fs40265-017-0851-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span> <span> </span><span class="NLM_article-title">The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2169</span>– <span class="NLM_lpage">2184</span>, <span class="refDoi"> DOI: 10.1080/14656566.2019.1660772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1080%2F14656566.2019.1660772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=31500471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslGnu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2169-2184&issue=17&author=K.+M.+Papp-Wallace&title=The+latest+advances+in+%CE%B2-lactam%2F%CE%B2-lactamase+inhibitor+combinations+for+the+treatment+of+Gram-negative+bacterial+infections&doi=10.1080%2F14656566.2019.1660772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2169-2184</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Antimicrobial resistance in Gram-neg. pathogens is a significant threat to global health. β-Lactams (BL) are one of the safest and most-prescribed classes of antibiotics on the market today.  The acquisition of β-lactamases, esp. those which hydrolyze carbapenems, is eroding the efficacy of BLs for the treatment of serious infections.  During the past decade, significant advances were made in the development of novel BL-β-lactamase inhibitor (BLI) combinations to target β-lactamase-mediated resistant Gram-negatives.: The latest progress in 20 different approved, developing, and preclin. BL-BLI combinations to target serine β-lactamases produced by Gram-negatives are reviewed based on primary literature, conference abstrs. (when available), and US clin. trial searches within the last 5 years.  The majority of the compds. that are discussed are being evaluated as part of a BL-BLI combination.: The current trajectory in BLI development is promising; however, a significant challenge resides in the selection of an appropriate BL partner as well as the development of resistance linked to the BL partner.  In addn., dosing regimens for these BL-BLI combinations need to be critically evaluated.  A revolution in bacterial diagnostics is essential to aid clinicians in the appropriate selection of novel BL-BLI combinations for the treatment of serious infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlWIU5sOUqv7Vg90H21EOLACvtfcHk0lgUpuqR0cbtxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslGnu7jL&md5=73f3e0ba8358820479bf1652b26fc4a8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F14656566.2019.1660772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2019.1660772%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26atitle%3DThe%2520latest%2520advances%2520in%2520%25CE%25B2-lactam%252F%25CE%25B2-lactamase%2520inhibitor%2520combinations%2520for%2520the%2520treatment%2520of%2520Gram-negative%2520bacterial%2520infections%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2019%26volume%3D20%26issue%3D17%26spage%3D2169%26epage%3D2184%26doi%3D10.1080%2F14656566.2019.1660772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeary, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, G.</span></span> <span> </span><span class="NLM_article-title">Progress toward inhibitors of metallo-β-lactamases</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.4155%2Ffmc-2017-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=28504895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=673-691&issue=7&author=R.+P.+McGearyauthor=D.+T.+C.+Tanauthor=G.+Schenk&title=Progress+toward+inhibitors+of+metallo-%CE%B2-lactamases&doi=10.4155%2Ffmc-2017-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward inhibitors of metallo-β-lactamases</span></div><div class="casAuthors">McGeary, Ross P.; Tan, Daniel T. C.; Schenk, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">673-691</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The global overuse of antibiotics has led to the emergence of drug-resistant pathogenic bacteria.  Bacteria can combat β-lactams by expressing β-lactamases.  Inhibitors of one class of β-lactamase, the serine-β-lactamases, are used clin. to prevent degrdn. of β-lactam antibiotics.  However, a second class of β-lactamase, the metallo-β-lactamases (MBLs), function by a different mechanism to serine-β-lactamases and no inhibitors of MBLs have progressed to be used in the clinic.  Bacteria that express MBLs are an increasingly important threat to human health.  This review outlines various approaches taken to discover MBL inhibitors, with an emphasis on the different chem. classes of inhibitors.  Recent progress, particularly new screening methods and the rational design of potent MBL inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWOugIHrl627Vg90H21EOLACvtfcHk0ljaaPz_JwauqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlSqsr4%253D&md5=9c83b0f8634de613083ce3db42bd4225</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0007%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeary%26aufirst%3DR.%2BP.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BC.%26aulast%3DSchenk%26aufirst%3DG.%26atitle%3DProgress%2520toward%2520inhibitors%2520of%2520metallo-%25CE%25B2-lactamases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D7%26spage%3D673%26epage%3D691%26doi%3D10.4155%2Ffmc-2017-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krajnc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduwawala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamps, J. J. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saward, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Bicyclic boronate VNRX-5133 inhibits metallo- and serine-β-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8544</span>– <span class="NLM_lpage">8556</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00911</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00911" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8544-8556&issue=18&author=A.+Krajncauthor=J.+Bremauthor=P.+Hinchliffeauthor=K.+Calvopinaauthor=T.+D.+Panduwawalaauthor=P.+A.+Langauthor=J.+J.+A.+G.+Kampsauthor=J.+M.+Tyrrellauthor=E.+Widlakeauthor=B.+G.+Sawardauthor=T.+R.+Walshauthor=J.+Spencerauthor=C.+J.+Schofield&title=Bicyclic+boronate+VNRX-5133+inhibits+metallo-+and+serine-%CE%B2-lactamases&doi=10.1021%2Facs.jmedchem.9b00911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases</span></div><div class="casAuthors">Krajnc, Alen; Brem, Jurgen; Hinchliffe, Philip; Calvopina, Karina; Panduwawala, Tharindi D.; Lang, Pauline A.; Kamps, Jos J. A. G.; Tyrrell, Jonathan M.; Widlake, Emma; Saward, Benjamin G.; Walsh, Timothy R.; Spencer, James; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8544-8556</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clin. development.  We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clin. important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2.  VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not obsd.  Crystallog. reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1.  The crystallog. results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species.  The structures imply conserved binding of the bicyclic core with SBLs/MBLs.  With NDM-1, by crystallog., we obsd. an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core.  Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization.  The results further support the "high-energy-intermediate" analog approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1jdsxZI6F7bVg90H21EOLACvtfcHk0ljaaPz_JwauqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksLjM&md5=8b494fcd6f481e0721805144866eaf56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00911%26sid%3Dliteratum%253Aachs%26aulast%3DKrajnc%26aufirst%3DA.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DPanduwawala%26aufirst%3DT.%2BD.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DKamps%26aufirst%3DJ.%2BJ.%2BA.%2BG.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DWidlake%26aufirst%3DE.%26aulast%3DSaward%26aufirst%3DB.%2BG.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DBicyclic%2520boronate%2520VNRX-5133%2520inhibits%2520metallo-%2520and%2520serine-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D18%26spage%3D8544%26epage%3D8556%26doi%3D10.1021%2Facs.jmedchem.9b00911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic boronates inhibit all classes of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e02260-16</span> <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=28115348" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&issue=4&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+boronates+inhibit+all+classes+of+%CE%B2-lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520boronates%2520inhibit%2520all%2520classes%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D4%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-lactamase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5312</span>– <span class="NLM_lpage">5321</span>, <span class="refDoi"> DOI: 10.1021/bi992505b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992505b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5312-5321&issue=18&author=S.+Nessauthor=R.+Martinauthor=A.+M.+Kindlerauthor=M.+Paetzelauthor=M.+Goldauthor=S.+E.+Jensenauthor=J.+B.+Jonesauthor=N.+C.+Strynadka&title=Structure-based+design+guides+the+improved+efficacy+of+deacylation+transition+state+analogue+inhibitors+of+TEM-1+beta-lactamase&doi=10.1021%2Fbi992505b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design Guides the Improved Efficacy of Deacylation Transition State Analogue Inhibitors of TEM-1 β-Lactamase</span></div><div class="casAuthors">Ness, Steven; Martin, Richard; Kindler, Alois M.; Paetzel, Mark; Gold, Marvin; Jensen, Susan E.; Jones, J. Bryan; Strynadka, Natalie C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5312-5321</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition state analog boronic acid inhibitors mimicking the structures and interactions of good penicillin substrates for the TEM-1 β-lactamase of Escherichia coli were designed using graphic analyses based on the enzyme's 1.7 Å crystallog. structure.  The synthesis of two of these transition state analogs, (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1) and (1R)-1-acetamido-2-(3-carboxy-2-hydroxyphenyl)ethylboronic acid (2), is reported.  Kinetic measurements show that, as designed, compds. 1 and 2 are highly effective deacylation transition state analog inhibitors of TEM-1 β-lactamase, with inhibition consts. of 5.9 and 13 nM, resp.  These values identify them as among the most potent competitive inhibitors yet reported for a β-lactamase.  The best inhibitor of the current series was (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1, KI = 5.9 nM), which resembles most closely the best known substrate of TEM-1, benzylpenicillin (penicillin G).  The high-resoln. crystallog. structures of these two inhibitors covalently bound to TEM-1 are also described.  In addn. to verifying the design features, these two structures show interesting and unanticipated changes in the active site area, including strong hydrogen bond formation, water displacement, and rearrangement of side chains.  The structures provide new insights into the further design of this potent class of β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aQSFfZl_R7Vg90H21EOLACvtfcHk0lioNON7e2teyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D&md5=441c78891c1860f80e29660283299961</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fbi992505b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992505b%26sid%3Dliteratum%253Aachs%26aulast%3DNess%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DKindler%26aufirst%3DA.%2BM.%26aulast%3DPaetzel%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26atitle%3DStructure-based%2520design%2520guides%2520the%2520improved%2520efficacy%2520of%2520deacylation%2520transition%2520state%2520analogue%2520inhibitors%2520of%2520TEM-1%2520beta-lactamase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26issue%3D18%26spage%3D5312%26epage%3D5321%26doi%3D10.1021%2Fbi992505b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2009064414A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+Burns&author=R.+W.+Jackson&author=R.+Goswami&author=H.+Xu&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of alpha-Aminoboronic Acids as Beta-lactamase Inhibitors</span>.  Patent <span class="NLM_patent">US 20100120715A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+J.+Burns&author=R.+W.+Jackson&author=R.+Goswami&author=H.+Xu&title=Preparation+of+alpha-Aminoboronic+Acids+as+Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520alpha-Aminoboronic%2520Acids%2520as%2520Beta-lactamase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Lessen, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Pevear, D.</span>; <span class="NLM_string-name">Tirunahari, P. K.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2010130708A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+J.+Burns&author=R.+Goswami&author=R.+W.+Jackson&author=T.+Lessen&author=W.+Li&author=D.+Pevear&author=P.+K.+Tirunahari&author=H.+Xu&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2009064413A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+Burns&author=R.+W.+Jackson&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Glinka, T.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Hecker, S.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2014107535A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Reddy&author=T.+Glinka&author=M.+Totrov&author=S.+Hecker&title=Boronic+Acid+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26atitle%3DBoronic%2520Acid%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G.</span>; <span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Hecker, S.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Griffith, D. C.</span>; <span class="NLM_string-name">Rodny, O.</span>; <span class="NLM_string-name">Dudley, M. N.</span>; <span class="NLM_string-name">Boyer, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2012021455A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Hirst&author=R.+Reddy&author=S.+Hecker&author=M.+Totrov&author=D.+C.+Griffith&author=O.+Rodny&author=M.+N.+Dudley&author=S.+Boyer&title=Cyclic+Boronic+Acid+Ester+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DG.%26atitle%3DCyclic%2520Boronic%2520Acid%2520Ester%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span>; <span class="NLM_string-name">Reddy, K. R.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Hirst, G. C.</span>; <span class="NLM_string-name">Lomovskaya, O.</span>; <span class="NLM_string-name">Griffith, D. C.</span>; <span class="NLM_string-name">King, P.</span>; <span class="NLM_string-name">Tsivkovski, R.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Sabet, M.</span>; <span class="NLM_string-name">Tarazi, Z.</span>; <span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of RPX7009, a broad-spectrum beta-lactamase inhibitor with utility vs. class A serine carbapenemases</span>. In  <i>Abstracts of Papers</i>, 52nd International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, <span class="NLM_year">2012</span>; F-848.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+J.+Hecker&author=K.+R.+Reddy&author=M.+Totrov&author=G.+C.+Hirst&author=O.+Lomovskaya&author=D.+C.+Griffith&author=P.+King&author=R.+Tsivkovski&author=D.+Sun&author=M.+Sabet&author=Z.+Tarazi&author=M.+N.+Dudley&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520RPX7009%252C%2520a%2520broad-spectrum%2520beta-lactamase%2520inhibitor%2520with%2520utility%2520vs.%2520class%2520A%2520serine%2520carbapenemases%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loutit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a cyclic boronic acid β-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3682-3692&issue=9&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=M.+Totrovauthor=G.+C.+Hirstauthor=O.+Lomovskayaauthor=D.+C.+Griffithauthor=P.+Kingauthor=R.+Tsivkovskiauthor=D.+Sunauthor=M.+Sabetauthor=Z.+Taraziauthor=M.+C.+Cliftonauthor=K.+Atkinsauthor=A.+Raymondauthor=K.+T.+Pottsauthor=J.+Abendrothauthor=S.+H.+Boyerauthor=J.+S.+Loutitauthor=E.+E.+Morganauthor=S.+Dursoauthor=M.+N.+Dudley&title=Discovery+of+a+cyclic+boronic+acid+%CE%B2-lactamase+inhibitor+%28RPX7009%29+with+utility+vs+class+A+serine+carbapenemases&doi=10.1021%2Facs.jmedchem.5b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span></div><div class="casAuthors">Hecker, Scott J.; Reddy, K. Raja; Totrov, Maxim; Hirst, Gavin C.; Lomovskaya, Olga; Griffith, David C.; King, Paula; Tsivkovski, Ruslan; Sun, Dongxu; Sabet, Mojgan; Tarazi, Ziad; Clifton, Matthew C.; Atkins, Kateri; Raymond, Amy; Potts, Kristy T.; Abendroth, Jan; Boyer, Serge H.; Loutit, Jeffrey S.; Morgan, Elizabeth E.; Durso, Stephanie; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing dissemination of carbapenemases in Gram-neg. bacteria has threatened the clin. usefulness of the β-lactam class of antimicrobials.  A program was initiated to discover a new series of serine β-lactamase inhibitors contg. a boronic acid pharmacophore, with the goal of finding a potent inhibitor of serine carbapenemase enzymes that are currently compromising the utility of the carbapenem class of antibacterials.  Potential lead structures were screened in silico by modeling into the active sites of key serine β-lactamases.  Promising candidate mols. were synthesized and evaluated in biochem. and whole-cell assays.  Inhibitors were identified with potent inhibition of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhibition of mammalian serine proteases.  Studies in vitro and in vivo show that RPX7009 (9f) is a broad-spectrum inhibitor, notably restoring the activity of carbapenems against KPC-producing strains.  Combined with a carbapenem, 9f is a promising product for the treatment of multidrug resistant Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpE5YX_dRNLVg90H21EOLACvtfcHk0lhTF5DgeVQL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D&md5=965fbf2b42f2e1b38eccc3b23dfa374f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00127%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DTarazi%26aufirst%3DZ.%26aulast%3DClifton%26aufirst%3DM.%2BC.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DRaymond%26aufirst%3DA.%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLoutit%26aufirst%3DJ.%2BS.%26aulast%3DMorgan%26aufirst%3DE.%2BE.%26aulast%3DDurso%26aufirst%3DS.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520cyclic%2520boronic%2520acid%2520%25CE%25B2-lactamase%2520inhibitor%2520%2528RPX7009%2529%2520with%2520utility%2520vs%2520class%2520A%2520serine%2520carbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D9%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Facs.jmedchem.5b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Trout, R.</span>; <span class="NLM_string-name">Zulli, A.</span>; <span class="NLM_string-name">Mesaros, E.</span>; <span class="NLM_string-name">Jackson, R.</span>; <span class="NLM_string-name">Boyd, S.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McLaughlin, L.</span>; <span class="NLM_string-name">Chatwin, C.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Pevear, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of VNRX-7145: A broad-spectrum orally bioavailable beta-lactamase inhibitor (BLI) for highly resistant bacterial infections (“superbugs“)</span>. Presented at the 257th National Meeting & Exposition of the American Chemical Society, Orlando, FL, U.S., Mar 31–Apr 4, <span class="NLM_year">2019</span>; MEDI-0259.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=C.+J.+Burns&author=R.+Trout&author=A.+Zulli&author=E.+Mesaros&author=R.+Jackson&author=S.+Boyd&author=B.+Liu&author=L.+McLaughlin&author=C.+Chatwin&author=J.+Hamrick&author=D.+Daigle&author=D.+Pevear&title=Discovery+of+VNRX-7145%3A+A+broad-spectrum+orally+bioavailable+beta-lactamase+inhibitor+%28BLI%29+for+highly+resistant+bacterial+infections+%28%E2%80%9Csuperbugs%E2%80%9C%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520VNRX-7145%253A%2520A%2520broad-spectrum%2520orally%2520bioavailable%2520beta-lactamase%2520inhibitor%2520%2528BLI%2529%2520for%2520highly%2520resistant%2520bacterial%2520infections%2520%2528%25E2%2580%259Csuperbugs%25E2%2580%259C%2529%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Chu, G.-H.</span>; <span class="NLM_string-name">Trout, R.</span>; <span class="NLM_string-name">Jackson, R.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Cusick, S.</span>; <span class="NLM_string-name">Pevear, D.</span>; <span class="NLM_string-name">Xerri, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of VNRX-5133: A broad-spectrum serine- and metallo-beta-lactamase inhibitor (BLI) for carbapenem-resistant bacterial infections (“superbugs“)</span>.. Presented at the 255th National Meeting & Exposition of the American Chemical Society, New Orleans, LA, U.S., March 18–22, <span class="NLM_year">2018</span>; MEDI-309.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Burns&author=B.+Liu&author=G.-H.+Chu&author=R.+Trout&author=R.+Jackson&author=D.+McGarry&author=J.+Hamrick&author=D.+Daigle&author=S.+Cusick&author=D.+Pevear&author=L.+Xerri&title=Discovery+of+VNRX-5133%3A+A+broad-spectrum+serine-+and+metallo-beta-lactamase+inhibitor+%28BLI%29+for+carbapenem-resistant+bacterial+infections+%28%E2%80%9Csuperbugs%E2%80%9C%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520VNRX-5133%253A%2520A%2520broad-spectrum%2520serine-%2520and%2520metallo-beta-lactamase%2520inhibitor%2520%2528BLI%2529%2520for%2520carbapenem-resistant%2520bacterial%2520infections%2520%2528%25E2%2580%259Csuperbugs%25E2%2580%259C%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Glinka, T.</span>; <span class="NLM_string-name">Hecker, S.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Rodny, O.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2015179308A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Reddy&author=T.+Glinka&author=S.+Hecker&author=M.+Totrov&author=O.+Rodny&title=Boronic+Acid+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26atitle%3DBoronic%2520Acid%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2015191907</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=R.+W.+Jackson&author=J.+Hamrick&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span>; <span class="NLM_string-name">Jackson, R. W.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">US 20140194386</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&author=R.+W.+Jackson&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2014151958</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Aminoboronic Acids and Amino-1,2-benzoxaborins as Inhibitors of Bacterial Beta-lactamases and Antibacterial Agents</span>. Patent <span class="NLM_patent">WO 2014089365</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Aminoboronic+Acids+and+Amino-1%2C2-benzoxaborins+as+Inhibitors+of+Bacterial+Beta-lactamases+and+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DAminoboronic%2520Acids%2520and%2520Amino-1%252C2-benzoxaborins%2520as%2520Inhibitors%2520of%2520Bacterial%2520Beta-lactamases%2520and%2520Antibacterial%2520Agents%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizer, R.</span></span> <span> </span><span class="NLM_article-title">Dynamics of boron acid complexation reactions. Formation of 1:1 boron acid-ligand complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1021/ic50203a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50203a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADyaL3cXhtVSgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=56-61&issue=1&author=L.+Babcockauthor=R.+Pizer&title=Dynamics+of+boron+acid+complexation+reactions.+Formation+of+1%3A1+boron+acid-ligand+complexes&doi=10.1021%2Fic50203a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of boron acid complexation reactions.  Formation of 1:1 boron acid-ligand complexes</span></div><div class="casAuthors">Babcock, Lucia; Pizer, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">Boron acids form 1:1 complexes with a variety of bidentate chelating ligands according to the equation RB(OH)2 + H2L ↹ RB(OH)L- + H3O+.  The acids m-NO2PhB(OH)2, PhB(OH)2, B(OH)3, and MeB(OH)2 were studied and 10 different ligands were examd..  Stability consts. were detd. by pH titrn. methods, and the kinetics. were detd. by a temp. jump method at μ = 0.1 M (KNO3) and 25°.  The stability consts. are affected by the acidities of both the boron acids and ligands; the stability consts. increase as the ligand and boron acid become more acidic.  Various kinetic pathways are possible.  Trigonal boron acids, RB(OH)2, react with fully protonated ligands or ligand anions.  The pattern of reactivity is different for each case.  The rate consts. for the reactions of fully protonated ligands vary systematically with both ligand acidity and boron substituent.  This is discussed in terms of a mechanism which involves proton transfer.  The ligand anions do not display a simple correlation with any single ligand parameter and their reactivities are discussed in terms of a no. of ligand-specific effects.  Borate anions, RB(OH)3-, react with high rate consts. with fully protonated ligands and with somewhat lower rate consts. with ligand anions.  Possible reasons for this are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWpCEDmtVP0rVg90H21EOLACvtfcHk0lixjRnT_gvLWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhtVSgsr4%253D&md5=fd956a63d5de583c1bb889559a3e2829</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fic50203a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50203a013%26sid%3Dliteratum%253Aachs%26aulast%3DBabcock%26aufirst%3DL.%26aulast%3DPizer%26aufirst%3DR.%26atitle%3DDynamics%2520of%2520boron%2520acid%2520complexation%2520reactions.%2520Formation%2520of%25201%253A1%2520boron%2520acid-ligand%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D1980%26volume%3D19%26issue%3D1%26spage%3D56%26epage%3D61%26doi%3D10.1021%2Fic50203a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of QPX7728, a New Ultra-Broad-Spectrum Beta-lactamase Inhibitor of Serine and Metallo-Beta-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1128/AAC.00130-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1128%2FAAC.00130-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+Tsivkovskiauthor=O.+Lomovskayaauthor=M.+Totrov&title=Biochemical+Characterization+of+QPX7728%2C+a+New+Ultra-Broad-Spectrum+Beta-lactamase+Inhibitor+of+Serine+and+Metallo-Beta-Lactamases&doi=10.1128%2FAAC.00130-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1128%2FAAC.00130-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00130-20%26sid%3Dliteratum%253Aachs%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DBiochemical%2520Characterization%2520of%2520QPX7728%252C%2520a%2520New%2520Ultra-Broad-Spectrum%2520Beta-lactamase%2520Inhibitor%2520of%2520Serine%2520and%2520Metallo-Beta-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2020%26doi%3D10.1128%2FAAC.00130-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdelet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Straightforward and efficient synthesis of 3-benzyloxy-4-bromopicolinate ester and 3-benzyloxy-5-bromopicolinate ester, common building blocks for pharmaceuticals and agrochemicals</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">8757</span>– <span class="NLM_lpage">8762</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.tet.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12kt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=8757-8762&issue=45&author=T.+Verdeletauthor=G.+Merceyauthor=N.+Correaauthor=L.+Jeanauthor=P.-Y.+Renard&title=Straightforward+and+efficient+synthesis+of+3-benzyloxy-4-bromopicolinate+ester+and+3-benzyloxy-5-bromopicolinate+ester%2C+common+building+blocks+for+pharmaceuticals+and+agrochemicals&doi=10.1016%2Fj.tet.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Straightforward and efficient synthesis of 3-benzyloxy-4-bromopicolinate ester and 3-benzyloxy-5-bromopicolinate ester, common building blocks for pharmaceuticals and agrochemicals</span></div><div class="casAuthors">Verdelet, Tristan; Mercey, Guillaume; Correa, Nobi; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8757-8762</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A practical and rapid prepn. of 3-benzyloxy-4-bromo- and 3-benzyloxy-5-bromopicolinate esters was developed in four steps, resp., in 38% and 31% overall yield.  Then their viability as partners for cross-coupling reactions was evaluated in Suzuki-Miyaura, Hartwig-Buchwald, and Sonogashira reactions to synthesize biol. relevant targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY-NcF7BfGr7Vg90H21EOLACvtfcHk0lixjRnT_gvLWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12kt7jN&md5=c7deb2edb267a4fbf6c155360966a9ea</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DVerdelet%26aufirst%3DT.%26aulast%3DMercey%26aufirst%3DG.%26aulast%3DCorrea%26aufirst%3DN.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DStraightforward%2520and%2520efficient%2520synthesis%2520of%25203-benzyloxy-4-bromopicolinate%2520ester%2520and%25203-benzyloxy-5-bromopicolinate%2520ester%252C%2520common%2520building%2520blocks%2520for%2520pharmaceuticals%2520and%2520agrochemicals%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26issue%3D45%26spage%3D8757%26epage%3D8762%26doi%3D10.1016%2Fj.tet.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">CLSI</span>.  <i>Methods for Dilution Antimicrobial Susceptibility Tests
for Bacteria That Grow Aerobically</i>, <span class="NLM_edition">11</span>th ed.; CLSI Standard M07; <span class="NLM_publisher-name">Clinical and Laboratory
Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=CLSI&title=Methods+for+Dilution+Antimicrobial+Susceptibility+Tests%0Afor+Bacteria+That+Grow+Aerobically"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DMethods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%2520Tests%250Afor%2520Bacteria%2520That%2520Grow%2520Aerobically%26pub%3DClinical%2520and%2520Laboratory%250AStandards%2520Institute%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waley, S. G.</span></span> <span> </span><span class="NLM_article-title">A quick method for the determination of inhibition constants</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1042/bj2050631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1042%2Fbj2050631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=7150236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADyaL3sXjtVClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1982&pages=631-633&issue=3&author=S.+G.+Waley&title=A+quick+method+for+the+determination+of+inhibition+constants&doi=10.1042%2Fbj2050631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A quick method for the determination of inhibition constants</span></div><div class="casAuthors">Waley, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-3</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The Ki value, in the common case of competitive inhibition, can be obtained by simple comparison of progress curves in the presence and in the absence of inhibitor.  The difference between the times taken for the concn. of substrate to fall to the same value is used to obtain the Ki.  The procedure to use when the product inhibits is described.  When there is mixed inhibition, reactions at different substrate concns. are used to obtain both Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyNMowjJf3C7Vg90H21EOLACvtfcHk0liDtMKQg1FAZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXjtVClsg%253D%253D&md5=48ebdbd7e9daa2446c42ce218c1c0a26</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2Fbj2050631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2050631%26sid%3Dliteratum%253Aachs%26aulast%3DWaley%26aufirst%3DS.%2BG.%26atitle%3DA%2520quick%2520method%2520for%2520the%2520determination%2520of%2520inhibition%2520constants%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D205%26issue%3D3%26spage%3D631%26epage%3D633%26doi%3D10.1042%2Fbj2050631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00158</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00158" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3525-3530&issue=8&author=O.+A.+Pembertonauthor=X.+Zhangauthor=Y.+Chen&title=Molecular+basis+of+substrate+recognition+and+product+release+by+the+Klebsiella+pneumoniae+carbapenemase+%28KPC-2%29&doi=10.1021%2Facs.jmedchem.7b00158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span></div><div class="casAuthors">Pemberton, Orville A.; Zhang, Xiujun; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3525-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the prodn. of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase.  Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics contg. hydrolyzed cefotaxime and faropenem.  They provide exptl. insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity.  These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRxiGIa-agP7Vg90H21EOLACvtfcHk0liDtMKQg1FAZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D&md5=4ec87803561ad874f178f1345e9a3dda</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00158%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMolecular%2520basis%2520of%2520substrate%2520recognition%2520and%2520product%2520release%2520by%2520the%2520Klebsiella%2520pneumoniae%2520carbapenemase%2520%2528KPC-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3525%26epage%3D3530%26doi%3D10.1021%2Facs.jmedchem.7b00158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl phosphonates as noncovalent inhibitors of both serine- and metallocarbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8480</span>– <span class="NLM_lpage">8496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslSqtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8480-8496&issue=18&author=O.+A.+Pembertonauthor=P.+Jaishankarauthor=A.+Akhtarauthor=J.+L.+Adamsauthor=L.+N.+Shawauthor=A.+R.+Rensloauthor=Y.+Chen&title=Heteroaryl+phosphonates+as+noncovalent+inhibitors+of+both+serine-+and+metallocarbapenemases&doi=10.1021%2Facs.jmedchem.9b00728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases</span></div><div class="casAuthors">Pemberton, Orville A.; Jaishankar, Priyadarshini; Akhtar, Afroza; Adams, Jessie L.; Shaw, Lindsey N.; Renslo, Adam R.; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8480-8496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gram-neg. pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), esp. those with carbapenemase activity, threaten the clin. utility of almost all β-lactam antibiotics.  Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2.  The most potent lead, compd. 16, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2.  Compd. 16 potentiated imipenem efficacy against resistant clin. and lab. bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concns. above 100μg/mL.  Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes.  These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-neg. pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWWKarmjAYXrVg90H21EOLACvtfcHk0ljE4ZnKDfuYEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslSqtrrF&md5=f1f220ababa55c9a1041883d1d058db8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00728%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DAkhtar%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DHeteroaryl%2520phosphonates%2520as%2520noncovalent%2520inhibitors%2520of%2520both%2520serine-%2520and%2520metallocarbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D18%26spage%3D8480%26epage%3D8496%26doi%3D10.1021%2Facs.jmedchem.9b00728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span> <span> </span><span class="NLM_article-title">iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&issue=Part+4&author=T.+G.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+Leslie&title=iMOSFLM%3A+a+new+graphical+interface+for+diffraction-image+processing+with+MOSFLM&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0ljE4ZnKDfuYEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26atitle%3DiMOSFLM%253A%2520a%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520MOSFLM%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3DPart%25204%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">Part 7</span>),  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&issue=Part+7&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0ljE4ZnKDfuYEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26issue%3DPart%25207%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit33"><span><span> </span><span class="NLM_article-title">The CCP4
suite: programs for protein crystallography. Collaborative
Computational Project, Number 4</span>.  <i>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume">50</span> (<span class="NLM_issue">Part 5</span>),  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1107/S0907444994003112</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+CCP4%0Asuite%3A+programs+for+protein+crystallography.+Collaborative%0AComputational+Project%2C+Number+4.+Acta+Crystallogr.%2C%0ASect.+D%3A+Biol.+Crystallogr.+1994%2C+50+%28Part+5%29%2C+760%E2%80%93763%2C+10.1107%2FS0907444994003112."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%250Asuite%253A%2520programs%2520for%2520protein%2520crystallography.%2520Collaborative%250AComputational%2520Project%252C%2520Number%25204%26jtitle%3DActa%2520Crystallogr.%252C%250ASect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26issue%3DPart%25205%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&issue=Part+4&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0liETk8DszzgSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26issue%3DPart%25204%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&issue=Part+4&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0ljI5rQUnogmOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26issue%3DPart%25204%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">The Phenix software for automated determination of macromolecular structures</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2011.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.ymeth.2011.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=21821126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=94-106&issue=1&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=S.+Jainauthor=G.+J.+Kapralauthor=R.+W.+Grosse+Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+D.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=The+Phenix+software+for+automated+determination+of+macromolecular+structures&doi=10.1016%2Fj.ymeth.2011.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Phenix software for automated determination of macromolecular structures</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li-Wei; Jain, Swati; Kapral, Gary J.; Grosse Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert D.; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-106</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  X-ray crystallog. is a crit. tool in the study of biol. systems.  It is able to provide information that has been a prerequisite to understanding the fundamentals of life.  It is also a method that is central to the development of new therapeutics for human disease.  Significant time and effort are required to det. and optimize many macromol. structures because of the need for manual interpretation of complex numerical data, often using many different software packages, and the repeated use of interactive three-dimensional graphics.  The Phenix software package has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on automation.  This has required the development of new algorithms that minimize or eliminate subjective input in favor of built-in expert-systems knowledge, the automation of procedures that are traditionally performed by hand, and the development of a computational framework that allows a tight integration between the algorithms.  The application of automated methods is particularly appropriate in the field of structural proteomics, where high throughput is desired.  Features in Phenix for the automation of exptl. phasing with subsequent model building, mol. replacement, structure refinement and validation are described and examples given of running Phenix from both the command line and graphical user interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjdX_7M-NcLVg90H21EOLACvtfcHk0ljI5rQUnogmOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt73F&md5=ba8f207cab9f3597dc0c6db885667a3f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2011.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2011.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse%2BKunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%2BD.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Phenix%2520software%2520for%2520automated%2520determination%2520of%2520macromolecular%2520structures%26jtitle%3DMethods%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D94%26epage%3D106%26doi%3D10.1016%2Fj.ymeth.2011.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=Part+4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lit7UwJYR9vEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3DPart%25204%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">Part 10</span>),  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&issue=Part+10&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=Electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0lit7UwJYR9vEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DElectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26issue%3DPart%252010%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">Part 1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&issue=Part+1&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lh3CHvWaRpNCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3DPart%25201%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref100':['cit100'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Robert E. Trout, Allison Zulli, Eugen Mesaros, Randy W. Jackson, Steven Boyd, Bin Liu, Jodie Hamrick, Denis Daigle, Cassandra L. Chatwin, Kaitlyn John, Lisa McLaughlin, Susan M. Cusick, William J. Weiss, Mark E. Pulse, Daniel C. Pevear, Greg Moeck, Luigi Xerri, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Burns</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10155-10166. <a href="https://doi.org/10.1021/acs.jmedchem.1c00437" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00437</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00437%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BVNRX-7145%252B%252528VNRX-5236%252BEtzadroxil%252529%25253A%252BAn%252BOrally%252BBioavailable%252B%2525CE%2525B2-Lactamase%252BInhibitor%252Bfor%252BEnterobacterales%252BExpressing%252BAmbler%252BClass%252BA%25252C%252BC%25252C%252Band%252BD%252BEnzymes%26aulast%3DTrout%26aufirst%3DRobert%2BE.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10032021%26date%3D30062021%26volume%3D64%26issue%3D14%26spage%3D10155%26epage%3D10166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guillermo Bahr, Lisandro J. González, <span class="NLM_string-name hlFld-ContribAuthor">Alejandro J. Vila</span>. </span><span class="cited-content_cbyCitation_article-title">Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (13)
                                     , 7957-8094. <a href="https://doi.org/10.1021/acs.chemrev.1c00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.1c00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.1c00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.1c00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DMetallo-%2525CE%2525B2-lactamases%252Bin%252Bthe%252BAge%252Bof%252BMultidrug%252BResistance%25253A%252BFrom%252BStructure%252Band%252BMechanism%252Bto%252BEvolution%25252C%252BDissemination%25252C%252Band%252BInhibitor%252BDesign%26aulast%3DBahr%26aufirst%3DGuillermo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D15062021%26volume%3D121%26issue%3D13%26spage%3D7957%26epage%3D8094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Motohiro Fujiu, Katsuki Yokoo, Jun Sato, Satoru Shibuya, Kazuo Komano, Hiroki Kusano, Soichiro Sato, Toshiaki Aoki, Naoki Kohira, Sachi Kanazawa, Ryosuke Watari, Tomoyuki Kawachi, Yuya Hirakawa, Daiki Nagamatsu, Emi Kashiwagi, Hideki Maki, <span class="NLM_string-name hlFld-ContribAuthor">Kenji Yamawaki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-Sulfinyl-Diazabicyclooctane Derivatives, Potential Oral β-Lactamase Inhibitors for Infections Caused by Serine β-Lactamase-Producing Enterobacterales. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9496-9512. <a href="https://doi.org/10.1021/acs.jmedchem.1c00799" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-Sulfinyl-Diazabicyclooctane%252BDerivatives%25252C%252BPotential%252BOral%252B%2525CE%2525B2-Lactamase%252BInhibitors%252Bfor%252BInfections%252BCaused%252Bby%252BSerine%252B%2525CE%2525B2-Lactamase-Producing%252BEnterobacterales%26aulast%3DFujiu%26aufirst%3DMotohiro%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D03052021%26date%3D18062021%26volume%3D64%26issue%3D13%26spage%3D9496%26epage%3D9512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nichole K. Stewart, Marta Toth, Anastasiya Stasyuk, Sergei B. Vakulenko, <span class="NLM_string-name hlFld-ContribAuthor">Clyde A. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , 1765-1776. <a href="https://doi.org/10.1021/acsinfecdis.1c00094" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00094%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DIn%252BCrystallo%252BTime-Resolved%252BInteraction%252Bof%252Bthe%252BClostridioides%252Bdifficile%252BCDD-1%252Benzyme%252Bwith%252BAvibactam%252BProvides%252BNew%252BInsights%252Binto%252Bthe%252BCatalytic%252BMechanism%252Bof%252BClass%252BD%252B%2525CE%2525B2-lactamases%26aulast%3DStewart%26aufirst%3DNichole%2BK.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21022021%26date%3D28042021%26volume%3D7%26issue%3D6%26spage%3D1765%26epage%3D1776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David T. Davies, <span class="NLM_string-name hlFld-ContribAuthor">Martin Everett</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (9)
                                     , 2055-2064. <a href="https://doi.org/10.1021/acs.accounts.0c00863" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00863%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDesigning%252BInhibitors%252Bof%252B%2525CE%2525B2-Lactamase%252BEnzymes%252Bto%252BOvercome%252BCarbapenem%252BResistance%252Bin%252BGram-Negative%252BBacteria%26aulast%3DDavies%26aufirst%3DDavid%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21122020%26date%3D31032021%26volume%3D54%26issue%3D9%26spage%3D2055%26epage%3D2064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David T. Davies, Simon Leiris, Magdalena Zalacain, Nicolas Sprynski, Jérôme Castandet, Justine Bousquet, Clarisse Lozano, Agustina Llanos, Laethitia Alibaud, Srinivas Vasa, Ramesh Pattipati, Ravindar Valige, Bhaskar Kummari, Srinivasu Pothukanuri, Cyntia De Piano, Ian Morrissey, Kirsty Holden, Peter Warn, Francesca Marcoccia, Manuela Benvenuti, Cecilia Pozzi, Giusy Tassone, Stefano Mangani, Jean-Denis Docquier, David Pallin, Richard Elliot, Marc Lemonnier, <span class="NLM_string-name hlFld-ContribAuthor">Martin Everett</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15802-15820. <a href="https://doi.org/10.1021/acs.jmedchem.0c01535" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01535%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BANT3310%25252C%252Ba%252BNovel%252BBroad-Spectrum%252BSerine%252B%2525CE%2525B2-Lactamase%252BInhibitor%252Bof%252Bthe%252BDiazabicyclooctane%252BClass%25252C%252BWhich%252BStrongly%252BPotentiates%252BMeropenem%252BActivity%252Bagainst%252BCarbapenem-Resistant%252BEnterobacterales%252Band%252BAcinetobacter%252Bbaumannii%26aulast%3DDavies%26aufirst%3DDavid%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02092020%26date%3D11122020%26volume%3D63%26issue%3D24%26spage%3D15802%26epage%3D15820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Thomas F. Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, Xiaoyun Wu, Tricia L. May-Dracka, Jan Antoinette C. Romero, Frank Wu, April Chen, Adam B. Shapiro, Nicole M. Carter, Sarah M. McLeod, Robert A. Giacobbe, Jeroen C. Verheijen, Sushmita D. Lahiri, Michael D. Sacco, Yu Chen, John P. O’Donnell, Alita A. Miller, John P. Mueller, <span class="NLM_string-name hlFld-ContribAuthor">Rubén A. Tommasi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12511-12525. <a href="https://doi.org/10.1021/acs.jmedchem.0c00579" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00579</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00579%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BOrally%252BAvailable%252BDiazabicyclooctane%252BInhibitor%252B%252528ETX0282%252529%252Bof%252BClass%252BA%25252C%252BC%25252C%252Band%252BD%252BSerine%252B%2525CE%2525B2-Lactamases%26aulast%3DDurand-R%25C3%25A9ville%26aufirst%3DThomas%2BF.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08042020%26date%3D24072020%26date%3D13072020%26volume%3D63%26issue%3D21%26spage%3D12511%26epage%3D12525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Kaiju  Xu</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Rongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent research and development of NDM-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113667. <a href="https://doi.org/10.1016/j.ejmech.2021.113667" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113667%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bresearch%252Band%252Bdevelopment%252Bof%252BNDM-1%252Binhibitors%26aulast%3DWang%26aufirst%3DTing%26date%3D2021%26volume%3D223%26spage%3D113667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilio  Lence</span>, <span class="hlFld-ContribAuthor ">Concepción  González-Bello</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Basis of Bicyclic Boronate β-Lactamase Inhibitors of Ultrabroad Efficacy – Insights From Molecular Dynamics Simulation Studies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fmicb.2021.721826" title="DOI URL">https://doi.org/10.3389/fmicb.2021.721826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2021.721826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2021.721826%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DMolecular%252BBasis%252Bof%252BBicyclic%252BBoronate%252B%2525CE%2525B2-Lactamase%252BInhibitors%252Bof%252BUltrabroad%252BEfficacy%252B%2525E2%252580%252593%252BInsights%252BFrom%252BMolecular%252BDynamics%252BSimulation%252BStudies%26aulast%3DLence%26aufirst%3DEmilio%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Corsica</span>, <span class="hlFld-ContribAuthor ">Paola Sandra  Mercuri</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Rémi  Coulon</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Giulia  Cerboni</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Giulia  Chelini</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105024. <a href="https://doi.org/10.1016/j.bioorg.2021.105024" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D4-Alkyl-1%25252C2%25252C4-triazole-3-thione%252Banalogues%252Bas%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2021%26volume%3D113%26spage%3D105024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Woo Shik  Shin</span>, <span class="hlFld-ContribAuthor ">Megin E.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Alexander  Bergstrom</span>, <span class="hlFld-ContribAuthor ">Isabella R.  Jennings</span>, <span class="hlFld-ContribAuthor ">Michael W.  Crowder</span>, <span class="hlFld-ContribAuthor ">Ramaiah  Muthyala</span>, <span class="hlFld-ContribAuthor ">Yuk Yin  Sham</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment‐based screening and hit‐based substructure search: Rapid discovery of 8‐hydroxyquinoline‐7‐carboxylic acid as a low‐cytotoxic, nanomolar metallo β‐lactamase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>60 </em><a href="https://doi.org/10.1111/cbdd.13912" title="DOI URL">https://doi.org/10.1111/cbdd.13912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13912%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DFragment%2525E2%252580%252590based%252Bscreening%252Band%252Bhit%2525E2%252580%252590based%252Bsubstructure%252Bsearch%25253A%252BRapid%252Bdiscovery%252Bof%252B8%2525E2%252580%252590hydroxyquinoline%2525E2%252580%2525907%2525E2%252580%252590carboxylic%252Bacid%252Bas%252Ba%252Blow%2525E2%252580%252590cytotoxic%25252C%252Bnanomolar%252Bmetallo%252B%2525CE%2525B2%2525E2%252580%252590lactamase%252Binhibitor%26aulast%3DShin%26aufirst%3DWoo%2BShik%26date%3D2021%26date%3D2021%26volume%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cassandra L.  Chatwin</span>, <span class="hlFld-ContribAuthor ">Jodie C.  Hamrick</span>, <span class="hlFld-ContribAuthor ">Robert E. L.  Trout</span>, <span class="hlFld-ContribAuthor ">Cullen L.  Myers</span>, <span class="hlFld-ContribAuthor ">Susan M.  Cusick</span>, <span class="hlFld-ContribAuthor ">William J.  Weiss</span>, <span class="hlFld-ContribAuthor ">Mark E.  Pulse</span>, <span class="hlFld-ContribAuthor ">Luigi  Xerri</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Burns</span>, <span class="hlFld-ContribAuthor ">Gregory  Moeck</span>, <span class="hlFld-ContribAuthor ">Denis M.  Daigle</span>, <span class="hlFld-ContribAuthor ">Kaitlyn  John</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Uehara</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Pevear</span>. </span><span class="cited-content_cbyCitation_article-title">Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of
              Enterobacterales
              Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (8)
                                     <a href="https://doi.org/10.1128/AAC.00552-21" title="DOI URL">https://doi.org/10.1128/AAC.00552-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00552-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00552-21%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DMicrobiological%252BCharacterization%252Bof%252BVNRX-5236%25252C%252Ba%252BBroad-Spectrum%252B%2525CE%2525B2-Lactamase%252BInhibitor%252Bfor%252BRescue%252Bof%252Bthe%252BOrally%252BBioavailable%252BCephalosporin%252BCeftibuten%252Bas%252Ba%252BCarbapenem-Sparing%252BAgent%252Bagainst%252BStrains%252Bof%252BEnterobacterales%252BExpressing%252BExtended-Spectrum%252B%2525CE%2525B2-Lactamases%252Band%252BSerine%252BCarbapenemases%26aulast%3DChatwin%26aufirst%3DCassandra%2BL.%26date%3D2021%26volume%3D65%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria F  Mojica</span>, <span class="hlFld-ContribAuthor ">Maria-Agustina  Rossi</span>, <span class="hlFld-ContribAuthor ">Alejandro J  Vila</span>, <span class="hlFld-ContribAuthor ">Robert A  Bonomo</span>. </span><span class="cited-content_cbyCitation_article-title">The urgent need for metallo-β-lactamase inhibitors: an unattended global threat. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Infectious Diseases</span><span> <strong>2021,</strong> <em>198 </em><a href="https://doi.org/10.1016/S1473-3099(20)30868-9" title="DOI URL">https://doi.org/10.1016/S1473-3099(20)30868-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1473-3099(20)30868-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1473-3099%2820%2930868-9%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Infectious%2520Diseases%26atitle%3DThe%252Burgent%252Bneed%252Bfor%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%25253A%252Ban%252Bunattended%252Bglobal%252Bthreat%26aulast%3DMojica%26aufirst%3DMaria%2BF%26date%3D2021%26volume%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David M  Livermore</span>. </span><span class="cited-content_cbyCitation_article-title">Antibiotic resistance during and beyond COVID-19. </span><span class="cited-content_cbyCitation_journal-name">JAC-Antimicrobial Resistance</span><span> <strong>2021,</strong> <em>3 </em>
                                    (Supplement_1)
                                     , i5-i16. <a href="https://doi.org/10.1093/jacamr/dlab052" title="DOI URL">https://doi.org/10.1093/jacamr/dlab052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jacamr/dlab052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjacamr%2Fdlab052%26sid%3Dliteratum%253Aachs%26jtitle%3DJAC-Antimicrobial%2520Resistance%26atitle%3DAntibiotic%252Bresistance%252Bduring%252Band%252Bbeyond%252BCOVID-19%26aulast%3DLivermore%26aufirst%3DDavid%2BM%26date%3D2021%26date%3D2021%26volume%3D3%26issue%3DSupplement_1%26spage%3Di5%26epage%3Di16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Hang  Yan</span>, <span class="hlFld-ContribAuthor ">Zhao-Feng  Li</span>, <span class="hlFld-ContribAuthor ">Xiang-Li  Ning</span>, <span class="hlFld-ContribAuthor ">Ji  Deng</span>, <span class="hlFld-ContribAuthor ">Jun-Lin  Yu</span>, <span class="hlFld-ContribAuthor ">Yubin  Luo</span>, <span class="hlFld-ContribAuthor ">Zhenling  Wang</span>, <span class="hlFld-ContribAuthor ">Guo  Li</span>, <span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>, <span class="hlFld-ContribAuthor ">You-Cai  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>41 </em>, 127956. <a href="https://doi.org/10.1016/j.bmcl.2021.127956" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127956%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-aryl%252Bsubstituted%252Bbenzoxaboroles%252Bas%252Bbroad-spectrum%252Binhibitors%252Bof%252Bserine-%252Band%252Bmetallo-%2525CE%2525B2-lactamases%26aulast%3DYan%26aufirst%3DYu-Hang%26date%3D2021%26volume%3D41%26spage%3D127956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>, <span class="hlFld-ContribAuthor ">Debora  Rubio-Aparicio</span>, <span class="hlFld-ContribAuthor ">Kirk  Nelson</span>, <span class="hlFld-ContribAuthor ">Dongxu  Sun</span>, <span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Mariana  Castanheira</span>, <span class="hlFld-ContribAuthor ">Jill  Lindley</span>, <span class="hlFld-ContribAuthor ">Jeffery  Loutit</span>, <span class="hlFld-ContribAuthor ">Michael  Dudley</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2021,</strong> <em>65 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00210-21" title="DOI URL">https://doi.org/10.1128/AAC.00210-21</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00210-21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00210-21%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252BActivity%252Bof%252Bthe%252BUltrabroad-Spectrum%252BBeta-Lactamase%252BInhibitor%252BQPX7728%252Bin%252BCombination%252Bwith%252BMultiple%252BBeta-Lactam%252BAntibiotics%252Bagainst%252BPseudomonas%252Baeruginosa%26aulast%3DLomovskaya%26aufirst%3DOlga%26date%3D2021%26volume%3D65%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilio  Lence</span>, <span class="hlFld-ContribAuthor ">Concepción  González‐Bello</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens. </span><span class="cited-content_cbyCitation_journal-name">Advanced Therapeutics</span><span> <strong>2021,</strong> <em>4 </em>
                                    (5)
                                     , 2000246. <a href="https://doi.org/10.1002/adtp.202000246" title="DOI URL">https://doi.org/10.1002/adtp.202000246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adtp.202000246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadtp.202000246%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Therapeutics%26atitle%3DBicyclic%252BBoronate%252B%2525CE%2525B2%2525E2%252580%252590Lactamase%252BInhibitors%25253A%252BThe%252BPresent%252BHope%252Bagainst%252BDeadly%252BBacterial%252BPathogens%26aulast%3DLence%26aufirst%3DEmilio%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D5%26spage%3D2000246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra V.  Krivitskaya</span>, <span class="hlFld-ContribAuthor ">Maria G.  Khrenova</span>. </span><span class="cited-content_cbyCitation_article-title">Boronic Acids as Prospective Inhibitors of Metallo-β-Lactamases: Efficient Chemical Reaction in the Enzymatic Active Site Revealed by Molecular Modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 2026. <a href="https://doi.org/10.3390/molecules26072026" title="DOI URL">https://doi.org/10.3390/molecules26072026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26072026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26072026%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBoronic%252BAcids%252Bas%252BProspective%252BInhibitors%252Bof%252BMetallo-%2525CE%2525B2-Lactamases%25253A%252BEfficient%252BChemical%252BReaction%252Bin%252Bthe%252BEnzymatic%252BActive%252BSite%252BRevealed%252Bby%252BMolecular%252BModeling%26aulast%3DKrivitskaya%26aufirst%3DAlexandra%2BV.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qidi  Kong</span>, <span class="hlFld-ContribAuthor ">Yushe  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>35 </em>, 127799. <a href="https://doi.org/10.1016/j.bmcl.2021.127799" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127799%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252Bantibacterial%252Bagents%26aulast%3DKong%26aufirst%3DQidi%26date%3D2021%26volume%3D35%26spage%3D127799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shu  Song</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Jacob  Kongsted</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments in the medicinal chemistry of single boron atom-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>73 </em><a href="https://doi.org/10.1016/j.apsb.2021.01.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.01.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.01.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DRecent%252Bdevelopments%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bsingle%252Bboron%252Batom-containing%252Bcompounds%26aulast%3DSong%26aufirst%3DShu%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Bremner</span>. </span><span class="cited-content_cbyCitation_article-title">Antibacterial Combinations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 21-49. <a href="https://doi.org/10.1007/978-981-16-0999-2_2" title="DOI URL">https://doi.org/10.1007/978-981-16-0999-2_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0999-2_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0999-2_2%26sid%3Dliteratum%253Aachs%26atitle%3DAntibacterial%252BCombinations%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26date%3D2021%26spage%3D21%26epage%3D49%26pub%3DSpringer%2520Singapore%26atitle%3DMultiple%252BAction-Based%252BDesign%252BApproaches%252Bto%252BAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David P.  Rotella</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocycles in drug discovery: Properties and preparation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 149-183. <a href="https://doi.org/10.1016/bs.aihch.2020.10.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DHeterocycles%252Bin%252Bdrug%252Bdiscovery%25253A%252BProperties%252Band%252Bpreparation%26aulast%3DRotella%26aufirst%3DDavid%2BP.%26date%3D2021%26spage%3D149%26epage%3D183%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Boron and covalent inhibition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 135-201. <a href="https://doi.org/10.1016/bs.armc.2020.10.002" title="DOI URL">https://doi.org/10.1016/bs.armc.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2020.10.002%26sid%3Dliteratum%253Aachs%26atitle%3DBoron%252Band%252Bcovalent%252Binhibition%26aulast%3DLeach%26aufirst%3DAndrew%2BG.%26date%3D2021%26spage%3D135%26epage%3D201%26pub%3DElsevier%26atitle%3DThe%252BDesign%252Bof%252BCovalent-Based%252BInhibitors%26date%3D2021%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Montserrat  Mora-Ochomogo</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lohans</span>. </span><span class="cited-content_cbyCitation_article-title">β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>6 </em><a href="https://doi.org/10.1039/D1MD00200G" title="DOI URL">https://doi.org/10.1039/D1MD00200G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00200G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00200G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B2-Lactam%252Bantibiotic%252Btargets%252Band%252Bresistance%252Bmechanisms%25253A%252Bfrom%252Bcovalent%252Binhibitors%252Bto%252Bsubstrates%26aulast%3DMora-Ochomogo%26aufirst%3DMontserrat%26date%3D2021%26date%3D2021%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan C.  Vázquez-Ucha</span>, <span class="hlFld-ContribAuthor ">Jorge  Arca-Suárez</span>, <span class="hlFld-ContribAuthor ">Germán  Bou</span>, <span class="hlFld-ContribAuthor ">Alejandro  Beceiro</span>. </span><span class="cited-content_cbyCitation_article-title">New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9308. <a href="https://doi.org/10.3390/ijms21239308" title="DOI URL">https://doi.org/10.3390/ijms21239308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239308%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNew%252BCarbapenemase%252BInhibitors%25253A%252BClearing%252Bthe%252BWay%252Bfor%252Bthe%252B%2525CE%2525B2-Lactams%26aulast%3DV%25C3%25A1zquez-Ucha%26aufirst%3DJuan%2BC.%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Paola  Mercuri</span>, <span class="hlFld-ContribAuthor ">Carine  Bebrone</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Giulia  Cerboni</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Damien  Baud</span>, <span class="hlFld-ContribAuthor ">Giuliano  Cutolo</span>, <span class="hlFld-ContribAuthor ">Benoît  Bestgen</span>, <span class="hlFld-ContribAuthor ">Giulia  Chelini</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Cecilia  Pozzi</span>, <span class="hlFld-ContribAuthor ">Manuela  Benvenuti</span>, <span class="hlFld-ContribAuthor ">Karolina  Kwapien</span>, <span class="hlFld-ContribAuthor ">Marina  Fischer</span>, <span class="hlFld-ContribAuthor ">Katja  Becker</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Frère</span>, <span class="hlFld-ContribAuthor ">Stefano  Mangani</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Dorothée  Berthomieu</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112720. <a href="https://doi.org/10.1016/j.ejmech.2020.112720" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112720%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Amino-1%25252C2%25252C4-triazole-3-thione-derived%252BSchiff%252Bbases%252Bas%252Bmetallo-%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2020%26volume%3D208%26spage%3D112720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Kewu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium complexes as prospective inhibitors of metallo-β-lactamases to reverse carbapenem resistance. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (40)
                                     , 14099-14105. <a href="https://doi.org/10.1039/D0DT02430A" title="DOI URL">https://doi.org/10.1039/D0DT02430A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02430A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02430A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DRuthenium%252Bcomplexes%252Bas%252Bprospective%252Binhibitors%252Bof%252Bmetallo-%2525CE%2525B2-lactamases%252Bto%252Breverse%252Bcarbapenem%252Bresistance%26aulast%3DChen%26aufirst%3DCheng%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D40%26spage%3D14099%26epage%3D14105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mojgan  Sabet</span>, <span class="hlFld-ContribAuthor ">Ziad  Tarazi</span>, <span class="hlFld-ContribAuthor ">David C.  Griffith</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo
              Activity of QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor, in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (11)
                                     <a href="https://doi.org/10.1128/AAC.01267-20" title="DOI URL">https://doi.org/10.1128/AAC.01267-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01267-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01267-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVivo%252BActivity%252Bof%252BQPX7728%25252C%252Ban%252BUltrabroad-Spectrum%252BBeta-Lactamase%252BInhibitor%25252C%252Bin%252BCombination%252Bwith%252BBeta-Lactams%252Bagainst%252BCarbapenem-Resistant%252BKlebsiella%252Bpneumoniae%26aulast%3DSabet%26aufirst%3DMojgan%26date%3D2020%26volume%3D64%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirk  Nelson</span>, <span class="hlFld-ContribAuthor ">Debora  Rubio-Aparicio</span>, <span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Dongxu  Sun</span>, <span class="hlFld-ContribAuthor ">Maxim  Totrov</span>, <span class="hlFld-ContribAuthor ">Michael  Dudley</span>, <span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (11)
                                     <a href="https://doi.org/10.1128/AAC.01406-20" title="DOI URL">https://doi.org/10.1128/AAC.01406-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01406-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01406-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252BActivity%252Bof%252Bthe%252BUltra-Broad-Spectrum%252BBeta-Lactamase%252BInhibitor%252BQPX7728%252Bin%252BCombination%252Bwith%252BMeropenem%252Bagainst%252BClinical%252BIsolates%252Bof%252BCarbapenem-Resistant%252BAcinetobacter%252Bbaumannii%26aulast%3DNelson%26aufirst%3DKirk%26date%3D2020%26volume%3D64%26issue%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanan  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Guo</span>, <span class="hlFld-ContribAuthor ">Yonglin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yawen  Gao</span>, <span class="hlFld-ContribAuthor ">Xiyan  Wang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaodi  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Natural Allosteric Inhibitor That Targets NDM-1 Against Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.581001" title="DOI URL">https://doi.org/10.3389/fphar.2020.581001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.581001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.581001%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BNatural%252BAllosteric%252BInhibitor%252BThat%252BTargets%252BNDM-1%252BAgainst%252BEscherichia%252Bcoli%26aulast%3DYang%26aufirst%3DYanan%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Ke-Wu  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of covalent inhibitors targeting metallo-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112573. <a href="https://doi.org/10.1016/j.ejmech.2020.112573" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112573</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112573%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdesign%252Bof%252Bcovalent%252Binhibitors%252Btargeting%252Bmetallo-%2525CE%2525B2-lactamases%26aulast%3DChen%26aufirst%3DCheng%26date%3D2020%26volume%3D203%26spage%3D112573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Synthesis of β-Lactamase Inhibitor QPX7728. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2020,</strong>,, 1137. <a href="https://doi.org/10.1055/s-0040-1705897" title="DOI URL">https://doi.org/10.1055/s-0040-1705897</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705897%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B2-Lactamase%252BInhibitor%252BQPX7728%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D10%26spage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariana Pereira  Silva</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Madalena  Pinto</span>, <span class="hlFld-ContribAuthor ">Maria Emília  Sousa</span>. </span><span class="cited-content_cbyCitation_article-title">Boronic Acids and Their Derivatives in Medicinal Chemistry: Synthesis and Biological Applications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4323. <a href="https://doi.org/10.3390/molecules25184323" title="DOI URL">https://doi.org/10.3390/molecules25184323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184323%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBoronic%252BAcids%252Band%252BTheir%252BDerivatives%252Bin%252BMedicinal%252BChemistry%25253A%252BSynthesis%252Band%252BBiological%252BApplications%26aulast%3DSilva%26aufirst%3DMariana%2BPereira%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Gavara</span>, <span class="hlFld-ContribAuthor ">Federica  Verdirosa</span>, <span class="hlFld-ContribAuthor ">Alice  Legru</span>, <span class="hlFld-ContribAuthor ">Paola Sandra  Mercuri</span>, <span class="hlFld-ContribAuthor ">Lionel  Nauton</span>, <span class="hlFld-ContribAuthor ">Laurent  Sevaille</span>, <span class="hlFld-ContribAuthor ">Georges  Feller</span>, <span class="hlFld-ContribAuthor ">Dorothée  Berthomieu</span>, <span class="hlFld-ContribAuthor ">Filomena  Sannio</span>, <span class="hlFld-ContribAuthor ">Francesca  Marcoccia</span>, <span class="hlFld-ContribAuthor ">Silvia  Tanfoni</span>, <span class="hlFld-ContribAuthor ">Filomena  De Luca</span>, <span class="hlFld-ContribAuthor ">Nohad  Gresh</span>, <span class="hlFld-ContribAuthor ">Moreno  Galleni</span>, <span class="hlFld-ContribAuthor ">Jean-Denis  Docquier</span>, <span class="hlFld-ContribAuthor ">Jean-François  Hernandez</span>. </span><span class="cited-content_cbyCitation_article-title">4-(N-Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (8)
                                     , 1094. <a href="https://doi.org/10.3390/biom10081094" title="DOI URL">https://doi.org/10.3390/biom10081094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10081094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10081094%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3D4-%252528N-Alkyl-%252Band%252B-Acyl-amino%252529-1%25252C2%25252C4-triazole-3-thione%252BAnalogs%252Bas%252BMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%25253A%252BImpact%252Bof%252B4-Linker%252Bon%252BPotency%252Band%252BSpectrum%252Bof%252BInhibition%26aulast%3DGavara%26aufirst%3DLaurent%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D8%26spage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajmer Singh  Grewal</span>, <span class="hlFld-ContribAuthor ">Komal  Thapa</span>, <span class="hlFld-ContribAuthor ">Neelam  Sharma</span>, <span class="hlFld-ContribAuthor ">Sukhbir  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">New Delhi metallo-β-lactamase-1 inhibitors for combating antibiotic drug resistance: recent developments. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (8)
                                     , 1301-1320. <a href="https://doi.org/10.1007/s00044-020-02580-x" title="DOI URL">https://doi.org/10.1007/s00044-020-02580-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02580-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02580-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DNew%252BDelhi%252Bmetallo-%2525CE%2525B2-lactamase-1%252Binhibitors%252Bfor%252Bcombating%252Bantibiotic%252Bdrug%252Bresistance%25253A%252Brecent%252Bdevelopments%26aulast%3DGrewal%26aufirst%3DAjmer%2BSingh%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D8%26spage%3D1301%26epage%3D1320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivakumar S.  Jalde</span>, <span class="hlFld-ContribAuthor ">Hyun Kyung  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the development of β-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Microbiology</span><span> <strong>2020,</strong> <em>58 </em>
                                    (8)
                                     , 633-647. <a href="https://doi.org/10.1007/s12275-020-0285-z" title="DOI URL">https://doi.org/10.1007/s12275-020-0285-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12275-020-0285-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12275-020-0285-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Microbiology%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252B%2525CE%2525B2-lactamase%252Binhibitors%26aulast%3DJalde%26aufirst%3DShivakumar%2BS.%26date%3D2020%26date%3D2020%26volume%3D58%26issue%3D8%26spage%3D633%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nakita  Reddy</span>, <span class="hlFld-ContribAuthor ">Mbongeni  Shungube</span>, <span class="hlFld-ContribAuthor ">Per I  Arvidsson</span>, <span class="hlFld-ContribAuthor ">Sooraj  Baijnath</span>, <span class="hlFld-ContribAuthor ">Hendrik G  Kruger</span>, <span class="hlFld-ContribAuthor ">Thavendran  Govender</span>, <span class="hlFld-ContribAuthor ">Tricia  Naicker</span>. </span><span class="cited-content_cbyCitation_article-title">A 2018–2019 patent review of metallo beta-lactamase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (7)
                                     , 541-555. <a href="https://doi.org/10.1080/13543776.2020.1767070" title="DOI URL">https://doi.org/10.1080/13543776.2020.1767070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1767070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1767070%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252B2018%2525E2%252580%2525932019%252Bpatent%252Breview%252Bof%252Bmetallo%252Bbeta-lactamase%252Binhibitors%26aulast%3DReddy%26aufirst%3DNakita%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D7%26spage%3D541%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonela R.  Palacios</span>, <span class="hlFld-ContribAuthor ">María-Agustina  Rossi</span>, <span class="hlFld-ContribAuthor ">Graciela S.  Mahler</span>, <span class="hlFld-ContribAuthor ">Alejandro J.  Vila</span>. </span><span class="cited-content_cbyCitation_article-title">Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (6)
                                     , 854. <a href="https://doi.org/10.3390/biom10060854" title="DOI URL">https://doi.org/10.3390/biom10060854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10060854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10060854%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMetallo-%2525CE%2525B2-Lactamase%252BInhibitors%252BInspired%252Bon%252BSnapshots%252Bfrom%252Bthe%252BCatalytic%252BMechanism%26aulast%3DPalacios%26aufirst%3DAntonela%2BR.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D6%26spage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pauline A.  Lang</span>, <span class="hlFld-ContribAuthor ">Anete  Parkova</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Leissing</span>, <span class="hlFld-ContribAuthor ">Karina  Calvopiña</span>, <span class="hlFld-ContribAuthor ">Ricky  Cain</span>, <span class="hlFld-ContribAuthor ">Alen  Krajnc</span>, <span class="hlFld-ContribAuthor ">Tharindi D.  Panduwawala</span>, <span class="hlFld-ContribAuthor ">Jules  Philippe</span>, <span class="hlFld-ContribAuthor ">Colin W. G.  Fishwick</span>, <span class="hlFld-ContribAuthor ">Peteris  Trapencieris</span>, <span class="hlFld-ContribAuthor ">Malcolm G. P.  Page</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">Jürgen  Brem</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (6)
                                     , 899. <a href="https://doi.org/10.3390/biom10060899" title="DOI URL">https://doi.org/10.3390/biom10060899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10060899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10060899%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DBicyclic%252BBoronates%252Bas%252BPotent%252BInhibitors%252Bof%252BAmpC%25252C%252Bthe%252BClass%252BC%252B%2525CE%2525B2-Lactamase%252Bfrom%252BEscherichia%252Bcoli%26aulast%3DLang%26aufirst%3DPauline%2BA.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D6%26spage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>, <span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Kirk  Nelson</span>, <span class="hlFld-ContribAuthor ">Debora  Rubio-Aparicio</span>, <span class="hlFld-ContribAuthor ">Dongxu  Sun</span>, <span class="hlFld-ContribAuthor ">Maxim  Totrov</span>, <span class="hlFld-ContribAuthor ">Michael N.  Dudley</span>. </span><span class="cited-content_cbyCitation_article-title">Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00212-20" title="DOI URL">https://doi.org/10.1128/AAC.00212-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00212-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00212-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DSpectrum%252Bof%252BBeta-Lactamase%252BInhibition%252Bby%252Bthe%252BCyclic%252BBoronate%252BQPX7728%25252C%252Ban%252BUltrabroad-Spectrum%252BBeta-Lactamase%252BInhibitor%252Bof%252BSerine%252Band%252BMetallo-Beta-Lactamases%25253A%252BEnhancement%252Bof%252BActivity%252Bof%252BMultiple%252BAntibiotics%252Bagainst%252BIsogenic%252BStrains%252BExpressing%252BSingle%252BBeta-Lactamases%26aulast%3DLomovskaya%26aufirst%3DOlga%26date%3D2020%26volume%3D64%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruslan  Tsivkovski</span>, <span class="hlFld-ContribAuthor ">Maxim  Totrov</span>, <span class="hlFld-ContribAuthor ">Olga  Lomovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2020,</strong> <em>64 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/AAC.00130-20" title="DOI URL">https://doi.org/10.1128/AAC.00130-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00130-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00130-20%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DBiochemical%252BCharacterization%252Bof%252BQPX7728%25252C%252Ba%252BNew%252BUltrabroad-Spectrum%252BBeta-Lactamase%252BInhibitor%252Bof%252BSerine%252Band%252BMetallo-Beta-Lactamases%26aulast%3DTsivkovski%26aufirst%3DRuslan%26date%3D2020%26volume%3D64%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott T.  Lefurgy</span>, <span class="hlFld-ContribAuthor ">Emilia  Caselli</span>, <span class="hlFld-ContribAuthor ">Magdalena A.  Taracila</span>, <span class="hlFld-ContribAuthor ">Vladimir N.  Malashkevich</span>, <span class="hlFld-ContribAuthor ">Beena  Biju</span>, <span class="hlFld-ContribAuthor ">Krisztina M.  Papp-Wallace</span>, <span class="hlFld-ContribAuthor ">Jeffrey B.  Bonanno</span>, <span class="hlFld-ContribAuthor ">Fabio  Prati</span>, <span class="hlFld-ContribAuthor ">Steven C.  Almo</span>, <span class="hlFld-ContribAuthor ">Robert A.  Bonomo</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of FOX-4 Cephamycinase in Complex with Transition-State Analog Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (5)
                                     , 671. <a href="https://doi.org/10.3390/biom10050671" title="DOI URL">https://doi.org/10.3390/biom10050671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10050671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10050671%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DStructures%252Bof%252BFOX-4%252BCephamycinase%252Bin%252BComplex%252Bwith%252BTransition-State%252BAnalog%252BInhibitors%26aulast%3DLefurgy%26aufirst%3DScott%2BT.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanling  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaodi  Sun</span>, <span class="hlFld-ContribAuthor ">Fanrong  Kong</span>, <span class="hlFld-ContribAuthor ">Lining  Xia</span>, <span class="hlFld-ContribAuthor ">Xuming  Deng</span>, <span class="hlFld-ContribAuthor ">Dacheng  Wang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive Enterobacteriaceae in vitro. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Environmental Research and Public Health</span><span> <strong>2020,</strong> <em>17 </em>
                                    (6)
                                     , 2162. <a href="https://doi.org/10.3390/ijerph17062162" title="DOI URL">https://doi.org/10.3390/ijerph17062162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijerph17062162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijerph17062162%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Environmental%2520Research%2520and%2520Public%2520Health%26atitle%3DSpecific%252BNDM-1%252BInhibitor%252Bof%252BIsoliquiritin%252BEnhances%252Bthe%252BActivity%252Bof%252BMeropenem%252Bagainst%252BNDM-1-positive%252BEnterobacteriaceae%252Bin%252Bvitro%26aulast%3DWang%26aufirst%3DYanling%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D6%26spage%3D2162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Recently introduced β-lactamase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. The benzoxaborinine β-lactamase inhibitors lead that started it all.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Benzoxaborinine <b>4a</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Putative structures of dimer <b>5a</b> and trimer <b>5b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>6a</b>–<b>r</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oxidative deboronation of <b>17b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compound <b>35</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High resolution structures of <b>35</b> with multiple enzymes. Hydrogen atoms were added using ICM-Pro (Molsoft, San Diego). Accession codes are the following: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J">6V1J</a> (KPC-2:<b>35</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M">6V1M</a> (NDM-1:<b>35</b>), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O">6V1O</a> (OXA-48:<b>35</b>), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P">6V1P</a> (VIM-2:<b>35</b>)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Activity of meropenem alone or in combination with compound <b>35</b> against <i>K. pneumoniae</i> KP1244 in a 24 h neutropenic mouse thigh infection model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/medium/jm9b01976_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Evolution of β-lactamase inhibitors leading to compound <b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.9b01976/20200716/images/large/jm9b01976_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01976&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i69">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dortet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirel, L.</span></span> <span> </span><span class="NLM_article-title">Carbapenem resistance in Enterobacteriaceae: here is the storm</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2012.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.molmed.2012.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=22480775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=263-272&issue=5&author=P.+Nordmannauthor=L.+Dortetauthor=L.+Poirel&title=Carbapenem+resistance+in+Enterobacteriaceae%3A+here+is+the+storm&doi=10.1016%2Fj.molmed.2012.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Carbapenem resistance in Enterobacteriaceae: here is the storm</span></div><div class="casAuthors">Nordmann, Patrice; Dortet, Laurent; Poirel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The current worldwide emergence of resistance to the powerful antibiotic carbapenem in Enterobacteriaceae constitutes an important growing public health threat.  Sporadic outbreaks or endemic situations with enterobacterial isolates not susceptible to carbapenems are now reported not only in hospital settings but also in the community.  Acquired class A (KPC), class B (IMP, VIM, NDM), or class D (OXA-48, OXA-181) carbapenemases, are the most important determinants sustaining resistance to carbapenems.  The corresponding genes are mostly plasmid-located and assocd. with various mobile genetic structures (insertion sequences, integrons, transposons), further enhancing their spread.  This review summarizes the current knowledge on carbapenem resistance in Enterobacteriaceae, including activity, distribution, clin. impact, and possible novel antibiotic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw3NvxiXmzF7Vg90H21EOLACvtfcHk0lg07155J7gVUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmslyiuro%253D&md5=afb14fc82cdcf73cb9c1fdf17b3c1a2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2012.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2012.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DNordmann%26aufirst%3DP.%26aulast%3DDortet%26aufirst%3DL.%26aulast%3DPoirel%26aufirst%3DL.%26atitle%3DCarbapenem%2520resistance%2520in%2520Enterobacteriaceae%253A%2520here%2520is%2520the%2520storm%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2012%26volume%3D18%26issue%3D5%26spage%3D263%26epage%3D272%26doi%3D10.1016%2Fj.molmed.2012.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zasowski, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, M. J.</span></span> <span> </span><span class="NLM_article-title">The β-lactams strike back: ceftazidime-avibactam</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/phar.1622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1002%2Fphar.1622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=26289307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2mur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=755-770&issue=8&author=E.+J.+Zasowskiauthor=J.+M.+Rybakauthor=M.+J.+Rybak&title=The+%CE%B2-lactams+strike+back%3A+ceftazidime-avibactam&doi=10.1002%2Fphar.1622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The β-Lactams Strike Back: Ceftazidime-Avibactam</span></div><div class="casAuthors">Zasowski, Evan J.; Rybak, Jeffrey M.; Rybak, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">755-770</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Gram-neg. resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics.  Ceftazidime-avibactam is a newly approved agent combining ceftazidime and a novel β-lactamase inhibitor with activity against multidrug-resistant gram-neg. bacteria.  Avibactam has increased potency and expanded spectrum of inhibition of class A and C β-lactamases relative to available β-lactamase inhibitors, including extended-spectrum β-lactamases, AmpC, and Klebsiella pneumoniae carbapenemase (KPC) enzymes.  Avibactam expands ceftazidime's spectrum of activity to include many ceftazidime- and carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa.  Early clin. data indicate that ceftazidime-avibactam is effective and well tolerated in patients with complicated urinary tract infections (cUTIs) and complicated intraabdominal infections (cIAI).  In a phase II trial of patients with cUTIs, ceftazidime-avibactam produced similar rates of clin. and microbiol. success compared with imipenem-cilastatin (70.5% and 71.4% microbiol. success rates, resp.).  Likewise, patients receiving ceftazidime-avibactam plus metronidazole in a phase II study of patients with cIAI had similar response rates to those receiving meropenem (91.2% and 93.4% clin. success rates, resp.).  Based on available in vitro, in vivo, and phase II trial data, as well as preliminary phase III trial results in ceftazidime-resistant, gram-neg. cUTI and cIAI, ceftazidime-avibactam received U.S. Food and Drug Administration approval for treatment of cUTI, including pyelonephritis, and cIAI, in combination with metronidazole, in adult patients with limited or no alternative treatment options.  The approved dosage, ceftazidime 2 g-avibactam 0.5 g administered as a 2-h infusion every 8 h, was selected based on pharmacodynamic anal. and available clin. data.  This dosage is under further investigation in patients with cUTI, cIAI, and nosocomial or ventilator-assocd. pneumonia.  The current body of evidence suggests that ceftazidime-avibactam is a promising addn. to our therapeutic armamentarium with potential to answer an urgent unmet medical need.  Further data in highly resistant gram-neg. infections, particularly those caused by KPC-producing Enterobacteriaceae, are needed.  As it is introduced into clin. use, careful stewardship and rational use are essential to preserve ceftazidime-avibactam's potential utility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOTOxxlFRVx7Vg90H21EOLACvtfcHk0lg07155J7gVUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2mur7O&md5=6b383e5adb9ef14545f750d36541e15a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fphar.1622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.1622%26sid%3Dliteratum%253Aachs%26aulast%3DZasowski%26aufirst%3DE.%2BJ.%26aulast%3DRybak%26aufirst%3DJ.%2BM.%26aulast%3DRybak%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520%25CE%25B2-lactams%2520strike%2520back%253A%2520ceftazidime-avibactam%26jtitle%3DPharmacotherapy%26date%3D2015%26volume%3D35%26issue%3D8%26spage%3D755%26epage%3D770%26doi%3D10.1002%2Fphar.1622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zmarlicka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaeer, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, J.</span></span> <span> </span><span class="NLM_article-title">Meropenem/vaborbactam, the first carbapenem/β-lactamase inhibitor combination</span>. <i>Ann. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">769</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1177/1060028018763288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1177%2F1060028018763288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=29514462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlSktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2018&pages=769-779&issue=8&author=J.+C.+Choauthor=M.+T.+Zmarlickaauthor=K.+M.+Shaeerauthor=J.+Pardo&title=Meropenem%2Fvaborbactam%2C+the+first+carbapenem%2F%CE%B2-lactamase+inhibitor+combination&doi=10.1177%2F1060028018763288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Meropenem/Vaborbactam, the First Carbapenem/β-Lactamase Inhibitor Combination</span></div><div class="casAuthors">Cho, Jonathan C.; Zmarlicka, Monika T.; Shaeer, Kristy M.; Pardo, Joe</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">769-779</span>CODEN:
                <span class="NLM_cas:coden">APHRER</span>;
        ISSN:<span class="NLM_cas:issn">1542-6270</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Objective: To review the pharmacol., spectrum of activity, pharmacokinetics, pharmacodynamics, safety, efficacy, administration, and considerations for clin. use of meropenem/vaborbactam (M/V).  Data Sources: A literature search using PubMed and clinicaltrials.gov (June 2013 to Dec. 2017) was conducted using the search terms meropenem, vaborbactam, RPX7009, biapenem, RPX2003, and carbavance.  Refs. from relevant articles and conference abstrs. were also reviewed.  Study Selection and Data Extn.: Preclin., phase I studies, and phase III studies written in the English language were evaluated.  Data Synthesis: M/V is a novel carbapenem/β-lactamase inhibitor antimicrobial with in vitro activity against nearly 99% of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.  M/V is approved for the treatment of adults with complicated urinary tract infections (cUTIs), including pyelonephritis.  In a phase III cUTI trial (TANGO I), 98.4% of patients treated with M/V experienced overall clin. success compared with 94% of patients treated with piperacillin/tazobactam (95% CI = 0.7 to 9.1).  When compared with best available therapy for carbapenem-resistant Enterobacteriaceae (CRE) infections in TANGO II, patients receiving M/V were more likely to achieve clin. cure at both the end of therapy (64.3% vs 33.3%, P = 0.04) as well as at the test of cure (57.1% vs 26.7%, P = 0.04).  The most common adverse effects assocd. with M/V were headache, infusion-site reactions, and diarrhea.  Conclusion: M/V has a valuable role in the treatment of CRE and should be used judiciously to preserve its use for resistant infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIPjYbVsLZ7rVg90H21EOLACvtfcHk0lhXwo4x8Ta70Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlSktLbM&md5=efe79ffa9105cea570d2f78f38c2858c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1177%2F1060028018763288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1060028018763288%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DJ.%2BC.%26aulast%3DZmarlicka%26aufirst%3DM.%2BT.%26aulast%3DShaeer%26aufirst%3DK.%2BM.%26aulast%3DPardo%26aufirst%3DJ.%26atitle%3DMeropenem%252Fvaborbactam%252C%2520the%2520first%2520carbapenem%252F%25CE%25B2-lactamase%2520inhibitor%2520combination%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2018%26volume%3D52%26issue%3D8%26spage%3D769%26epage%3D779%26doi%3D10.1177%2F1060028018763288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelenitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhanel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagacé-Wiens, P. R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denisuik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoban, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. P.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlowsky, J. A.</span></span> <span> </span><span class="NLM_article-title">Imipenem-relebactam and meropenem-vaborbactam: two novel carbapenem-β-lactamase inhibitor combinations</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/s40265-017-0851-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1007%2Fs40265-017-0851-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=29230684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=65-98&issue=1&author=G.+G.+Zhanelauthor=C.+K.+Lawrenceauthor=H.+Adamauthor=F.+Schweizerauthor=S.+Zelenitskyauthor=M.+Zhanelauthor=P.+R.+S.+Lagac%C3%A9-Wiensauthor=A.+Walktyauthor=A.+Denisuikauthor=A.+Goldenauthor=A.+S.+Ginauthor=D.+J.+Hobanauthor=J.+P.+Lynchauthor=J.+A.+Karlowsky&title=Imipenem-relebactam+and+meropenem-vaborbactam%3A+two+novel+carbapenem-%CE%B2-lactamase+inhibitor+combinations&doi=10.1007%2Fs40265-017-0851-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations</span></div><div class="casAuthors">Zhanel, George G.; Lawrence, Courtney K.; Adam, Heather; Schweizer, Frank; Zelenitsky, Sheryl; Zhanel, Michael; Lagace-Wiens, Philippe R. S.; Walkty, Andrew; Denisuik, Andrew; Golden, Alyssa; Gin, Alfred S.; Hoban, Daryl J.; Lynch, Joseph P., III; Karlowsky, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-98</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam, differing by the addn. of a piperidine ring to the 2-position carbonyl group.  Vaborbactam (formerly known as RPX7009) is a non-β-lactam, cyclic, boronic acid-based, β-lactamase inhibitor.  The structure of vaborbactam is unlike any other currently marketed β-lactamase inhibitor.  Both inhibitors display activity against Ambler class A [including extended-spectrum β-lactamases (ESBLs), Klebsiella pneumoniae carbapenemases (KPCs)] and class C β-lactamases (AmpC).  Little is known about the potential for relebactam or vaborbactam to select for resistance; however, inactivation of the porin protein OmpK36 in K. pneumoniae has been reported to confer resistance to both imipenem-relebactam and meropenem-vaborbactam.  The addn. of relebactam significantly improves the activity of imipenem against most species of Enterobacteriaceae [by lowering the min. inhibitory concn. (MIC) by 2- to 128-fold] depending on the presence or absence of β-lactamase enzymes.  Against Pseudomonas aeruginosa, the addn. of relebactam also improves the activity of imipenem (MIC reduced eightfold).  Based on the data available, the addn. of relebactam does not improve the activity of imipenem against Acinetobacter baumannii, Stenotrophomonas maltophilia and most anaerobes.  Similar to imipenem-relebactam, the addn. of vaborbactam significantly (2- to > 1024-fold MIC redn.) improves the activity of meropenem against most species of Enterobacteriaceae depending on the presence or absence of β-lactamase enzymes.  Limited data suggest that the addn. of vaborbactam does not improve the activity of meropenem against A. baumannii, P. aeruginosa, or S. maltophilia.  The pharmacokinetics of both relebactam and vaborbactam are described by a two-compartment, linear model and do not appear to be altered by the co-administration of imipenem and meropenem, resp.  Relebactam's approx. vol. of distribution (Vd) and elimination half-life (t1/2) of ∼ 18 L and 1.2-2.1 h, resp., are similar to imipenem.  Likewise, vaborbactam's Vd and t1/2 of ∼ 18 L and 1.3-2.0 h, resp., are comparable to meropenem.  Like imipenem and meropenem, relebactam and vaborbactam are both primarily renally excreted, and clearance correlates with creatinine clearance.  In vitro and in vivo pharmacodynamic studies have reported bactericidal activity for imipenem-relebactam and meropenem-vaborbactam against various Gram-neg. β-lactamase-producing bacilli that are not inhibited by their resp. carbapenems alone.  These data also suggest that pharmacokinetic-pharmacodynamic parameters correlating with efficacy include time above the MIC for the carbapenems and overall exposure for their companion β-lactamase inhibitors.  Phase II clin. trials to date have reported that imipenem-relebactam is as effective as imipenem alone for treatment of complicated intra-abdominal infections and complicated urinary tract infections, including acute pyelonephritis.  Imipenem-relebactam is currently in two phase III clin. trials for the treatment of imipenem-resistant bacterial infections, as well as hospital-assocd. bacterial pneumonia (HABP) and ventilator-assocd. bacterial pneumonia (VABP).  A phase III clin. trial has reported superiority of meropenem-vaborbactam over piperacillin-tazobactam for the treatment of complicated urinary tract infections, including acute pyelonephritis.  Meropenem-vaborbactam has recently demonstrated higher clin. cure rates vs. best available therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE), as well as for HABP and VABP.  The safety and tolerability of imipenem-relebactam and meropenem-vaborbactam has been reported in various phase I pharmacokinetic studies and phase II and III clin. trials.  Both combinations appear to be well tolerated in healthy subjects and hospitalized patients, with few serious drug-related treatment-emergent adverse events reported to date.  In conclusion, relebactam and vaborbactam serve to broaden the spectrum of imipenem and meropenem, resp., against β-lactamase-producing Gram-neg. bacilli.  The exact roles for imipenem-relebactam and meropenem-vaborbactam will be defined by efficacy and safety data from further clin. trials.  Potential roles in therapy for these agents include the treatment of suspected or documented infections caused by resistant Gram-neg. bacilli-producing ESBL, KPC, and/or AmpC β-lactamases.  The usage of these agents in patients with CRE infections will likely become the std. of care.  Finally, increased activity of imipenem-relebactam against P. aeruginosa may be of clin. benefit to patients with suspected or documented P. aeruginosa infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYBXUqPtdemrVg90H21EOLACvtfcHk0lhXwo4x8Ta70Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFKmu7bK&md5=a8506d493387208f8ac429057ca15a49</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40265-017-0851-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-017-0851-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26aulast%3DLawrence%26aufirst%3DC.%2BK.%26aulast%3DAdam%26aufirst%3DH.%26aulast%3DSchweizer%26aufirst%3DF.%26aulast%3DZelenitsky%26aufirst%3DS.%26aulast%3DZhanel%26aufirst%3DM.%26aulast%3DLagac%25C3%25A9-Wiens%26aufirst%3DP.%2BR.%2BS.%26aulast%3DWalkty%26aufirst%3DA.%26aulast%3DDenisuik%26aufirst%3DA.%26aulast%3DGolden%26aufirst%3DA.%26aulast%3DGin%26aufirst%3DA.%2BS.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DLynch%26aufirst%3DJ.%2BP.%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26atitle%3DImipenem-relebactam%2520and%2520meropenem-vaborbactam%253A%2520two%2520novel%2520carbapenem-%25CE%25B2-lactamase%2520inhibitor%2520combinations%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26issue%3D1%26spage%3D65%26epage%3D98%26doi%3D10.1007%2Fs40265-017-0851-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papp-Wallace, K. M.</span></span> <span> </span><span class="NLM_article-title">The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2169</span>– <span class="NLM_lpage">2184</span>, <span class="refDoi"> DOI: 10.1080/14656566.2019.1660772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1080%2F14656566.2019.1660772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=31500471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslGnu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2169-2184&issue=17&author=K.+M.+Papp-Wallace&title=The+latest+advances+in+%CE%B2-lactam%2F%CE%B2-lactamase+inhibitor+combinations+for+the+treatment+of+Gram-negative+bacterial+infections&doi=10.1080%2F14656566.2019.1660772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections</span></div><div class="casAuthors">Papp-Wallace, Krisztina M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2169-2184</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  : Antimicrobial resistance in Gram-neg. pathogens is a significant threat to global health. β-Lactams (BL) are one of the safest and most-prescribed classes of antibiotics on the market today.  The acquisition of β-lactamases, esp. those which hydrolyze carbapenems, is eroding the efficacy of BLs for the treatment of serious infections.  During the past decade, significant advances were made in the development of novel BL-β-lactamase inhibitor (BLI) combinations to target β-lactamase-mediated resistant Gram-negatives.: The latest progress in 20 different approved, developing, and preclin. BL-BLI combinations to target serine β-lactamases produced by Gram-negatives are reviewed based on primary literature, conference abstrs. (when available), and US clin. trial searches within the last 5 years.  The majority of the compds. that are discussed are being evaluated as part of a BL-BLI combination.: The current trajectory in BLI development is promising; however, a significant challenge resides in the selection of an appropriate BL partner as well as the development of resistance linked to the BL partner.  In addn., dosing regimens for these BL-BLI combinations need to be critically evaluated.  A revolution in bacterial diagnostics is essential to aid clinicians in the appropriate selection of novel BL-BLI combinations for the treatment of serious infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlWIU5sOUqv7Vg90H21EOLACvtfcHk0liaUI1Bxk2aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslGnu7jL&md5=73f3e0ba8358820479bf1652b26fc4a8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1080%2F14656566.2019.1660772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14656566.2019.1660772%26sid%3Dliteratum%253Aachs%26aulast%3DPapp-Wallace%26aufirst%3DK.%2BM.%26atitle%3DThe%2520latest%2520advances%2520in%2520%25CE%25B2-lactam%252F%25CE%25B2-lactamase%2520inhibitor%2520combinations%2520for%2520the%2520treatment%2520of%2520Gram-negative%2520bacterial%2520infections%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2019%26volume%3D20%26issue%3D17%26spage%3D2169%26epage%3D2184%26doi%3D10.1080%2F14656566.2019.1660772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeary, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenk, G.</span></span> <span> </span><span class="NLM_article-title">Progress toward inhibitors of metallo-β-lactamases</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.4155%2Ffmc-2017-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=28504895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=673-691&issue=7&author=R.+P.+McGearyauthor=D.+T.+C.+Tanauthor=G.+Schenk&title=Progress+toward+inhibitors+of+metallo-%CE%B2-lactamases&doi=10.4155%2Ffmc-2017-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Progress toward inhibitors of metallo-β-lactamases</span></div><div class="casAuthors">McGeary, Ross P.; Tan, Daniel T. C.; Schenk, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">673-691</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The global overuse of antibiotics has led to the emergence of drug-resistant pathogenic bacteria.  Bacteria can combat β-lactams by expressing β-lactamases.  Inhibitors of one class of β-lactamase, the serine-β-lactamases, are used clin. to prevent degrdn. of β-lactam antibiotics.  However, a second class of β-lactamase, the metallo-β-lactamases (MBLs), function by a different mechanism to serine-β-lactamases and no inhibitors of MBLs have progressed to be used in the clinic.  Bacteria that express MBLs are an increasingly important threat to human health.  This review outlines various approaches taken to discover MBL inhibitors, with an emphasis on the different chem. classes of inhibitors.  Recent progress, particularly new screening methods and the rational design of potent MBL inhibitors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWOugIHrl627Vg90H21EOLACvtfcHk0liaUI1Bxk2aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlSqsr4%253D&md5=9c83b0f8634de613083ce3db42bd4225</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0007%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeary%26aufirst%3DR.%2BP.%26aulast%3DTan%26aufirst%3DD.%2BT.%2BC.%26aulast%3DSchenk%26aufirst%3DG.%26atitle%3DProgress%2520toward%2520inhibitors%2520of%2520metallo-%25CE%25B2-lactamases%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26issue%3D7%26spage%3D673%26epage%3D691%26doi%3D10.4155%2Ffmc-2017-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krajnc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinchliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvopina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panduwawala, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamps, J. J. A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widlake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saward, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Bicyclic boronate VNRX-5133 inhibits metallo- and serine-β-lactamases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8544</span>– <span class="NLM_lpage">8556</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00911</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00911" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8544-8556&issue=18&author=A.+Krajncauthor=J.+Bremauthor=P.+Hinchliffeauthor=K.+Calvopinaauthor=T.+D.+Panduwawalaauthor=P.+A.+Langauthor=J.+J.+A.+G.+Kampsauthor=J.+M.+Tyrrellauthor=E.+Widlakeauthor=B.+G.+Sawardauthor=T.+R.+Walshauthor=J.+Spencerauthor=C.+J.+Schofield&title=Bicyclic+boronate+VNRX-5133+inhibits+metallo-+and+serine-%CE%B2-lactamases&doi=10.1021%2Facs.jmedchem.9b00911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases</span></div><div class="casAuthors">Krajnc, Alen; Brem, Jurgen; Hinchliffe, Philip; Calvopina, Karina; Panduwawala, Tharindi D.; Lang, Pauline A.; Kamps, Jos J. A. G.; Tyrrell, Jonathan M.; Widlake, Emma; Saward, Benjamin G.; Walsh, Timothy R.; Spencer, James; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8544-8556</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clin. development.  We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clin. important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2.  VNRX-5133 activity against IMP-1 and tested B2/B3 MBLs was lower/not obsd.  Crystallog. reveals how VNRX-5133 binds to the class D SBL OXA-10 and MBL NDM-1.  The crystallog. results highlight the ability of bicyclic boronates to inhibit SBLs and MBLs via binding of a tetrahedral (sp3) boron species.  The structures imply conserved binding of the bicyclic core with SBLs/MBLs.  With NDM-1, by crystallog., we obsd. an unanticipated VNRX-5133 binding mode involving cyclization of its acylamino oxygen onto the boron of the bicyclic core.  Different side-chain binding modes for bicyclic boronates for SBLs and MBLs imply scope for side-chain optimization.  The results further support the "high-energy-intermediate" analog approach for broad-spectrum β-lactamase inhibitor development and highlight the ability of boron inhibitors to interchange between different hybridization states/binding modes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1jdsxZI6F7bVg90H21EOLACvtfcHk0liaUI1Bxk2aCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksLjM&md5=8b494fcd6f481e0721805144866eaf56</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00911%26sid%3Dliteratum%253Aachs%26aulast%3DKrajnc%26aufirst%3DA.%26aulast%3DBrem%26aufirst%3DJ.%26aulast%3DHinchliffe%26aufirst%3DP.%26aulast%3DCalvopina%26aufirst%3DK.%26aulast%3DPanduwawala%26aufirst%3DT.%2BD.%26aulast%3DLang%26aufirst%3DP.%2BA.%26aulast%3DKamps%26aufirst%3DJ.%2BJ.%2BA.%2BG.%26aulast%3DTyrrell%26aufirst%3DJ.%2BM.%26aulast%3DWidlake%26aufirst%3DE.%26aulast%3DSaward%26aufirst%3DB.%2BG.%26aulast%3DWalsh%26aufirst%3DT.%2BR.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DBicyclic%2520boronate%2520VNRX-5133%2520inhibits%2520metallo-%2520and%2520serine-%25CE%25B2-lactamases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D18%26spage%3D8544%26epage%3D8556%26doi%3D10.1021%2Facs.jmedchem.9b00911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohans, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wareham, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oswin, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishwick, C. W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, J.</span></span> <span> </span><span class="NLM_article-title">Cyclic boronates inhibit all classes of β-lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">4</span>), <span class="NLM_elocation-id">e02260-16</span> <span class="refDoi"> DOI: 10.1128/AAC.02260-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1128%2FAAC.02260-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=28115348" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&issue=4&author=S.+T.+Cahillauthor=R.+Cainauthor=D.+Y.+Wangauthor=C.+T.+Lohansauthor=D.+W.+Warehamauthor=H.+P.+Oswinauthor=J.+Mohammedauthor=J.+Spencerauthor=C.+W.+G.+Fishwickauthor=M.+A.+McDonoughauthor=C.+J.+Schofieldauthor=J.+Brem&title=Cyclic+boronates+inhibit+all+classes+of+%CE%B2-lactamases&doi=10.1128%2FAAC.02260-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FAAC.02260-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02260-16%26sid%3Dliteratum%253Aachs%26aulast%3DCahill%26aufirst%3DS.%2BT.%26aulast%3DCain%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DLohans%26aufirst%3DC.%2BT.%26aulast%3DWareham%26aufirst%3DD.%2BW.%26aulast%3DOswin%26aufirst%3DH.%2BP.%26aulast%3DMohammed%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DFishwick%26aufirst%3DC.%2BW.%2BG.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrem%26aufirst%3DJ.%26atitle%3DCyclic%2520boronates%2520inhibit%2520all%2520classes%2520of%2520%25CE%25B2-lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26issue%3D4%26doi%3D10.1128%2FAAC.02260-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paetzel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strynadka, N. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-lactamase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5312</span>– <span class="NLM_lpage">5321</span>, <span class="refDoi"> DOI: 10.1021/bi992505b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi992505b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=5312-5321&issue=18&author=S.+Nessauthor=R.+Martinauthor=A.+M.+Kindlerauthor=M.+Paetzelauthor=M.+Goldauthor=S.+E.+Jensenauthor=J.+B.+Jonesauthor=N.+C.+Strynadka&title=Structure-based+design+guides+the+improved+efficacy+of+deacylation+transition+state+analogue+inhibitors+of+TEM-1+beta-lactamase&doi=10.1021%2Fbi992505b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design Guides the Improved Efficacy of Deacylation Transition State Analogue Inhibitors of TEM-1 β-Lactamase</span></div><div class="casAuthors">Ness, Steven; Martin, Richard; Kindler, Alois M.; Paetzel, Mark; Gold, Marvin; Jensen, Susan E.; Jones, J. Bryan; Strynadka, Natalie C. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5312-5321</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition state analog boronic acid inhibitors mimicking the structures and interactions of good penicillin substrates for the TEM-1 β-lactamase of Escherichia coli were designed using graphic analyses based on the enzyme's 1.7 Å crystallog. structure.  The synthesis of two of these transition state analogs, (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1) and (1R)-1-acetamido-2-(3-carboxy-2-hydroxyphenyl)ethylboronic acid (2), is reported.  Kinetic measurements show that, as designed, compds. 1 and 2 are highly effective deacylation transition state analog inhibitors of TEM-1 β-lactamase, with inhibition consts. of 5.9 and 13 nM, resp.  These values identify them as among the most potent competitive inhibitors yet reported for a β-lactamase.  The best inhibitor of the current series was (1R)-1-phenylacetamido-2-(3-carboxyphenyl)ethylboronic acid (1, KI = 5.9 nM), which resembles most closely the best known substrate of TEM-1, benzylpenicillin (penicillin G).  The high-resoln. crystallog. structures of these two inhibitors covalently bound to TEM-1 are also described.  In addn. to verifying the design features, these two structures show interesting and unanticipated changes in the active site area, including strong hydrogen bond formation, water displacement, and rearrangement of side chains.  The structures provide new insights into the further design of this potent class of β-lactamase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-aQSFfZl_R7Vg90H21EOLACvtfcHk0ljO-aVJteBm5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVelsr8%253D&md5=441c78891c1860f80e29660283299961</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fbi992505b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi992505b%26sid%3Dliteratum%253Aachs%26aulast%3DNess%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DKindler%26aufirst%3DA.%2BM.%26aulast%3DPaetzel%26aufirst%3DM.%26aulast%3DGold%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DJ.%2BB.%26aulast%3DStrynadka%26aufirst%3DN.%2BC.%26atitle%3DStructure-based%2520design%2520guides%2520the%2520improved%2520efficacy%2520of%2520deacylation%2520transition%2520state%2520analogue%2520inhibitors%2520of%2520TEM-1%2520beta-lactamase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26issue%3D18%26spage%3D5312%26epage%3D5321%26doi%3D10.1021%2Fbi992505b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2009064414A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+Burns&author=R.+W.+Jackson&author=R.+Goswami&author=H.+Xu&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Preparation of alpha-Aminoboronic Acids as Beta-lactamase Inhibitors</span>.  Patent <span class="NLM_patent">US 20100120715A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+J.+Burns&author=R.+W.+Jackson&author=R.+Goswami&author=H.+Xu&title=Preparation+of+alpha-Aminoboronic+Acids+as+Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DPreparation%2520of%2520alpha-Aminoboronic%2520Acids%2520as%2520Beta-lactamase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Goswami, R.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Lessen, T.</span>; <span class="NLM_string-name">Li, W.</span>; <span class="NLM_string-name">Pevear, D.</span>; <span class="NLM_string-name">Tirunahari, P. K.</span>; <span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2010130708A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+J.+Burns&author=R.+Goswami&author=R.+W.+Jackson&author=T.+Lessen&author=W.+Li&author=D.+Pevear&author=P.+K.+Tirunahari&author=H.+Xu&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Jackson, R. W.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2009064413A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=C.+J.+Burns&author=R.+W.+Jackson&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Glinka, T.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Hecker, S.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2014107535A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+Reddy&author=T.+Glinka&author=M.+Totrov&author=S.+Hecker&title=Boronic+Acid+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26atitle%3DBoronic%2520Acid%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G.</span>; <span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Hecker, S.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Griffith, D. C.</span>; <span class="NLM_string-name">Rodny, O.</span>; <span class="NLM_string-name">Dudley, M. N.</span>; <span class="NLM_string-name">Boyer, S.</span></span> <span> </span><span class="NLM_article-title">Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2012021455A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Hirst&author=R.+Reddy&author=S.+Hecker&author=M.+Totrov&author=D.+C.+Griffith&author=O.+Rodny&author=M.+N.+Dudley&author=S.+Boyer&title=Cyclic+Boronic+Acid+Ester+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHirst%26aufirst%3DG.%26atitle%3DCyclic%2520Boronic%2520Acid%2520Ester%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span>; <span class="NLM_string-name">Reddy, K. R.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Hirst, G. C.</span>; <span class="NLM_string-name">Lomovskaya, O.</span>; <span class="NLM_string-name">Griffith, D. C.</span>; <span class="NLM_string-name">King, P.</span>; <span class="NLM_string-name">Tsivkovski, R.</span>; <span class="NLM_string-name">Sun, D.</span>; <span class="NLM_string-name">Sabet, M.</span>; <span class="NLM_string-name">Tarazi, Z.</span>; <span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of RPX7009, a broad-spectrum beta-lactamase inhibitor with utility vs. class A serine carbapenemases</span>. In  <i>Abstracts of Papers</i>, 52nd International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, <span class="NLM_year">2012</span>; F-848.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=S.+J.+Hecker&author=K.+R.+Reddy&author=M.+Totrov&author=G.+C.+Hirst&author=O.+Lomovskaya&author=D.+C.+Griffith&author=P.+King&author=R.+Tsivkovski&author=D.+Sun&author=M.+Sabet&author=Z.+Tarazi&author=M.+N.+Dudley&title=Abstracts+of+Papers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26atitle%3DDiscovery%2520of%2520RPX7009%252C%2520a%2520broad-spectrum%2520beta-lactamase%2520inhibitor%2520with%2520utility%2520vs.%2520class%2520A%2520serine%2520carbapenemases%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarazi, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raymond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potts, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abendroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loutit, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, M. N.</span></span> <span> </span><span class="NLM_article-title">Discovery of a cyclic boronic acid β-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">3682</span>– <span class="NLM_lpage">3692</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3682-3692&issue=9&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=M.+Totrovauthor=G.+C.+Hirstauthor=O.+Lomovskayaauthor=D.+C.+Griffithauthor=P.+Kingauthor=R.+Tsivkovskiauthor=D.+Sunauthor=M.+Sabetauthor=Z.+Taraziauthor=M.+C.+Cliftonauthor=K.+Atkinsauthor=A.+Raymondauthor=K.+T.+Pottsauthor=J.+Abendrothauthor=S.+H.+Boyerauthor=J.+S.+Loutitauthor=E.+E.+Morganauthor=S.+Dursoauthor=M.+N.+Dudley&title=Discovery+of+a+cyclic+boronic+acid+%CE%B2-lactamase+inhibitor+%28RPX7009%29+with+utility+vs+class+A+serine+carbapenemases&doi=10.1021%2Facs.jmedchem.5b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases</span></div><div class="casAuthors">Hecker, Scott J.; Reddy, K. Raja; Totrov, Maxim; Hirst, Gavin C.; Lomovskaya, Olga; Griffith, David C.; King, Paula; Tsivkovski, Ruslan; Sun, Dongxu; Sabet, Mojgan; Tarazi, Ziad; Clifton, Matthew C.; Atkins, Kateri; Raymond, Amy; Potts, Kristy T.; Abendroth, Jan; Boyer, Serge H.; Loutit, Jeffrey S.; Morgan, Elizabeth E.; Durso, Stephanie; Dudley, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3682-3692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The increasing dissemination of carbapenemases in Gram-neg. bacteria has threatened the clin. usefulness of the β-lactam class of antimicrobials.  A program was initiated to discover a new series of serine β-lactamase inhibitors contg. a boronic acid pharmacophore, with the goal of finding a potent inhibitor of serine carbapenemase enzymes that are currently compromising the utility of the carbapenem class of antibacterials.  Potential lead structures were screened in silico by modeling into the active sites of key serine β-lactamases.  Promising candidate mols. were synthesized and evaluated in biochem. and whole-cell assays.  Inhibitors were identified with potent inhibition of serine carbapenemases, particularly the Klebsiella pneumoniae carbapenemase (KPC), with no inhibition of mammalian serine proteases.  Studies in vitro and in vivo show that RPX7009 (9f) is a broad-spectrum inhibitor, notably restoring the activity of carbapenems against KPC-producing strains.  Combined with a carbapenem, 9f is a promising product for the treatment of multidrug resistant Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpE5YX_dRNLVg90H21EOLACvtfcHk0liRs7TN1UzIlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksl2gs7g%253D&md5=965fbf2b42f2e1b38eccc3b23dfa374f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00127%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DTotrov%26aufirst%3DM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DGriffith%26aufirst%3DD.%2BC.%26aulast%3DKing%26aufirst%3DP.%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DSabet%26aufirst%3DM.%26aulast%3DTarazi%26aufirst%3DZ.%26aulast%3DClifton%26aufirst%3DM.%2BC.%26aulast%3DAtkins%26aufirst%3DK.%26aulast%3DRaymond%26aufirst%3DA.%26aulast%3DPotts%26aufirst%3DK.%2BT.%26aulast%3DAbendroth%26aufirst%3DJ.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLoutit%26aufirst%3DJ.%2BS.%26aulast%3DMorgan%26aufirst%3DE.%2BE.%26aulast%3DDurso%26aufirst%3DS.%26aulast%3DDudley%26aufirst%3DM.%2BN.%26atitle%3DDiscovery%2520of%2520a%2520cyclic%2520boronic%2520acid%2520%25CE%25B2-lactamase%2520inhibitor%2520%2528RPX7009%2529%2520with%2520utility%2520vs%2520class%2520A%2520serine%2520carbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D9%26spage%3D3682%26epage%3D3692%26doi%3D10.1021%2Facs.jmedchem.5b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Trout, R.</span>; <span class="NLM_string-name">Zulli, A.</span>; <span class="NLM_string-name">Mesaros, E.</span>; <span class="NLM_string-name">Jackson, R.</span>; <span class="NLM_string-name">Boyd, S.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McLaughlin, L.</span>; <span class="NLM_string-name">Chatwin, C.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Pevear, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of VNRX-7145: A broad-spectrum orally bioavailable beta-lactamase inhibitor (BLI) for highly resistant bacterial infections (“superbugs“)</span>. Presented at the 257th National Meeting & Exposition of the American Chemical Society, Orlando, FL, U.S., Mar 31–Apr 4, <span class="NLM_year">2019</span>; MEDI-0259.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=C.+J.+Burns&author=R.+Trout&author=A.+Zulli&author=E.+Mesaros&author=R.+Jackson&author=S.+Boyd&author=B.+Liu&author=L.+McLaughlin&author=C.+Chatwin&author=J.+Hamrick&author=D.+Daigle&author=D.+Pevear&title=Discovery+of+VNRX-7145%3A+A+broad-spectrum+orally+bioavailable+beta-lactamase+inhibitor+%28BLI%29+for+highly+resistant+bacterial+infections+%28%E2%80%9Csuperbugs%E2%80%9C%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520of%2520VNRX-7145%253A%2520A%2520broad-spectrum%2520orally%2520bioavailable%2520beta-lactamase%2520inhibitor%2520%2528BLI%2529%2520for%2520highly%2520resistant%2520bacterial%2520infections%2520%2528%25E2%2580%259Csuperbugs%25E2%2580%259C%2529%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Chu, G.-H.</span>; <span class="NLM_string-name">Trout, R.</span>; <span class="NLM_string-name">Jackson, R.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Cusick, S.</span>; <span class="NLM_string-name">Pevear, D.</span>; <span class="NLM_string-name">Xerri, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of VNRX-5133: A broad-spectrum serine- and metallo-beta-lactamase inhibitor (BLI) for carbapenem-resistant bacterial infections (“superbugs“)</span>.. Presented at the 255th National Meeting & Exposition of the American Chemical Society, New Orleans, LA, U.S., March 18–22, <span class="NLM_year">2018</span>; MEDI-309.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Burns&author=B.+Liu&author=G.-H.+Chu&author=R.+Trout&author=R.+Jackson&author=D.+McGarry&author=J.+Hamrick&author=D.+Daigle&author=S.+Cusick&author=D.+Pevear&author=L.+Xerri&title=Discovery+of+VNRX-5133%3A+A+broad-spectrum+serine-+and+metallo-beta-lactamase+inhibitor+%28BLI%29+for+carbapenem-resistant+bacterial+infections+%28%E2%80%9Csuperbugs%E2%80%9C%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520VNRX-5133%253A%2520A%2520broad-spectrum%2520serine-%2520and%2520metallo-beta-lactamase%2520inhibitor%2520%2528BLI%2529%2520for%2520carbapenem-resistant%2520bacterial%2520infections%2520%2528%25E2%2580%259Csuperbugs%25E2%2580%259C%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, R.</span>; <span class="NLM_string-name">Glinka, T.</span>; <span class="NLM_string-name">Hecker, S.</span>; <span class="NLM_string-name">Totrov, M.</span>; <span class="NLM_string-name">Rodny, O.</span></span> <span> </span><span class="NLM_article-title">Boronic Acid Derivatives and Therapeutic Uses Thereof</span>. Patent <span class="NLM_patent">WO 2015179308A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Reddy&author=T.+Glinka&author=S.+Hecker&author=M.+Totrov&author=O.+Rodny&title=Boronic+Acid+Derivatives+and+Therapeutic+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DR.%26atitle%3DBoronic%2520Acid%2520Derivatives%2520and%2520Therapeutic%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Jackson, R. W.</span>; <span class="NLM_string-name">Hamrick, J.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2015191907</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=R.+W.+Jackson&author=J.+Hamrick&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span>; <span class="NLM_string-name">Jackson, R. W.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">US 20140194386</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&author=R.+W.+Jackson&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Beta-lactamase Inhibitors</span>. Patent <span class="NLM_patent">WO 2014151958</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Beta-lactamase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DBeta-lactamase%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burns, C. J.</span>; <span class="NLM_string-name">Daigle, D.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">McGarry, D.</span>; <span class="NLM_string-name">Pevear, D. C.</span>; <span class="NLM_string-name">Trout, R. E. L.</span></span> <span> </span><span class="NLM_article-title">Aminoboronic Acids and Amino-1,2-benzoxaborins as Inhibitors of Bacterial Beta-lactamases and Antibacterial Agents</span>. Patent <span class="NLM_patent">WO 2014089365</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+J.+Burns&author=D.+Daigle&author=B.+Liu&author=D.+McGarry&author=D.+C.+Pevear&author=R.+E.+L.+Trout&title=Aminoboronic+Acids+and+Amino-1%2C2-benzoxaborins+as+Inhibitors+of+Bacterial+Beta-lactamases+and+Antibacterial+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26atitle%3DAminoboronic%2520Acids%2520and%2520Amino-1%252C2-benzoxaborins%2520as%2520Inhibitors%2520of%2520Bacterial%2520Beta-lactamases%2520and%2520Antibacterial%2520Agents%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babcock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizer, R.</span></span> <span> </span><span class="NLM_article-title">Dynamics of boron acid complexation reactions. Formation of 1:1 boron acid-ligand complexes</span>. <i>Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1021/ic50203a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ic50203a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADyaL3cXhtVSgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1980&pages=56-61&issue=1&author=L.+Babcockauthor=R.+Pizer&title=Dynamics+of+boron+acid+complexation+reactions.+Formation+of+1%3A1+boron+acid-ligand+complexes&doi=10.1021%2Fic50203a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics of boron acid complexation reactions.  Formation of 1:1 boron acid-ligand complexes</span></div><div class="casAuthors">Babcock, Lucia; Pizer, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Inorganic Chemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">INOCAJ</span>;
        ISSN:<span class="NLM_cas:issn">0020-1669</span>.
    </div><div class="casAbstract">Boron acids form 1:1 complexes with a variety of bidentate chelating ligands according to the equation RB(OH)2 + H2L ↹ RB(OH)L- + H3O+.  The acids m-NO2PhB(OH)2, PhB(OH)2, B(OH)3, and MeB(OH)2 were studied and 10 different ligands were examd..  Stability consts. were detd. by pH titrn. methods, and the kinetics. were detd. by a temp. jump method at μ = 0.1 M (KNO3) and 25°.  The stability consts. are affected by the acidities of both the boron acids and ligands; the stability consts. increase as the ligand and boron acid become more acidic.  Various kinetic pathways are possible.  Trigonal boron acids, RB(OH)2, react with fully protonated ligands or ligand anions.  The pattern of reactivity is different for each case.  The rate consts. for the reactions of fully protonated ligands vary systematically with both ligand acidity and boron substituent.  This is discussed in terms of a mechanism which involves proton transfer.  The ligand anions do not display a simple correlation with any single ligand parameter and their reactivities are discussed in terms of a no. of ligand-specific effects.  Borate anions, RB(OH)3-, react with high rate consts. with fully protonated ligands and with somewhat lower rate consts. with ligand anions.  Possible reasons for this are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWpCEDmtVP0rVg90H21EOLACvtfcHk0liEflzkoP6VxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXhtVSgsr4%253D&md5=fd956a63d5de583c1bb889559a3e2829</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fic50203a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fic50203a013%26sid%3Dliteratum%253Aachs%26aulast%3DBabcock%26aufirst%3DL.%26aulast%3DPizer%26aufirst%3DR.%26atitle%3DDynamics%2520of%2520boron%2520acid%2520complexation%2520reactions.%2520Formation%2520of%25201%253A1%2520boron%2520acid-ligand%2520complexes%26jtitle%3DInorg.%2520Chem.%26date%3D1980%26volume%3D19%26issue%3D1%26spage%3D56%26epage%3D61%26doi%3D10.1021%2Fic50203a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsivkovski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomovskaya, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span> <span> </span><span class="NLM_article-title">Biochemical Characterization of QPX7728, a New Ultra-Broad-Spectrum Beta-lactamase Inhibitor of Serine and Metallo-Beta-Lactamases</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1128/AAC.00130-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1128%2FAAC.00130-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=R.+Tsivkovskiauthor=O.+Lomovskayaauthor=M.+Totrov&title=Biochemical+Characterization+of+QPX7728%2C+a+New+Ultra-Broad-Spectrum+Beta-lactamase+Inhibitor+of+Serine+and+Metallo-Beta-Lactamases&doi=10.1128%2FAAC.00130-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1128%2FAAC.00130-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00130-20%26sid%3Dliteratum%253Aachs%26aulast%3DTsivkovski%26aufirst%3DR.%26aulast%3DLomovskaya%26aufirst%3DO.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DBiochemical%2520Characterization%2520of%2520QPX7728%252C%2520a%2520New%2520Ultra-Broad-Spectrum%2520Beta-lactamase%2520Inhibitor%2520of%2520Serine%2520and%2520Metallo-Beta-Lactamases%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2020%26doi%3D10.1128%2FAAC.00130-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Verdelet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Straightforward and efficient synthesis of 3-benzyloxy-4-bromopicolinate ester and 3-benzyloxy-5-bromopicolinate ester, common building blocks for pharmaceuticals and agrochemicals</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">8757</span>– <span class="NLM_lpage">8762</span>, <span class="refDoi"> DOI: 10.1016/j.tet.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.tet.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12kt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=8757-8762&issue=45&author=T.+Verdeletauthor=G.+Merceyauthor=N.+Correaauthor=L.+Jeanauthor=P.-Y.+Renard&title=Straightforward+and+efficient+synthesis+of+3-benzyloxy-4-bromopicolinate+ester+and+3-benzyloxy-5-bromopicolinate+ester%2C+common+building+blocks+for+pharmaceuticals+and+agrochemicals&doi=10.1016%2Fj.tet.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Straightforward and efficient synthesis of 3-benzyloxy-4-bromopicolinate ester and 3-benzyloxy-5-bromopicolinate ester, common building blocks for pharmaceuticals and agrochemicals</span></div><div class="casAuthors">Verdelet, Tristan; Mercey, Guillaume; Correa, Nobi; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">8757-8762</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A practical and rapid prepn. of 3-benzyloxy-4-bromo- and 3-benzyloxy-5-bromopicolinate esters was developed in four steps, resp., in 38% and 31% overall yield.  Then their viability as partners for cross-coupling reactions was evaluated in Suzuki-Miyaura, Hartwig-Buchwald, and Sonogashira reactions to synthesize biol. relevant targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY-NcF7BfGr7Vg90H21EOLACvtfcHk0ljOFQF_JEsbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12kt7jN&md5=c7deb2edb267a4fbf6c155360966a9ea</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DVerdelet%26aufirst%3DT.%26aulast%3DMercey%26aufirst%3DG.%26aulast%3DCorrea%26aufirst%3DN.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.-Y.%26atitle%3DStraightforward%2520and%2520efficient%2520synthesis%2520of%25203-benzyloxy-4-bromopicolinate%2520ester%2520and%25203-benzyloxy-5-bromopicolinate%2520ester%252C%2520common%2520building%2520blocks%2520for%2520pharmaceuticals%2520and%2520agrochemicals%26jtitle%3DTetrahedron%26date%3D2011%26volume%3D67%26issue%3D45%26spage%3D8757%26epage%3D8762%26doi%3D10.1016%2Fj.tet.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">CLSI</span>.  <i>Methods for Dilution Antimicrobial Susceptibility Tests
for Bacteria That Grow Aerobically</i>, <span class="NLM_edition">11</span>th ed.; CLSI Standard M07; <span class="NLM_publisher-name">Clinical and Laboratory
Standards Institute</span>: <span class="NLM_publisher-loc">Wayne, PA</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=CLSI&title=Methods+for+Dilution+Antimicrobial+Susceptibility+Tests%0Afor+Bacteria+That+Grow+Aerobically"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DMethods%2520for%2520Dilution%2520Antimicrobial%2520Susceptibility%2520Tests%250Afor%2520Bacteria%2520That%2520Grow%2520Aerobically%26pub%3DClinical%2520and%2520Laboratory%250AStandards%2520Institute%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waley, S. G.</span></span> <span> </span><span class="NLM_article-title">A quick method for the determination of inhibition constants</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">633</span>, <span class="refDoi"> DOI: 10.1042/bj2050631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1042%2Fbj2050631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=7150236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADyaL3sXjtVClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1982&pages=631-633&issue=3&author=S.+G.+Waley&title=A+quick+method+for+the+determination+of+inhibition+constants&doi=10.1042%2Fbj2050631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A quick method for the determination of inhibition constants</span></div><div class="casAuthors">Waley, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-3</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    </div><div class="casAbstract">The Ki value, in the common case of competitive inhibition, can be obtained by simple comparison of progress curves in the presence and in the absence of inhibitor.  The difference between the times taken for the concn. of substrate to fall to the same value is used to obtain the Ki.  The procedure to use when the product inhibits is described.  When there is mixed inhibition, reactions at different substrate concns. are used to obtain both Ki values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyNMowjJf3C7Vg90H21EOLACvtfcHk0ljOFQF_JEsbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXjtVClsg%253D%253D&md5=48ebdbd7e9daa2446c42ce218c1c0a26</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2Fbj2050631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj2050631%26sid%3Dliteratum%253Aachs%26aulast%3DWaley%26aufirst%3DS.%2BG.%26atitle%3DA%2520quick%2520method%2520for%2520the%2520determination%2520of%2520inhibition%2520constants%26jtitle%3DBiochem.%2520J.%26date%3D1982%26volume%3D205%26issue%3D3%26spage%3D631%26epage%3D633%26doi%3D10.1042%2Fbj2050631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3525</span>– <span class="NLM_lpage">3530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00158</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00158" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3525-3530&issue=8&author=O.+A.+Pembertonauthor=X.+Zhangauthor=Y.+Chen&title=Molecular+basis+of+substrate+recognition+and+product+release+by+the+Klebsiella+pneumoniae+carbapenemase+%28KPC-2%29&doi=10.1021%2Facs.jmedchem.7b00158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2)</span></div><div class="casAuthors">Pemberton, Orville A.; Zhang, Xiujun; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3525-3530</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the prodn. of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase.  Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics contg. hydrolyzed cefotaxime and faropenem.  They provide exptl. insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity.  These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRxiGIa-agP7Vg90H21EOLACvtfcHk0ljOFQF_JEsbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVejsrY%253D&md5=4ec87803561ad874f178f1345e9a3dda</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00158%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DMolecular%2520basis%2520of%2520substrate%2520recognition%2520and%2520product%2520release%2520by%2520the%2520Klebsiella%2520pneumoniae%2520carbapenemase%2520%2528KPC-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3525%26epage%3D3530%26doi%3D10.1021%2Facs.jmedchem.7b00158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pemberton, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaishankar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akhtar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renslo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl phosphonates as noncovalent inhibitors of both serine- and metallocarbapenemases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">8480</span>– <span class="NLM_lpage">8496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00728</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00728" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslSqtrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8480-8496&issue=18&author=O.+A.+Pembertonauthor=P.+Jaishankarauthor=A.+Akhtarauthor=J.+L.+Adamsauthor=L.+N.+Shawauthor=A.+R.+Rensloauthor=Y.+Chen&title=Heteroaryl+phosphonates+as+noncovalent+inhibitors+of+both+serine-+and+metallocarbapenemases&doi=10.1021%2Facs.jmedchem.9b00728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Heteroaryl Phosphonates as Noncovalent Inhibitors of Both Serine- and Metallocarbapenemases</span></div><div class="casAuthors">Pemberton, Orville A.; Jaishankar, Priyadarshini; Akhtar, Afroza; Adams, Jessie L.; Shaw, Lindsey N.; Renslo, Adam R.; Chen, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8480-8496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gram-neg. pathogens expressing serine β-lactamases (SBLs) and metallo-β-lactamases (MBLs), esp. those with carbapenemase activity, threaten the clin. utility of almost all β-lactam antibiotics.  Here we describe the discovery of a heteroaryl phosphonate scaffold that exhibits noncovalent cross-class inhibition of representative carbapenemases, specifically the SBL KPC-2 and the MBLs NDM-1 and VIM-2.  The most potent lead, compd. 16, exhibited low nM to low μM inhibition of KPC-2, NDM-1, and VIM-2.  Compd. 16 potentiated imipenem efficacy against resistant clin. and lab. bacterial strains expressing carbapenemases while showing some cytotoxicity toward human HEK293T cells only at concns. above 100μg/mL.  Complex structures with KPC-2, NDM-1, and VIM-2 demonstrate how these inhibitors achieve high binding affinity to both enzyme classes.  These findings provide a structurally and mechanistically new scaffold for drug discovery targeting multidrug resistant Gram-neg. pathogens and more generally highlight the active site features of carbapenemases that can be leveraged for lead discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWWKarmjAYXrVg90H21EOLACvtfcHk0ljOFQF_JEsbyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslSqtrrF&md5=f1f220ababa55c9a1041883d1d058db8</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00728%26sid%3Dliteratum%253Aachs%26aulast%3DPemberton%26aufirst%3DO.%2BA.%26aulast%3DJaishankar%26aufirst%3DP.%26aulast%3DAkhtar%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BL.%26aulast%3DShaw%26aufirst%3DL.%2BN.%26aulast%3DRenslo%26aufirst%3DA.%2BR.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DHeteroaryl%2520phosphonates%2520as%2520noncovalent%2520inhibitors%2520of%2520both%2520serine-%2520and%2520metallocarbapenemases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D18%26spage%3D8480%26epage%3D8496%26doi%3D10.1021%2Facs.jmedchem.9b00728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battye, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kontogiannis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, A. G.</span></span> <span> </span><span class="NLM_article-title">iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1107/S0907444910048675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444910048675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=21460445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=271-281&issue=Part+4&author=T.+G.+Battyeauthor=L.+Kontogiannisauthor=O.+Johnsonauthor=H.+R.+Powellauthor=A.+G.+Leslie&title=iMOSFLM%3A+a+new+graphical+interface+for+diffraction-image+processing+with+MOSFLM&doi=10.1107%2FS0907444910048675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM</span></div><div class="casAuthors">Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen; Powell, Harold R.; Leslie, Andrew G. W.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-281</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">IMOSFLM is a graphical user interface to the diffraction data-integration program MOSFLM.  It is designed to simplify data processing by dividing the process into a series of steps, which are normally carried out sequentially.  Each step has its own display pane, allowing control over parameters that influence that step and providing graphical feedback to the user.  Suitable values for integration parameters are set automatically, but addnl. menus provide a detailed level of control for experienced users.  The image display and the interfaces to the different tasks (indexing, strategy calcn., cell refinement, integration and history) are described.  The most important parameters for each step and the best way of assessing success or failure are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeZl2UOMg3_bVg90H21EOLACvtfcHk0ljobcdh5POteA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLw%253D&md5=852651253f8d9c9a81e0513b6633c705</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444910048675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910048675%26sid%3Dliteratum%253Aachs%26aulast%3DBattye%26aufirst%3DT.%2BG.%26aulast%3DKontogiannis%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DO.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26atitle%3DiMOSFLM%253A%2520a%2520new%2520graphical%2520interface%2520for%2520diffraction-image%2520processing%2520with%2520MOSFLM%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26issue%3DPart%25204%26spage%3D271%26epage%3D281%26doi%3D10.1107%2FS0907444910048675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">Part 7</span>),  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&issue=Part+7&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0ljobcdh5POteA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26issue%3DPart%25207%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span> </span><span class="NLM_article-title">The CCP4
suite: programs for protein crystallography. Collaborative
Computational Project, Number 4</span>.  <i>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume">50</span> (<span class="NLM_issue">Part 5</span>),  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1107/S0907444994003112</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+CCP4%0Asuite%3A+programs+for+protein+crystallography.+Collaborative%0AComputational+Project%2C+Number+4.+Acta+Crystallogr.%2C%0ASect.+D%3A+Biol.+Crystallogr.+1994%2C+50+%28Part+5%29%2C+760%E2%80%93763%2C+10.1107%2FS0907444994003112."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26atitle%3DThe%2520CCP4%250Asuite%253A%2520programs%2520for%2520protein%2520crystallography.%2520Collaborative%250AComputational%2520Project%252C%2520Number%25204%26jtitle%3DActa%2520Crystallogr.%252C%250ASect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26issue%3DPart%25205%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&issue=Part+4&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljobcdh5POteA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26issue%3DPart%25204%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustyakimov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urzhumtsev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Towards automated crystallographic structure refinement with phenix.refine</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">352</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444912001308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444912001308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=22505256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2012&pages=352-367&issue=Part+4&author=P.+V.+Afonineauthor=R.+W.+Grosse-Kunstleveauthor=N.+Echolsauthor=J.+J.+Headdauthor=N.+W.+Moriartyauthor=M.+Mustyakimovauthor=T.+C.+Terwilligerauthor=A.+Urzhumtsevauthor=P.+H.+Zwartauthor=P.+D.+Adams&title=Towards+automated+crystallographic+structure+refinement+with+phenix.refine&doi=10.1107%2FS0907444912001308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Towards automated crystallographic structure refinement with phenix.refine</span></div><div class="casAuthors">Afonine, Pavel V.; Grosse-Kunstleve, Ralf W.; Echols, Nathaniel; Headd, Jeffrey J.; Moriarty, Nigel W.; Mustyakimov, Marat; Terwilliger, Thomas C.; Urzhumtsev, Alexandre; Zwart, Peter H.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">352-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phenix.refine is a program within the PHENIX package that supports crystallog. structure refinement against exptl. data with a wide range of upper resoln. limits using a large repertoire of model parameterizations.  It has several automation features and is also highly flexible.  Several hundred parameters enable extensive customizations for complex use cases.  Multiple user-defined refinement strategies can be applied to specific parts of the model in a single refinement run.  An intuitive graphical user interface is available to guide novice users and to assist advanced users in managing refinement projects.  X-ray or neutron diffraction data can be used sep. or jointly in refinement. phenix.refine is tightly integrated into the PHENIX suite, where it serves as a crit. component in automated model building, final structure refinement, structure validation and deposition to the wwPDB.  This paper presents an overview of the major phenix.refine features, with extensive literature refs. for readers interested in more detailed discussions of the methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnhn9QwIEkTbVg90H21EOLACvtfcHk0lhFgxXkg2SqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Ggu7c%253D&md5=1cc7da2cea396f1a75646ea709140cf1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1107%2FS0907444912001308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444912001308%26sid%3Dliteratum%253Aachs%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DMustyakimov%26aufirst%3DM.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DTowards%2520automated%2520crystallographic%2520structure%2520refinement%2520with%2520phenix.refine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2012%26volume%3D68%26issue%3DPart%25204%26spage%3D352%26epage%3D367%26doi%3D10.1107%2FS0907444912001308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">The Phenix software for automated determination of macromolecular structures</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2011.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1016%2Fj.ymeth.2011.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=21821126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2011&pages=94-106&issue=1&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=S.+Jainauthor=G.+J.+Kapralauthor=R.+W.+Grosse+Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+D.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=The+Phenix+software+for+automated+determination+of+macromolecular+structures&doi=10.1016%2Fj.ymeth.2011.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The Phenix software for automated determination of macromolecular structures</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li-Wei; Jain, Swati; Kapral, Gary J.; Grosse Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert D.; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-106</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  X-ray crystallog. is a crit. tool in the study of biol. systems.  It is able to provide information that has been a prerequisite to understanding the fundamentals of life.  It is also a method that is central to the development of new therapeutics for human disease.  Significant time and effort are required to det. and optimize many macromol. structures because of the need for manual interpretation of complex numerical data, often using many different software packages, and the repeated use of interactive three-dimensional graphics.  The Phenix software package has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on automation.  This has required the development of new algorithms that minimize or eliminate subjective input in favor of built-in expert-systems knowledge, the automation of procedures that are traditionally performed by hand, and the development of a computational framework that allows a tight integration between the algorithms.  The application of automated methods is particularly appropriate in the field of structural proteomics, where high throughput is desired.  Features in Phenix for the automation of exptl. phasing with subsequent model building, mol. replacement, structure refinement and validation are described and examples given of running Phenix from both the command line and graphical user interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjdX_7M-NcLVg90H21EOLACvtfcHk0lhFgxXkg2SqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaqt73F&md5=ba8f207cab9f3597dc0c6db885667a3f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2011.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2011.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse%2BKunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%2BD.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DThe%2520Phenix%2520software%2520for%2520automated%2520determination%2520of%2520macromolecular%2520structures%26jtitle%3DMethods%26date%3D2011%26volume%3D55%26issue%3D1%26spage%3D94%26epage%3D106%26doi%3D10.1016%2Fj.ymeth.2011.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">Part 4</span>),  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=Part+4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhFgxXkg2SqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3DPart%25204%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span> <span> </span><span class="NLM_article-title">Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">Part 10</span>),  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1107/S0907444909029436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444909029436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=19770504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=1074-1080&issue=Part+10&author=N.+W.+Moriartyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adams&title=Electronic+Ligand+Builder+and+Optimization+Workbench+%28eLBOW%29%3A+a+tool+for+ligand+coordinate+and+restraint+generation&doi=10.1107%2FS0907444909029436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation</span></div><div class="casAuthors">Moriarty, Nigel W.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The electronic Ligand Builder and Optimization Workbench (eLBOW) is a program module of the PHENIX suite of computational crystallog. software.  It is designed to be a flexible procedure that uses simple and fast quantum-chem. techniques to provide chem. accurate information for novel and known ligands alike.  A variety of input formats and options allow the attainment of a no. of diverse goals including geometry optimization and generation of restraints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojnN4AVY_DwrVg90H21EOLACvtfcHk0licgk1tDjMcZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFKnsLnN&md5=3f9a9c6c31c9a4b014a9f151fb6aa8d9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909029436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909029436%26sid%3Dliteratum%253Aachs%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26atitle%3DElectronic%2520Ligand%2520Builder%2520and%2520Optimization%2520Workbench%2520%2528eLBOW%2529%253A%2520a%2520tool%2520for%2520ligand%2520coordinate%2520and%2520restraint%2520generation%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26issue%3DPart%252010%26spage%3D1074%26epage%3D1080%26doi%3D10.1107%2FS0907444909029436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">Part 1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&issue=Part+1&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0licgk1tDjMcZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3DPart%25201%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J','PDB','6V1J'); return false;">PDB: 6V1J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M','PDB','6V1M'); return false;">PDB: 6V1M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O','PDB','6V1O'); return false;">PDB: 6V1O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P','PDB','6V1P'); return false;">PDB: 6V1P</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UL8','PDB','5UL8'); return false;">PDB: 5UL8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4TZF','PDB','4TZF'); return false;">PDB: 4TZF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HBR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HBR','PDB','3HBR'); return false;">PDB: 3HBR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KO3','PDB','1KO3'); return false;">PDB: 1KO3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i65"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01976">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_40633"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01976?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01976</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Methods for synthesis and characterization data on all compounds except those in the main manuscript; HPLC, MS data, and structure assignments for oligomers of compound <b>4a</b>; crystallographic statistics for enzymes bound to compound <b>35</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and microbiological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_002.csv">CSV</a>)</p></li><li><p class="inline">Legend for data in molecular formula string table (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_001.pdf">jm9b01976_si_001.pdf (1.58 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_002.csv">jm9b01976_si_002.csv (5.51 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01976/suppl_file/jm9b01976_si_003.pdf">jm9b01976_si_003.pdf (127.09 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1J">6V1J</a> (KPC-2:QPX7728), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1M">6V1M</a> (NDM-1:QPX7728), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1O">6V1O</a> (OXA-48:QPX7728), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6V1P">6V1P</a> (VIM-2:QPX7728).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01976&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-14%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01976" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01976" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799285f3d1b3db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
